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It is now accepted that Schizophrenia, a neurodevelopmental disorder which affects around 
1% of the population, is influenced by both genetic and environmental risk factors. 
Schizophrenia is evidenced as being heritable with twin-heritability estimates of around 80%. 
Recently, the disorder has been demonstrated to be polygenic in nature; many genetic variants 
with individually small effects contribute to the overall phenotypic variation. Furthermore, 
cannabis use, adverse events, urbanicity, obstetric complications and migration, are five 
environmental risk factors that have been evidenced as being associated with an increased 
risk of developing the disorder. Abnormalities in brain structure are also well evidenced in 
individuals with schizophrenia, in particular, reduced cortical thickness, volume and surface 
area have been linked to those with schizophrenia when compared to healthy controls. It has 
been posited that these cortical alterations may predate disorder onset, for example, 
disruptions in brain development may be a function of experiencing schizophrenia-associated 
genetic and environmental risk factors. However, the link between genes, environment and 
brain structure within schizophrenia remains unclear. In this thesis, we aimed to examine 
whether genetic and environmental risk factors for schizophrenia directly impact cortical brain 
structure.  
 
Methods and Results 
The current aims were assessed using measures of cortical thickness, volume and surface 
area, as defined by FreeSurfer, in three separate studies. Firstly, ANCOVA models were 
applied to a case-control sample, the Scottish Family Mental Health (SFMH) study, 
ncontrols/npatients = 41/58) to determine whether PolyGenic Risk Scores for Schizophrenia 
(PGRS-SCZ) are associated with lower cortical thickness both globally and within regions of 
interest (frontal and temporal lobes) as well as to examine whether the effects of experiencing 
an accumulation of the five environmental risk factors (outlined above) is associated with 





was related to lower, global cortical thickness in the whole sample and not a result of group 
differences. With regards to environmental effects, the more environmental risk factors 
experienced, the lower the cortical thickness, this was specific to the temporal lobe. 
Secondly, to further investigate the link between environmental risk factors of schizophrenia, 
we focused on birth weight as a proxy for obstetric complications (Chapter Three). Linear 
mixed effects regression (LME) models were used to assess whether birth weight was 
associated with cortical thickness, surface area and volume in a UK Biobank (UKB) sample (n 
= 1,680). We then applied Mendelian Randomisation (MR) to determine if birth weight-
associated genetic variants were causally related to cortical structure. The results in this 
chapter suggested that higher weight at birth was associated with larger cortical volumes and 
surface area, both globally and in several cortical sub-regions. In contrast, a negative 
association was found between birth weight and cortical thickness in the lateral occipital 
parcel. MR analysis suggested a causal link of birth weight, as indexed by genetic variants, 
and insular lobe cortical volume as well as surface area globally, in the insular lobe and in 
middle temporal, medial orbitofrontal and inferior frontal gyrus parcels. 
Lastly, we tested whether the same association between PGRS-SCZ and cortical thickness 
(outlined in Chapter Two) could be replicated within a subset of UKB (Chapter Four). For this, 
we again utilised LME models using the second genetic data release of UKB (n = 2,864). We 
tested this globally, lobarly and within 27 bilateral cortical parcels for each of these parameters. 
We found a higher PGRS-SCZ to be associated with lower global cortical volume and 
thickness as well as insular lobe cortical thickness. To further test potential environmental 
influences (as outlined in Chapter Three) on these effects, we used a liner regression model 
to test for a relationship between PGRS-SCZ and birth weight as well as LME models to test 
for interactional effects. No relationship was found between PGRS-SCZ and birth weight nor 










Together, these studies highlight the fact that both genetic and environmental risk factors for 
schizophrenia may, indeed, directly but differentially impact cortical brain structure. This 
information may help us to further understand the progression of the disorder but also, by 
identifying and addressing these risk factors early, we may be able to minimise the impact that 
the disorder can have on cortical brain structure; particularly in relation to potentially modifiable 
factors, such as birth weight. We also highlight the importance of using large samples and 


























Schizophrenia is a major psychiatric disorder which affects around 1% of the population and 
is thought to be around 80% heritable. This disorder is characterised by a range of symptoms 
which can impact upon an array of behaviours such as; the way we think, our emotions and 
our perception. Perhaps the best-known symptom of schizophrenia is psychosis; where an 
individual may ‘hear voices’ or have delusions. Thus, (despite its low occurrence within the 
population) schizophrenia can have large detrimental impacts on lifestyle, is one of the most 
severe mental health disorders in terms of disability and can ultimately be a high global and 
economic burden. Despite the large amounts of research that have been conducted in relation 
to the symptoms of schizophrenia, we still know relatively little about a how a person develops 
the disorder. 
 
Genetic risk is thought to contribute to the development of schizophrenia. More recently, 
researchers have found evidence to suggest that schizophrenia is polygenic in nature. This 
means there are many genetic variants, each with small effects, that contribute to the 
development of the illness. These genetic variants, both common and uncommon, have been 
identified more often in individuals who have schizophrenia compared to healthy controls 
therefore, it has been possible to develop a score (known as a PolyGenic Risk Score; PGRS) 
which can be used to distinguish between schizophrenia patients and controls in many 
samples. Using this information, we can also determine whether individuals who possess more 
of these genetic risk variants are more likely to demonstrate other symptoms or brain 
abnormalities. This information may, in turn, help us to determine whether these symptoms or 
abnormalities predate the disorder and thus, can potentially be prevented. However, these 
scores have not been thoroughly tested for associations with variations in cortical brain 
structure. 
 
Although these kinds of genetic advances will prove crucial in our ability to more accurately 





genetics alone cannot fully explain the cause of schizophrenia and thus, environmental factors 
must also be considered. Several environmental risk factors for schizophrenia have been 
identified. The most compelling evidence suggests that cannabis use, migration, growing up 
in an urban as opposed to rural environment, obstetric complications and experiencing 
adverse life events are all connected with an increased risk of schizophrenia. What remains 
unclear is whether these factors are directly associated with the cortical brain structure deficits 
that are also demonstrated in individuals with schizophrenia. 
 
This thesis, examines the relationship between genetic and environmental risk factors for 
schizophrenia and how they impact cortical brain structure. Chapter Two suggests that both 
experiencing an accumulation of environmental risk factors and genetic risk factors for 
schizophrenia are directly associated with the thickness of the cortex (the distance between 
the white matter boundary and the brain surface) but in different ways. An increased genetic 
risk for schizophrenia was associated with global deficits in cortical thickness whereas, 
environmental risk factors impact more specific parts of the brain and only in patients.  
 
Chapter Three examines associations between birth weight (a factor with both genetic and 
environmental components) and cortical thickness, surface area and volume. Birth weight was 
used as a proxy for the schizophrenia risk factor - obstetric complications. This chapter 
highlights that birth weight is, indeed, associated with all three of the tested cortical 
parameters, to varying degrees. After using a genetic analysis method to determine whether 
these associations between birth weight and cortical structure were causal, this chapter also 
suggests that there is indeed a causal link between birth weight, as measured using genetic 
variants, and several cortical volume and surface area regions.  
 
In Chapter Four, we replicate the association between genetic risk for schizophrenia and 
cortical thickness (as outlined in Chapter Two), in a much larger sample (n = 2,864). We also 
found an additional effect whereby higher genetic loading for schizophrenia was related to 





Data’ in order to find robust results. Furthermore, building upon findings from Chapter Three, 
we also tested whether consideration of birth weight would affect these results. However, we 
found no link between PGRS-SCZ and birth weight nor did we find any evidence of birth weight 
and PGRS-SCZ interactions within the aforementioned regions. 
 
Together, these results suggest that both genetic and environmental risk factors for 
schizophrenia can impact upon brain structure, meaning that these factors may contribute to 
brain deficits associated with schizophrenia and may, potentially, predate the disorder. This 
information may help us to further understand the causation of the disorder but could also 
inform intervention; by identifying and addressing these risk factors early, we may be able to 
minimise potential damage to the brain in relation to schizophrenia, particularly when 
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Review of the Cortical Brain Structure Abnormalities Associated 
with Schizophrenia and Their Links with Polygenic and 
Environmental Risk Factors 
 
1.1 Introduction  
Schizophrenia is a chronic and debilitating psychiatric disorder which often manifests in 
adolescence or early adulthood (Bois et al., 2015a, Gogtay et al., 2011, Jablensky, 1997, 
Weinberger, 1987). Whilst the disorder is characterised by a multifaceted symptomatology, 
common symptoms include; positive symptoms (such as hallucinations, delusions and thought 
disorders), negative symptoms (such as social withdrawal and emotional blunting) (Picchioni 
and Murray, 2007) and cognitive impairments (Heinrichs, 2005). Schizophrenia is associated 
with an aberrant neurodevelopmental trajectory (Rapoport et al., 2012, Rapoport et al., 2005a, 
Weinberger, 1987) and poor prognosis (Volavka and Vevera, 2018, Bois et al., 2015a,) 
however, recent studies suggest that early detection and treatment, are associated with better 
clinical outcomes (Zipursky et al., 2018, Hegelstad et al., 2012, Lawrie et al., 2011, Henry et 
al., 2010). A recent paradigm shift from a neurodevelopmental perspective towards a 
‘Developmental Risk Factor Framework’ places schizophrenia on the negative extreme of a 
psychosis spectrum on which risk factors can impact both before and after development 
(Murray et al., 2017). This framework suggests both that there are a range of risk factors that 
can be considered in relation to brain structure and that, based on an understanding of these, 
interventions could be successfully devised and applied at more than one developmental time 
point (Murray et al., 2017). However, further research is needed in order to help us fully 
understand the relationship between schizophrenia risk and cortical structure and is thus, the 
focus of the current thesis.  
 
In utilising a range of neuroimaging and genetic methodologies, progress has been made in 
determining putative risk factors for the development of schizophrenia. To illustrate, family 
studies suggest the disorder is highly heritable (h2 ~80%; Boos et al., 2007), with first- and 





developing it (Byun et al., 2012, Johnstone et al., 2005, Keshavan et al., 2004, Johnstone et 
al., 2000). Moreover, it involves numerous brain structure abnormalities which precede 
disorder onset, with evidence of further abnormalities as the disorder progresses (Boos et al., 
2007). However, inconsistencies regarding the nature and timing of structural neuroimaging 
findings make it difficult to determine the underlying causes for cortical alterations (Bois et al., 
2015a). A potential reason for this may be lack of consideration for environmental risk factors. 
Historically, researchers have found environmental causes for schizophrenia less compelling 
than genetic causes (Dean and Murray, 2005), although recent evidence suggests that 
environmental risk factors, as well as gene × environment (G×E) interactions, are important in 
schizophrenia aetiology (Murray et al., 2017, Karl and Arnold, 2014, Stepniak et al., 2014, Stilo 
and Murray, 2010, Dean and Murray, 2005). Thus, a more comprehensive investigation into 
how the interplay between genetic and environmental risk factors directly relate to cortical 
abnormalities in schizophrenia is still required.  
 
The aim of this chapter is to provide a selective overview of current cortical structural imaging 
studies of schizophrenia, determine genetic and environmental risk factors identified for the 
disorder and, finally, outline how these factors may impact upon cortical structure. The 
importance of understanding the relationship between these three factors will be outlined, and 
how, in so doing, a more comprehensive understanding of the underlying causes of the 
disorder and potential interventions may be reached. This chapter will focus on cortical 
findings, from structural neuroimaging studies, associated with schizophrenia using three 
major cortical parameters; cortical volume (CV), thickness (CT) and surface area (SA). In 
addition, this chapter will outline the methodological considerations for employing both small 
case-control designs and large population-based cohorts to test for these relationships. 
 
The three cortical parameters considered in this review are defined as follows: CT, thickness 
(mm) between the white matter and pial surface averaged over all vertices; SA (mm2), the sum 
of the number of vertices in each region; and CV, which is a product of both SA and CT (mm3)  








Fig. 1.1 Image demonstrating how cortical parameters CV, CT and SA are measured Image from 
(Wierenga et al., 2014) 
 
The current review focuses on these three cortical metrics as they have been previously 
associated with cognitive functioning as well as a number of neurodevelopmental disorders, 
including schizophrenia, (Lee et al., 2016, Lyall et al., 2015). Furthermore, they have been 
previously asserted as appropriate metrics for investigation of the genetic relationship between 
schizophrenia and the brain (Lee et al., 2016). A vast amount of evidence suggests that 
variations in these cortical metrics are heritable; h2 ranges from 66-97% for regional CV (Peper 
et al., 2007) and averages around 80% for global CV (Kremen et al., 2010, Wright et al., 2002), 
81% for CT (Panizzon et al., 2009) and 89% for SA (Panizzon et al., 2009). However, the 
developmental trajectories of these measures are complex and not fully understood. It is 
established that CT and SA follow distinct, unique trajectories from both CV and each other 
(Wierenga et al., 2014). SA development peaks after CT but findings differ on the age in which 
this is achieved (Lyall et al., 2015, Wierenga et al., 2014, Shaw et al., 2012, Shaw et al., 2007). 
Despite the uncertainty of specific peak development timings, the most critical period for 
growth appears to be in the first two years of life, when all three parameters are highly 
susceptible to genetic and environmental insults (Lyall et al., 2015). Additionally, decreases 
with age in these three metrics have been reported in studies of adolescence (7-29 years) 
(Tamnes et al., 2017) and older age (18-87 years) (Lemaitre et al., 2012). CT has been linked 





the more rapid development occurring in early childhood (Lee et al., 2016). Therefore, 
investigating the associations between these three cortical structure metrics and the genetic 
and environmental risk factors for schizophrenia may be essential to fully understand the 
aetiology and development of schizophrenia.  
 
1.2 Cortical Structure and Schizophrenia 
1.2.1 Cortical Volume Regarding schizophrenia-associated abnormalities in cortical 
structure, CV (compared to CT and SA) has, historically, been the most studied cortical metric. 
Early reports describe decreased whole brain and hippocampal volume and increased lateral 
ventricles in schizophrenia (Harrisberger et al., 2016, Goldman et al., 2008, Shenton et al., 
2001, Wright et al., 2000, Lawrie and Abukmeil, 1998) with more recent findings reporting 
widespread cortical volume reductions in patients compared to controls (Kong et al., 2015, 
Gupta et al., 2015, Rimol et al., 2012, Gutiérrez-Galve et al., 2010, Ellison-Wright and 
Bullmore, 2010, Goldman et al., 2008, Honea et al., 2008, Goghari et al., 2007, Honea et al., 
2005), see Table 1.1.  
Studies of unaffected relatives of individuals with schizophrenia have also been used to inform 
this relationship as they can help determine if structural differences can be linked with a genetic 
liability for the disorder, avoiding confounds such as secondary effects of illness or 
antipsychotic medication (Lawrie et al., 2001). Some of these familial studies have found 
smaller global and/or regional CV in healthy relatives of individuals with schizophrenia, when 
compared to controls (Boos et al., 2007, Goghari et al., 2007, Cannon et al., 2002a) whereas, 
other studies have found no significant differences (Goldman et al., 2008, Honea et al., 2008) 
despite finding a similar pattern of deficit in both disordered individuals and their relatives 
(Honea et al., 2008). However, these studies used voxel-based morphometry methods (see 
Table 1.1) which have been traditionally criticised for their sensitivity to image registration 
procedures (Voets et al., 2008). Furthermore, as CV is the product of CT and SA (Wierenga 
et al., 2014, Jalbrzikowski et al., 2013, Panizzon et al., 2009)  investigation of all three of these 
metrics is required to reach a full understanding of the relationship between schizophrenia and 





Table 1.1 A selective overview of results from relative and non-relative studies investigating the link between cortical volume and schizophrenia 
along with sample sizes and age ranges 
Cortical Volume 
Author  
(Year of Publication) 
Study Type Sample Size 
(Age Range, Mean, S.D) 
Methodology  Result  
Gupta et al. (2015) Mega-analysis SCZ = 784 (18-64, NA, NA),  
HC = 936 (13-68, NA, NA) 
SBM and VBM on 
GMC images 
SCZ ↓ widespread GMC loss: 
most prominent in STG, inferior 
frontal gyrus and medial frontal 
cortex 
SCZ ↑ brain stem and cerebellum 
Kong et al. (2015) Meta-analysis SCZ = 22 (NA, 53.95 ±8.53),  




SCZ ↓ widespread; most 
prominent in frontal and temporal 
regions but occipital and insular 




Meta-analysis SCZ = 2,058 (NA, NA, NA) 
HC = 2,131 (NA, NA, NA) 
VBM SCZ ↓ GM in frontal, temporal, 
cingulate, insular cortex and 
thalamus 
SCZ ↑ basal ganglia 
Wright et al. (2000)* Meta-analysis SCZ = 1,588 (NA),  
Comparison Subjects (related and 
non-related) = 1,783 (NA) 
VBM/SBM SCZ ↓ global cerebral volume 
and medial temporal lobe 
SCZ ↑ total ventricular volume 
Rimol et al. (2012) Cross-sectional SCZ = 173 (NA, 32.3 ±9.0),  
HC = 207 (NA, 35.0, ±11.2) 
SBM, FreeSurfer SCZ ↓ widespread reductions in 
frontal, temporal, occipital and 
parietal regions 






SCZ (drug naive) = 26 (NA, 26.4 
±6.7),  
HC = 34 (NA, 25.2 ±6.2) 
 
Manual trace No differences in CV 
Gutiérrez-Galve et al. 
(2010) 
Cross-sectional  SCZ = 37 (16-49, 26.8 ±8.8),  
HC = 38 (16-37, 25.0 ±5.4) 
 
SBM, FreeSurfer No global differences in CV SCZ 
↓ temporal lobe 
 
RELATIVE STUDIES 





Relatives = 1,065 (NA),  
HC = 1,100 (NA) 
Relatives ↓ total GM volume 
compared to HC 
Ziermans et al. (2012) Longitudinal HR[ill] = 8 (NA, 16.8* ±2.2), 
HR[well] = 35 (NA, 15.3* ±2.1), 
HC = 30 (NA, 15.9* ±1.4) 
SBM/VBM No differences in total brain or 
GM  
 
Brans et al. (2008) Longitudinal, Twin 
Study 
Discordant SCZ twin pairs –  
MZ SCZ = 9, MZ healthy = 9  
(NA, 40.2 ±12.2),  
DZ SCZ = 10, DZ healthy = 10  
(NA, 37.1 ±11.9),  
HC twin pairs –  
MZ 1 = 14, MZ 2 = 14   
(NA, 35.5 ±11.8),  
DZ 1 = 13, DZ 2 = 13  
 (NA, 35.4 ±10.6) 
SBM SCZ and unaffected co-twins ↓ 
global, frontal and temporal lobe 
compared to HC 
Goldman et al. (2008) Cross-sectional SCZ = 169 (17.83-61.63, 36.48 
±10.13),  
SIBS = 183 (17.37-58.25, 36.83 
±9.60),   
HC = 221 (18.39-60.86, 32.82 ±9.51), 
VBM SCZ ↓ global GM 
SCZ ↑ total ventricular volume 
No differences in SIBS compared 
to HC 
Honea et al. (2008) Cross-sectional SCZ =169 (NA, 36.39 ±9.46),  
SIBS = 213 (NA, 36.5 ±9.75),  
HC =212 (NA, 33.1 ±9.86) 
VBM SCZ ↓ GM in frontal, temporal 
and parietal cortices compared to 
HC 
SIBS (nominal) ↓ medial frontal, 
STG and insular cortices 
Goghari et al. (2007) Cross-sectional Relatives = 19 (NA, 34.1 ±8.4),  
HC = 22 (NA, 34.2 ±1.1) 
SBM, FreeSurfer Relatives ↑ left global 
Relatives ↓ right cingulate gyrus 
Relatives ↑ bilateral 
parahippocampal gyri, left middle 
temporal lobe 
* = studies defined as containing ‘Big Data’ (> 1,000 Smith & Nichols, 2018), S.D = standard deviation, SCZ = schizophrenia, HC = healthy controls, SIBS 
= healthy siblings of individuals with schizophrenia, MZ = monozygotic, DZ = dizygotic, NA = age range not documented, VBM = voxel-based 






1.2.2 Cortical Thickness Lower CT in schizophrenia is associated with both specific brain 
regions (Kong et al., 2015, van Haren et al., 2011, Hartberg et al., 2011, Rimol et al., 2010, 
Fornito et al., 2008) and in widespread patterns across the cortex (Kong et al., 2015, Crespo-
Facorro et al., 2011, Rimol et al., 2010, Yang et al., 2010, Goghari et al., 2007, Narr et al., 
2005); resulting in global alterations. These deficits most consistently occur in the frontal and 
temporal lobes (Kong et al., 2015, van Haren et al., 2011, Rimol et al., 2010, Yang et al., 2010, 
Goldman et al., 2009, Nesvåg et al., 2008, Narr et al., 2005, Kuperberg et al., 2003). A similar 
pattern of results has also been evidenced in individuals at familial high-risk of schizophrenia 
when compared to healthy controls (Bois et al., 2015b, Byun et al., 2012, Jung et al., 2011, 
Goghari et al., 2007) and schizophrenia patients (Byun et al., 2012, Jung et al., 2011, Goldman 
et al., 2009), see Table 1.2.  
Clinically, both the frontal and temporal lobes have been implicated in the emergence of 
psychotic symptoms. Specifically, cortical thinning in the middle and superior temporal gyri 
have been linked to the development of auditory verbal hallucinations (Cui et al., 2018, Oertel-
Knöchel et al., 2013) and other positive symptoms (Walton et al., 2017), whereas lower CT in 
the frontal cortex has been related to negative symptoms (Walton et al., 2018) subjective 
cognitive dysfunction (Oertel-Knöchel et al., 2013) and disrupted verbal working memory 
(Guimond et al., 2016). Furthermore, there is evidence to suggest that these relationships are 
moderated by symptom severity (Guimond et al., 2016). As such, frontal and temporal CT 
could be particularly important neuroimaging markers upon which we could assess the 
potential impact of environmental risk factors for schizophrenia as well as measure the 





Table 1.2 A selective overview of results from relative and non-relative studies investigating the link between cortical thickness and 
schizophrenia along with sample sizes and age ranges 
Cortical Thickness 
Author  
(Year of Publication) 
Study Type Sample Size 
(Age Range, Mean, S.D) 
Method Result 
Kong et al. (2015) Meta-analysis SCZ = 22 (NA, 53.95 ±8.53),  
HC = 20 (NA, 52.75 ±8.10) 
 
VBM, SBM SCZ ↓ widespread: including 
temporal, frontal insular and 
occipital regions  
 
van Haren et al. (2011) Longitudinal  SCZ = 96 (16.88-56.25, 32.22 ±11.10)*1
HC = 113 (16.75-56.27, 35.28 ±12.25)*1
SBM No global differences 
SCZ ↓left orbitofrontal, right STG 
and parahippocampal gyrus 
SCZ ↑ superior parietal lobule 
and occipital pole 




SCZ (drug naive) = 26 (NA, 26.4 ±6.7), 




SCZ ↓ global, frontal, temporal, 
parietal and occipital cortices 
Hartberg et al. (2011) Cross-sectional  SCZ = 117 (NA, 31.7 ±7.9), 
HC = 192 (NA, 36.1 ±9.6) 
SBM, FreeSurfer SCZ ↓ right caudal and rostral 
middle frontal and fusiform, left 
middle temporal 
Gutiérrez-Galve et al. 
(2010) 
Cross-sectional  SCZ = 37 (16-49, 26.8 ±8.8),  
HC = 38 (16-37, 25.0 ±5.4) 
 
SBM, Freesurfer No global differences 
SCZ ↓ right STG  
Rimol et al. (2010) Cross-sectional SCZ = 173 (NA, 32.3 ±9.0),  
HC = 207 (NA, 36.2, ±9.7) 
SBM, FreeSurfer SCZ ↓widespread; most 
prominent in lateral and medial 
frontal lobes (including ACC) and 
temporal lobes 
Fornito et al. (2008) Cross-sectional SCZ = 40 (NA, 22.29 ±3.22), 
HC = 40 (NA, 21.66 ±3.22) 
SBM, FreeSurfer SCZ ↓ ACC 
Nesvåg et al. (2008) Cross-sectional SCZ = 96 (25-57, 42.1 ±7.3), 
HC = 107 (19-56, 41.6 ±9.0) 
SBM, FreeSurfer SCZ ↓ prefrontal and temporal 
cortex 
Narr et al. (2005) Cross-sectional SCZ = 72 (NA, 25.1 ±4.7), 
HC = 78 (NA, 27.3 ±6.6) 
SBM, manual 
trace 
SCZ ↓supragenual anterior and 





occipital regions in the medial 
cortex 
Kuperberg et al. (2003) Cross-sectional SCZ = 32 (NA, 39 ±11), 
HC = 32 (NA, 40 ±10) 
SBM, FreeSurfer SCZ ↓ temporal and prefrontal 
lobes 
RELATIVE STUDIES 
Bois et al (2015a) Longitudinal 
 
HR[ill] = 17 (16-23, 20 ±.40 a),  
HR[symp] = 57 (16-26, 21 ±.29 a), 
HR[well] = 68 (16-27, 22 ±.2 a),  
HC = 36 (16-26, 21 ±.28 a) 
SBM, FreeSurfer No global difference between all 
HR groups together and HC 
No global differences within the 
HR cohort 
Sprooten et al. (2013) Longitudinal 
 
SCZ = 34 (NA, 21.59 ±3.63), 
HR = 144 (NA, 21.19, ±3.01), 
HC = 36 (NA, 21.17 ±2.37) 
SBM, FreeSurfer SCZ ↓ global: most prominent in 
frontal, parietal, supramarginal 
and lateral occipital cortices 
compared to HR and HC 
HR ↓left middle temporal cortex 
compared to HC 
Ziermans et al. (2012) Longitudinal HR[ill] = 8 (NA, 16.8 ±2.2), 
HR[well] = 35 (NA, 15.3 ±2.1), 
HC = 30 (NA, 15.9 ±1.4) 
SBM/VBM HR[ill] ↓ widespread compared to 
HC including: ACC, precuneus, 
temporo-parieto-occipital regions 
HR[well] no differences 
compared to HC 
Hedman et al. (2016) Cross-sectional Discordant SCZ twin pairs –  
MZ SCZ = 9, MZ healthy = 9  
(NA, 40.2 ±12.2),  
DZ SCZ = 10, DZ healthy = 10  
(NA, 37.1 ±11.9),  
HC twin pairs –  
MZ 1 = 14, MZ 2 = 14   
(NA, 35.5 ±11.8),  
DZ 1 = 12 (NA, 34.0 ±9.9),  
DZ 2 = 12 (NA, 36.3 ±10.6) 
SBM  Discordant SCZ twin pairs ↓ 
global and STG compared to HC 
 
Byun et al. (2012) Cross-sectional SCZ = 31 (NA, 24.26 ±4.24), 
HR = 31 (NA, 22.61 ±5.47), 
HC = 29 (NA, 22.61 ±5.47) 
SBM SCZ ↓ widespread compared to 
HC, including: ACC, medial 
frontal, insula, temporal and 





HR ↓ widespread compared to 
HC, including: frontal, temporal, 
parietal and occipital and ACC 
regions 
SCZ ↓ compared to HR: ACC, 
frontal and lateral orbitofrontal 
and anterior temporal regions  
SCZ ↑ compared to HR: occipital, 
medial and inferior temporal 
areas and orbitofrontal cortex 
Jung et al. (2011) Cross-sectional SCZ = 31 (NA, 24.26 ±4.24), 
HR = 29 (NA, 22.24 ±4.33), 
HC = 29 (NA, 23.24 ±2.71) 
SBM SCZ ↓ widespread areas 
compared to HC including: 
superior frontal, inferior parietal 
and frontal, STG, ACC 
SCZ ↓ compared to HR, 
including: 
STG, superior and medial frontal, 
inferior temporal and parietal and 
ACC and insular regions 
HR ↓ widespread compared to 
HC, including: ACC, medial and 
inferior frontal prefrontal, STG 
and inferior parietal regions 
Gradual decreases could be 
found according to psychotic 
stages - HC > HR > SCZ  
Yang et al. (2010) Cross-sectional SCZ = 48 (NA, 31.8 ±9.0), 
SCZ SIBS = 24 (NA, 31.8 ±13.3), 
SCZ parents = 42 (NA, 55.6 ±9.6), 
HC = 27 (NA, 26.4 ±7.1), 
HC SIBS = 38 (NA, 26.9 ±9.4), 
HC parents = 39 (NA, 56.1 ±8.0), 
SBM SCZ ↓total GM volume compared 
to HC 
SCZ ↓ global CT compared to HC 
SCZ ↓global CT compared to 
SCZ relatives 
SCZ relatives no difference in 






Goldman et al. (2009) Cross-sectional SCZ = 115 (18.81-61.63, 37.39 
±10.46), 
SIBS = 192 (17.49-58.25, 37.49 ±9.77), 
HC = 196 (18.39-60.86, 33.51 ±9.67) 
SBM SCZ ↓ global compared to HC, 
most prominent: frontal lobe 
SCZ ↓ global compared to SIBS 
No differences in SIBS compared 
to HC 
Goghari et al. (2007) Cross-sectional Relatives = 19 (NA, 34.1 ±8.4),  
HC = 22 (NA, 34.2 ±1.1) 
SBM, FreeSurfer No global differences 
Relatives ↓ bilateral cingulate 
lobe 
S.D = standard deviation, SCZ = schizophrenia, HC = healthy controls, SIBS = healthy siblings of individuals with schizophrenia, MZ = monozygotic, DZ 
= dizygotic, NA = age range not documented, VBM = voxel-based morphometry,SBM = surface-based morphometry, HR[ill] = Individuals at familial high-
risk (HR) who subsequently developed schizophrenia, HR[symp] = Individuals at familial high-risk (HR) who subsequently presented only isolated 
symptoms but were not diagnosed with schizophrenia, HR[well] = Individuals at familial high-risk (HR) who remained well, ACC = anterior cingulate 
















1.2.3 Cortical Surface Area SA schizophrenia associations have received less empirical 
attention and existing studies report inconsistent findings (Gutiérrez-Galve et al., 2010). Whilst 
some evidence suggests cortical SA is lower in schizophrenia patients compared to controls 
both globally (Palaniyappan et al., 2011) and in specific regions (Rimol et al., 2012, 
Palaniyappan et al., 2011, Hartberg et al., 2011, Gutiérrez-Galve et al., 2010), others report 
SA to be higher (Bois et al., 2015b, Fornito et al., 2008) or no difference (Hedman et al., 2016, 
Crespo-Facorro et al., 2011) between these groups, see Table 1.3. Investigation into SA and 
genetic schizophrenia associations have been equally limited (Panizzon et al., 2009) and 
inconsistent. Lower cingulate and superior temporal SA, contrasting with increases in 
parahippocampal and middle temporal SA has been evidenced in unaffected relatives 
compared to controls (Goghari et al., 2007). Conversely, increased global, but not regional, 
SA has been reported in at-risk individuals (Bois et al., 2015b), although Hedman et al. (2016) 
provided no evidence of SA genetic liability. Further studies are required to fully explore the 














Table 1.3 A selective overview of results from relative and non-relative studies investigating the link between cortical surface area and 
schizophrenia along with sample sizes and age ranges 
Cortical Surface Area 
Author  
(Year of Publication) 
Study Type Sample Size 
(Age Range, Mean, S.D) 
Method Result 
Rimol et al. (2012) Cross-sectional SCZ = 173 (NA, 32.3 ±9.0),  
HC = 207 (NA, 35.0, ±11.2) 
SBM, FreeSurfer SCZ ↓ some reductions in frontal, 
temporal, occipital and parietal 
regions 




SCZ (drug naive) = 26 (NA, 26.4 
±6.7),  
HC = 34 (NA, 25.2 ±6.2) 
 
Manual trace SCZ ↓ right straight gyrus and left 
orbitofrontal cortex 
Hartberg et al. (2011) Cross-sectional  SCZ = 117 (NA, 31.7 ±7.9), 
HC = 192 (NA, 36.1 ±9.6) 
SBM, FreeSurfer SCZ ↓ widespread frontal and 
temporal regions 
Palinyappan et al. (2011) Cross-sectional SCZ = 57 (19-47, 26.10 ±7.49), 
HC = 41 (18-44, 28.04 ±6.63) 
SBM, FreeSurfer SCZ ↓ global particularly in 
several clusters of the left 
hemisphere 
Gutiérrez-Galve et al. 
(2010) 
Cross-sectional  SCZ = 37 (16-49, 26.8 ±8.8),  
HC = 38 (16-37, 25.0 ±5.4) 
 
SBM, FreeSurfer SCZ ↓ temporal lobe 
 
Fornito et al. (2008) Cross-sectional SCZ = 40 (NA, 22.29 ±3.22), 
HC = 40 (NA, 21.66 ±3.22) 
SBM, FreeSurfer SCZ ↑ ACC 
RELATIVE STUDIES 
Bois et al (2015a) Longitudinal 
 
HR[ill] = 17 (16-23, 20 ±.40 a),  
HR[symp] = 57 (16-26, 21 ±.29 a), 
HR[well] = 68 (16-27, 22 ±.25 a),  
HC = 36 (16-26, 21 ±.28 a) 
 
SBM, FreeSurfer No difference between all HR 
groups together and HC 
HR[ill] ↑ global compared to 
HR[well] 
Trend ↑ HR[symp] global 
compared to HR[well] 
Hedman et al. (2016) Cross-sectional Discordant SCZ twin pairs –  
MZ SCZ = 9, MZ healthy = 9  
(NA, 40.2 ±12.2),  
DZ SCZ = 10, DZ healthy = 10  
(NA, 37.1 ±11.9),  
SBM  discordant SCZ twin pairs no 







HC twin pairs –  
MZ 1 = 14, MZ 2 = 14   
(NA, 35.5 ±11.8),  
DZ 1 = 12 (NA, 34.0 ±9.9),  
DZ 2 = 12 (NA, 36.3 ±10.6) 
Goghari et al. (2007) Cross-sectional Relatives = 19 (NA, 34.1 ±8.4),  
HC = 22 (NA, 34.2 ±1.1) 
SBM, FreeSurfer Relatives ↑ left global 
Relatives ↓ right cingulate gyrus 
and STG 
Relatives ↑ bilateral 
parahippocampal gyri, left middle 
temporal lobe 
S.D = standard deviation, ACC = anterior cingulate cortex, SCZ = schizophrenia, HC = healthy controls, SIBS = healthy siblings of individuals with 
schizophrenia, MZ = monozygotic, DZ = dizygotic, NA = age range not documented, VBM = voxel-based morphometry, SBM = surface-based 
morphometry, HR[ill] = Individuals at familial high-risk (HR) who subsequently developed schizophrenia, HR[symp] = Individuals at familial high-risk (HR) 
who subsequently presented only isolated symptoms but were not diagnosed with schizophrenia, HR[well] = Individuals at familial high-risk (HR) who 









Thus, current reports suggest that there is evidence of alterations in all three of these cortical 
metrics which can be linked to schizophrenia, most consistently for global, frontal and temporal 
CV and CT. Frontal and temporal CT in particular has been related to schizophrenia 
symptomatology and therefore may signpost a potential mechanism by which to explore 
schizophrenia risk. These regions will be given specific attention in Chapter Two.  
Furthermore, cortical alterations have been consistently evidenced in individuals at risk of 
developing schizophrenia and highlighted as potential, important markers for detecting 
susceptibility to the disorder (Bois et al., 2015a, Lawrie et al., 2011). Thus, suggesting that 
these metrics will also be suitable for exploring the relationship between cortical structure and 
genetic risk for schizophrenia. 
 
1.3 Cortical Structure and Genetic High-Risk for Schizophrenia  
Comparing individuals at genetic or familial high-risk for schizophrenia to those who have 
already developed it and healthy controls allows researchers to determine if there are 
schizophrenia-associated cortical alterations apparent before disorder onset and can aid in 
efforts to detect schizophrenia earlier (Bois et al., 2015a). Longitudinal studies have 
highlighted a similar pattern in CV and CT as cross-sectional results; decreased global, frontal 
and temporal CV in patients compared to controls (Brans et al., 2008) and, widespread cortical 
thinning in schizophrenia patients and familial high-risk groups compared to controls (Sprooten 
et al., 2013, Ziermans et al., 2012). However, Bois et al. (2015b) found no evidence of SA 
alterations in familial high-risk groups compared to healthy volunteers. This type of evidence 
suggests that cortical alterations associated with schizophrenia can become worse as 
symptoms develop and thus, highlight potentially important stages for interventions that could 
help to limit these cortical deficits. However, due to the limited number of studies and the 
relatively small sample sizes and heterogeneity associated with them (see Tables 1.1-3), 
further investigation is required before this type of information can be incorporated into a 
clinical framework (Bois et al., 2015a). Furthermore, these types of methods cannot be utilised 






1.3.1 Methodological Considerations 
Neuroimaging samples are traditionally modest in size (n < 50; Smith and Nichols, 2018). In 
the literature referenced up to this point, sample cohort sizes range from 26 to 207 (excluding 
meta-analyses) with a mean of 91. Furthermore, family-based neuroimaging studies typically 
have even smaller sample sizes (current n range = 8-221, mean = 53), resulting from the 
necessity to investigate participants with familial relationships. However, the findings from 
these samples have been invaluable in developing our understanding of the cortical deficits 
associated with disorder and have the advantage of deep phenotyping (Gershon et al., 2018). 
Additionally, smaller samples are more practically achievable in terms of resources (e.g 
money, time, personnel, availability) (Monteith et al., 2015). But, being able to test these 
associations in larger samples, and with genetic instruments which require such sizes, would 
allow for opportunities to replicate findings as well as increase statistical power to detect 
smaller effects (Smith and Nichols, 2018). As such, both small and large sample studies are 
required and could be complimentary of one another. 
 
Recently, efforts have been made to increase neuroimaging and genetics sample sizes using 
‘Big Data’ ( > 1,000) (Smith and Nichols, 2018). One approach is to use multi-site, world-wide 
collaborations. A recent case-control study by ENIGMA (Enhancing Neuro Imaging Genetics 
through Meta-Analysis: http://enigma.ini.usc.edu/), which included 4,474 individuals with 
schizophrenia and 5,098 healthy volunteers, found those with schizophrenia to have 
significantly thinner cortices (particularly in frontal and temporal regions) as well as lower 
global SA, when compared to controls (van Erp et al., 2018). Furthermore, van Erp et al. (2018) 
found these regional deficits to be associated with symptom severity. This publication offers 
evidence, from the largest cohort to date, and replicates the consistently reported finding of 
lower frontal and temporal CT in schizophrenia. However, an inevitable limitation of this 
approach is the inability to completely control for disparities in sample variables across sites, 
e.g. differences in scanners, recruitment methods, clinical assessments etc. (van Erp et al., 
2018). Resources such as UK Biobank (UKB) will be necessary to fully control for such 






UKB is a population-based sample which aims to collect 100,000 neuroimaging scans in 
individuals aged 40-69, utilising a single scanner and the same analysis pipeline 
(http://www.ukbiobank.ac.uk/). From the perspective of the current thesis, this sample will be 
useful in terms of identifying effects of risk factors for schizophrenia within the general 
population. Furthermore, as the ‘Developmental Risk Factor Model’ of psychosis suggests that 
the same factors which contribute to the risk of schizophrenia will also contribute to the 
potential risk of more minor symptoms in the general population (Murray et al., 2017), 
researchers could expect a similar effect on cortical structure. Currently available data from 
the UKB sample is thus analysed in the current thesis (Chapters Three and Four) in order to 
both, determine if replication of effects found using a case-control sample (Chapter One) can 
be achieved, and identify risk factors that may be neurodevelopmentally detrimental for the 
general population. Further reasons for analysing this UKB subset include; ability to avoid the 
mentioned confounds of meta-analysis research (e.g. scanner variations and recruitment 
inconsistencies) as well as the opportunity to test for cortical associations in an age range that 
is currently underrepresented in schizophrenia imaging research (Kong et al., 2015). However, 
when using a population-based sample, alternative methods will need to be utilised to 
determine the participants’ genetic liability for schizophrenia. One such method is the recently 
developed PolyGenic Risk Scores (PGRS) (Dudbridge, 2013). 
 
 
1.3.2 Polygenic Risk Scores for Schizophrenia 
Genome Wide Association Studies (GWAS) have been utilised to identify disorder-associated 
genetic variants (SWG-PGC, 2014). GWAS have indicated that schizophrenia risk is likely 
determined by a large number of common allelic variations of small effect rather than specific 
susceptibility loci (Lee et al., 2012, Matheson et al., 2011, Gejman et al., 2010), which has led 
to the development of PGRS. To calculate PGRS for schizophrenia (PGRS-SCZ), 
schizophrenia-associated variants are first identified using a ‘discovery’ sample. The most 





loci using 36,989 schizophrenia cases and 113,075 controls (SWG-PGC, 2014). These pre-
identified variants are then found in an independent target sample, are weighted by their effect 
sizes in the discovery sample and summed across each individual genome (Dudbridge, 2013). 
PGRSs are thus used as a measure of genetic liability associated with a particular phenotype 
or disorder (Lewis and Vassos, 2017, Wray et al., 2014). For a PGRS-SCZ; the higher the 
PGRS-SCZ, the higher the risk of developing schizophrenia. These scores can, and are most 
commonly used, to predict case-control status in independent samples or to determine group 
differences in continuous phenotypes (Lewis and Vassos, 2017) but, they have some 
limitations. Firstly, the proportion of genetic variance explained by PGRS is relatively small 
(~2-3%) (Purcell et al., 2009), larger discovery and training samples could significantly 
increase the power of this method (Dudbridge, 2013). Secondly, the samples used to devise 
PGRS generally consist of participants with the same ethnic background (predominantly 
European) and thus may only be predictive in populations representing the same ethnicities 
(Warren, 2018). However, in their current state, PGRS-SCZ can also be applied to population-
based samples, such as UKB (containing predominantly individuals with white-British 
ancestry), to infer genetic high-risk of the disorder which can result in increasing neuroimaging 
sample sizes. Furthermore, for the purposes of the current thesis, we can investigate the 
potential associations between these scores and cortical imaging measures. 
 
1.3.3 Brain Structure and Polygenic Risk Scores for Schizophrenia  
Only a small number of studies have been used to determine the relationship between PGRS-
SCZ and brain structure phenotypes thus, some consideration will be given to subcortical and 
white matter volumes in the following section. 
 
1.3.3.1 Cortical Volume Reus et al. (2017) found no associations between regional 
subcortical volume or white matter microstructure and PGRS-SCZ using the first data release 
of the UKB sample (n = 978). Importantly, this study did not examine cortical metrics as, at the 
time of analysis, the data release did not include these parameters. However, whilst higher 





smaller case-control studies (n cases = 24 and 152, controls = 38 and 142) (Oertel-Knöchel 
et al., 2015, Terwisscha van Scheltinga et al., 2013), analyses of healthy controls have failed 
to replicate a global effect (Lancaster et al., 2018, van der Auwera et al., 2015, Papiol et al., 
2014) (n range = 197-763). These inconsistencies could be related to the varying sizes of both 
the discovery GWAS (SWG-PGC, 2014, SPGWASC, 2011) and target samples - it has been 
evidenced that the predictability of PGRS will be maximised as discovery and target sample 
sizes increase (Shen et al., 2017, Dima and Breen, 2015, Thompson et al., 2014, Lee et al., 
2012) - as well as the use of different volumetric measures (e.g. total brain, white matter, 
intracranial volume). Study of regional differences in CV remain warranted, particularly in the 
general population (van der Auwera et al., 2015).  
 
1.3.3.2 Cortical Thickness Using only healthy volunteers and splitting them into high (n = 
98) and low (n = 99) PGRS groups, Lancaster et al. (2018) found no associations between 
PGRS group and average CT and only nominal regional associations in the superior parietal 
cortex and precuneus (Lancaster et al., 2018). However, the SNP inclusion threshold used in 
this publication (P ≤ 0.5) is different to the one that will be tested in the current thesis (P ≤ 0.1). 
Although the P ≤ 0.5 threshold explained the most variance (schizophrenia liability) in the 
previous discovery GWAS (SPGWASC, 2011), the P ≤ 0.1 threshold explains more variance 
in the most recent GWAS (SWG-PGC, 2014) and hence is implemented here, though other 
thresholds are detailed in the appendices. Furthermore, regardless of this methodological 
consideration, results from the volumetric studies highlight the importance of replicating such 
results.  
 
1.3.3.3 Cortical Surface Area Lancaster et al. (2018) found no significant association 
between genetic loading for schizophrenia and global SA in healthy controls. No other studies 
investigating PGRS-SCZ and SA have currently been published.  
 
Given the reported inconsistencies, and their limited number and heterogeneity, further studies 





Chapter Two details a case-control investigation of this relationship between genetic loading 
for schizophrenia and cortical metrics and, in an effort to replicate any findings. Furthermore, 
investigating these relationships with larger sample sizes are required to increase the power 
of these findings, Chapter Four examines these within a larger general population-based 
cohort (UKB) study. 
 
Although advances in genetic methodologies have enabled researchers to uncover genetic 
variants associated with schizophrenia and have helped to broaden our understanding of the 
role they play in its development and prognosis, genetics cannot fully explain the disorder. 
Twin concordance rates of schizophrenia are still only considered to be around 40-50% 
(Gejman et al., 2010) and no single gene with a large effect has been linked to the disorder. 
This suggests that investigating environmental risk factors for schizophrenia will be necessary 
for a full understanding of disorder development (Stilo et al., 2011, Dean and Murray, 2005). 
 
1.4 Environmental Risk Factors for Schizophrenia 
1.4.1 Epidemiological Evidence Schizophrenia has been associated with a number of 
both biological and social environmental risk factors. Cannabis use, obstetric/birth 
complications, urbanicity, migration and adverse life events are amongst the most commonly 
reported schizophrenia-associated environmental risk factors (Stilo and Murray, 2010, Dean 
and Murray, 2005, Mäki et al., 2005, Matheson et al., 2011, Sullivan, 2005, Stilo et al., 2011) 
and will therefore be the focus of the current overview. 
 
1.4.1.1 Obstetric Complications Obstetric complications (OCs) are consistently 
associated with a greater incidence in people with schizophrenia (Forsyth et al., 2013, Clarke 
et al., 2006, Jablensky et al., 2005) as well as an increased risk for developing the disorder 
(pooled OR = 2) (Radua et al., 2018, Lærum et al., 2017, Rubio-Abadal et al., 2015, Forsyth 
et al., 2013, Cannon et al., 2002b, Geddes and Lawrie, 1995). Most commonly, the term OC 





growth and development (e.g. low birth weight and reduced head size) and delivery 
complications (e.g. asphyxia and emergency Caesarean section) (Matheson et al., 2011, Stilo 
and Murray, 2010, Mäki et al., 2005, Cannon et al., 2002b, Geddes and Lawrie, 1995) (see 
Fig. 1.2). Season of birth, maternal exposure to illnesses such as influenza and diabetes and 
advanced paternal age at birth have also been consistently noted as risk factors (Stilo and 
Murray, 2010, Matheson et al., 2011, Mäki et al., 2005). All of these factors will be considered 
in the current thesis (see Chapter Two) as well as a more thorough investigation of birth weight 
in Chapters Three and Four. 
 
 
Fig. 1.2 Image showing a selection of obstetric risk factors for schizophrenia and their related 
odds ratios Image and legend from (Sullivan, 2005) 
 
1.4.1.2 Adverse Events Adverse life events, particularly in childhood, have been 
consistently linked to schizophrenia and psychosis; childhood trauma is more commonly 
reported in schizophrenia patients than the general population and children who experience 
such trauma are at a greater risk of developing psychotic symptoms (Matheson et al., 2013, 
Schlosser et al., 2012, Dean and Murray, 2005). However, diverse understandings of what 
constitutes such an event have made it difficult to operationalise a definition and thus develop 
measures to test for its relationship with schizophrenia (Morgan and Fisher, 2007). As such, a 





schizophrenia: bullying (Arseneault et al., 2010, Stilo and Murray, 2010, Schreier et al., 2009), 
parental loss/separation (Morgan et al., 2014, Stilo and Murray, 2010, Morgan et al., 2007), 
abuse (Radua et al., 2018, Schlosser et al., 2012, Stilo et al., 2011, Dean and Murray, 2005, 
Read et al., 2005), physical abuse (Stilo and Murray, 2010, Read et al., 2005), sexual abuse 
(Matheson et al., 2011, Chen et al., 2010, Read et al., 2005), emotional abuse/neglect (Read 
et al., 2005).  
 
1.4.1.3 Cannabis Use Cannabis use has been consistently associated with an increased 
risk of schizophrenia (Dean and Murray, 2005, Arseneault et al., 2002), often in a dose-
dependent manner (Manrique-Garcia et al., 2012, Mäki et al., 2005,). Cannabis is currently 
the most commonly used illicit drug in individuals aged 15 to 64 (UNODC, 2015), and as such, 
connotes a promising target for intervention at the population level (Murray et al., 2017, 
Stepniak et al., 2014, Mäki et al., 2005). 
 
1.4.1.4 Urbanicity Higher incidence of schizophrenia and psychosis has been consistently 
associated with urban as opposed to rural areas (Haddad et al., 2015, Vassos et al., 2012, 
Dean and Murray, 2005, Freeman, 1994), with prospective studies suggesting a link between 
living in urban areas at birth or early childhood and the risk of developing the disorder (Dean 
and Murray, 2005). Furthermore, this risk may be increased by length of time spent in urban 
areas (Stilo and Murray, 2010, Dean and Murray, 2005, Pedersen and Mortensen, 2001). A 
recent systematic review identified urbanicity (and ethnic minority status) as a ‘true risk factor’ 
for schizophrenia (Radua et al., 2018, Kirkbride et al., 2017). 
 
1.4.1.5 Migration Migration status has been consistently evidenced as one of the strongest 
risk factors for schizophrenia (Radua et al., 2018, Akdeniz et al., 2017), particularly in African-
Caribbean migrants to England (Radua et al., 2018, Stilo and Murray, 2010). Such a finding 
has been reported in both first- and second-generation migrants (Akdeniz et al., 2017, Stilo 






In addition to their individual risk, recent evidence has also suggested that the accumulative 
effect of these environmental factors can be even more detrimental. Stepniak et al. (2014) 
reported an earlier onset age of up to nine years in individuals who experienced a higher 
number of environmental risks. Thus, consideration of the accumulative effect of the 
aforementioned risk factors on cortical structure may be just as important as testing them 
individually.   
 
A point that is consistently made to promote the investigation of environmental risk factors for 
schizophrenia is that, unlike genetic variants, these are potentially modifiable and can aid in 
the development of preventative interventions (Tiemeier and Korevaar, 2016, McGrath and 
Lawlor, 2011, Stilo et al., 2011, Mäki et al., 2005). Furthermore, as schizophrenia is considered 
to have a neurodevelopmental component (Murray et al., 2017, Rapoport et al., 2012, 
Rapoport et al., 2005a, Weinberger, 1987), it is also important to understand if and how these 
risk factors may impact upon the brain as well as if preventative strategies can reduce these 
brain alterations. Thus, further consideration is needed of the link between these 
schizophrenia-associated environmental risk factors and cortical structure.  
 
1.4.2 Cortical Structure and Environmental Risk Factors for Schizophrenia 
1.4.2.1 Obstetric Complications Haukvik et al. (2009) tested for associations between 
number and severity of OCs and cortical thickness (CT) in patients and controls. Although CT 
differences were found between patients and controls, there was no evidence to suggest that 
these were related to OCs (Haukvik et al., 2009). Similar findings were reported by Smith et 
al. (2015) whilst investigating perinatal hypoxia and foetal growth (Smith et al., 2015). Foetal 
growth restriction has however, been associated with lower cortical volume (CV) (S. Miller et 
al., 2016, Smith et al., 2015) and surface area (SA) (Smith et al., 2015). Additionally, subtle 
differences in birth weight, even within those born at full-term, have been linked to lower CV, 
SA (Raznahan et al., 2012, Haukvik et al., 2014, Walhovd et al., 2012) and CT (Raznahan et 
al., 2012) in later life. However, lack of consistency and accuracy in some perinatal (for 





1.4.2.2 Adverse Events Childhood adversity (defined by referral to the Children’s Panel) has 
been related to significantly lower SA in the right hemisphere (Barker et al., 2016a). This same 
study found no effect for CT  (Barker et al., 2016a). Habets et al. (2011) however, reported 
significantly lower CT in schizophrenia patients who experienced higher levels of 
developmental trauma (defined by the Childhood Trauma Questionnaire) (Bernstein et al., 
1997) compared to controls. Inconsistencies in these results could be related to variability in 
adversity measures and much lower numbers of exposed compared to control individuals in 
the Barker et al. (2016a) study. 
 
1.4.2.3 Cannabis Use In comparison to non- or occasional users, healthy, regular cannabis 
users  have been found to have lower grey matter volume in temporal, hippocampal, insular 
and frontal regions (Battistella et al., 2014). Lower CT was found in schizophrenia patients 
who were users compared to those who were non-users (Habets et al., 2011). Furthermore, 
significant CT differences have been found between patients and controls, who use cannabis, 
in inferior frontal, occipital and parietal regions (Rais et al., 2010). This suggests that cannabis 
use impacts cortical structure regardless of schizophrenia risk. However, it has been 
suggested cannabis use may be more detrimental for those who go on to develop the disorder 
(Welch et al., 2011a). 
 
1.4.2.4 Urbanicity and Migration Haddad et al. (2015) found lower CV in the dorso-lateral 
prefrontal cortex and the perigenual anterior cingulate cortex (ACC) for those who were born 
and raised in highly populated cities compared to those in rural or less populated areas. This 
perigenual ACC effect has also been replicated by Akdeniz et al. (2017) who, in addition, found 
the same region to be significantly lower in male (but not female) second-generation migrants. 
The authors assert that these effects could be related to social stress, defeat and 
discrimination impacting upon the brain at critical developmental periods (Akdeniz et al., 2017) 






Such findings provide evidence for a strong environmental component impacting upon cortical 
structure in individuals at-risk for developing schizophrenia. However, these findings are 
limited by the strict focus on volumetric measures. It is important to note that neither 
environmental or genetic factors alone can fully explain schizophrenia aetiology or 
development (Stilo et al., 2011, Dean and Murray, 2005), nor can they always be so easily 
distinguished between. For example, birth weight is considered to have both genetic and 
environmental components (Gielen et al., 2008). Furthermore, some of the presented literature 
alludes to global cortical associations with PGRS and regional associations for some 
environmental factors however, overlaps, in frontal and temporal lobes in particular, are also 
evident in both relative and environmental risk studies. Consideration of G × E interactions are 
therefore necessary to fully develop the clinical picture of schizophrenia (Karl and Arnold, 
2014, Dean and Murray, 2005). 
 
1.5 Brain Structure and Interactions Between Genetic and Environmental Risk 
Factors for Schizophrenia 
A G × E interaction is best defined as environmental factors exacerbating an individual’s 
genetic predisposition to a given trait or disorder (Karl and Arnold, 2014, Tsuang et al., 2004). 
Although it is now widely accepted that testing of these interactions in schizophrenia studies 
is necessary (Karl and Arnold, 2014), its execution is not straight forward and a number of 
different methodological approaches have been considered (van Os et al., 2008). In relation 
to schizophrenia and neuroimaging markers, the majority of research has tested the 
association between cortical structure and the experience of environmental risk factors in 
individuals with a genetic vulnerability to schizophrenia (Geoffroy et al., 2013). Testing 
variations in neuroimaging phenotypes may help us to determine potential mechanisms for 
these G × E interactions (Geoffroy et al., 2013). Thus far, G × E interactions for schizophrenia 







1.5.1 Obstetric Complications At present, foetal hypoxia is the only OC that has been 
studied in relation to potential G × E interactions for brain structure and schizophrenia. van 
Erp et al. (2002) found hippocampal volume to be associated with genetic risk for 
schizophrenia; the higher the genetic risk, the smaller the hippocampal volume. Smaller 
hippocampal volumes were found in individuals with schizophrenia who experienced foetal 
hypoxia, although such an effect was not found in healthy relatives or controls (van Erp et al., 
2002). Cannon et al. (2002a) analysed the same sample and found foetal hypoxia to be 
associated with lower grey matter (predominately in the temporal lobe) and higher cerebral 
spinal fluid in patients and their siblings but not in healthy controls. The latter results suggest 
clearer evidence of a G × E interaction and that cortical as opposed to subcortical parameters 
may be predominantly implicated in OC effects. Such interactions are yet to be investigated in 
relation to CT and SA. 
 
1.5.2 Cannabis Use Recent studies have investigated whether the potential impact of 
cannabis on brain structure interacts with schizophrenia risk. Welch and colleagues, found 
cannabis to be associated with, and a predictor of, increased ventricular (Welch et al., 2011a) 
and thalamic (Welch et al., 2011b) volume in those at genetic risk for schizophrenia but not in 
healthy controls. No studies have yet investigated this relationship in CV. In relation to CT, 
Habets et al. (2011) found cannabis to be associated with CT reductions in schizophrenia 
patients compared to patients who do not use the drug. A similar pattern was evident in those 
at risk of developing schizophrenia (siblings) but not in healthy controls (Habets et al., 2011). 
Furthermore, French et al. (2016) found decreased CT to be associated with a higher PGRS-
SCZ in males who used cannabis by the age of 16 compared to non-users, in three 
independent, population-based cohorts. The authors posit that cannabis use may disrupt 
cortical maturation and thus, early cannabis use may moderate the link between genetic 
liability for schizophrenia and these cortical abnormalities (French et al., 2015). No G × E 






Whilst researchers have attempted to disentangle the relationship between genetic and 
environmental risk factors for schizophrenia and how they impact upon cortical structure, 
further work is still required (Geoffroy et al., 2013). For example, many cortical structures have 
not been considered nor have other environmental risk factors (adverse events, urbanicity and 
migration) that are consistently associated with an increased risk of schizophrenia (Murray et 
al., 2017, Stilo et al., 2011, Stilo and Murray, 2010, Dean and Murray, 2005). 
 
1.6 Conclusion  
Despite the detrimental impact of schizophrenia on neurodevelopment and the poor prognosis 
of the disorder, recent research suggests a more optimistic outlook whereby the disorder can 
be more stable and manageable (Zipursky et al., 2018). Early detection is considered 
important for better clinical outcome (Zipursky et al., 2018, Murray et al., 2017, Bois et al., 
2015a, Agius et al., 2011, Lawrie et al., 2011, Häfner and Maurer, 2006, McGlashan and 
Johannessen, 1996) and, thanks to recent advances in research methodologies and sample 
collection, has become more achievable. Thus, the more schizophrenia-associated risk factors 
that we can identify, the easier it will be to construct a fuller clinical picture of the disorder and, 
in turn, make it easier to detect in its infancy. 
 
This overview details evidence of cortical structure abnormalities associated with 
schizophrenia, in addition to several genetic and environmental risk factors for developing the 
disorder as well as G × E interactions. To illustrate, evidence is provided which suggests that 
schizophrenia-associated cortical structure deficits are associated with a genetic liability for 
the disorder, whilst other studies provide support for environmental risk factors altering 
neuroimaging markers. However, current literature is limited, and further investigation of the 
link between environmental risk factors individually and in accumulation are necessary. A 
better understanding of environmental risk factors for schizophrenia may enable clinicians to 
reduce symptom severity or prevent disorder onset. Furthermore, a better understanding of G 
× E interactions will enable researchers and clinicians to develop efficacious preventative 





comprehensive view of the links between genetic, environmental and cortical imaging markers 
in schizophrenia aetiology or prognosis, will ultimately enable researchers to devise and 
execute successful interventions.  
 
This thesis aims to investigate the potential effects of five environmental risk factors for 
schizophrenia, as well as a genetic risk factor (PGRS-SCZ), on three different cortical metrics 
(CV, CT and SA). A case-control (Chapter Two) sample will be used to first determine if a link 
exists between schizophrenia and genetic and/or environmental risk factors and a large 
population-based sample (Chapters Three and Four) will be employed to try to replicate such 
relationships. Additionally, the work contained within this thesis will attempt to separate 




























The relationship between environmental and polygenic risk for 
schizophrenia and cortical thickness in SFMH 
 
2.1 Background  
This chapter aims to determine if environmental risk factors (previously outlined in Chapter 
One) or a PolyGenic Risk Score for Schizophrenia (PGRS-SCZ) can impact upon cortical 
thickness. Reductions in this parameter, particularly in the frontal and temporal regions, are 
commonly associated with schizophrenia (Hedman et al., 2016, Crespo-Facorro et al., 2011, 
Hartberg et al., 2011, van Haren et al., 2011, Yang et al., 2010, Rimol et al., 2010, Goldman 
et al., 2009, Nesvåg et al., 2008, Kuperberg et al., 2003) however, what causes these deficits 
is unclear. According to neurodevelopmental theories of the disorder, environmental and 
genetic factors may initially disrupt cortical development, making individuals more susceptible 
to developing schizophrenia (Weinberger, 2017, Brown, 2011, Weinberger, 1987). As outlined 
in Chapter One, both the genetic and environmental components must be investigated in order 
to fully understand schizophrenia onset, development and prognosis (Stepniak et al., 2014, 
Stilo and Murray, 2010, Dean and Murray, 2005). Although there is a vast amount of research 
outlining the links between genetic susceptibility to schizophrenia and cortical structure, as 
well as epidemiological evidence for a number of environmental risk factors to be associated 
with higher incidence or greater risk for the disorder (Brown, 2011, Stilo and Murray, 2010, 
Mäki et al., 2005, Dean and Murray, 2005); it is less clear how environmental factors associate 
with cortical structure, and their relationship with said genetic liability. 
 
In this chapter we introduce a method for determining whether an individual or accumulation 
of environmental risk factors, as well as the PGRS-SCZ can impact upon cortical thickness. 
Evidence of major risk factors being associated with this cortical structure could help us 
disentangle the relationship between schizophrenia risk, the disorder itself and cortical 






This chapter has been submitted and accepted as a journal article entitled ‘Effects of 
environmental risk and polygenic loading for schizophrenia on cortical thickness’ at 
Schizophrenia Research. The following chapter has been adapted to match the format of the 
current thesis. I can also confirm that I was responsible for the design of the experiment, 
analysing the data and writing the paper for this submission. 
 
2.2 Paper: Effects of environmental risks and polygenic loading for 
schizophrenia on cortical thickness 
 
2.3 Abstract 
Background: There are established differences in cortical thickness (CT) in schizophrenia 
(SCZ) and bipolar (BD) patients when compared to healthy controls (HC). However, it is 
unknown to what extent environmental or genetic risk factors impact on CT in these 
populations. We have investigated the effect of Environmental Risk Scores (ERS) and 
Polygenic Risk Scores for SCZ (PGRS-SCZ) on CT.  
Methods: Structural MRI scans were acquired at 3T for patients with SCZ or BD (n = 57) and 
controls (n = 41). Cortical reconstructions were generated in FreeSurfer (v5.3). The ERS was 
created by determining exposure to cannabis use, childhood adverse events, migration, 
urbanicity and obstetric complications. The PGRS-SCZ were generated, for a subset of the 
sample (Patients = 43, HC = 32), based on the latest PGC GWAS findings. ANCOVAs were 
used to test the hypotheses that ERS and PGRS-SCZ relate to CT globally, and in frontal and 
temporal lobes. 
Results: An increase in ERS was negatively associated with CT within temporal lobe for 
patients. A higher PGRS-SCZ was also related to global cortical thinning for patients. ERS 
effects remained significant when including PGRS-SCZ as a fixed effect. No relationship which 
survived FDR correction was found for ERS and PGRS-SCZ in controls. 
Conclusions: Environmental risk for SCZ was related to localised cortical thinning in patients 
with SCZ and BD, while increased PGRS-SCZ was associated with global cortical thinning. 





This provides a mechanistic means by which different risk factors may contribute to the 
development of SCZ and BD.  
 
2.4 Introduction  
Schizophrenia (SCZ) and bipolar disorder (BD) are psychiatric disorders characterised by 
overlapping symptomatology (Bois et al., 2015a, Hilty et al., 2006) and multifactorial 
aetiologies (Hilty et al., 2006, Jablensky, 1997). Both are highly heritable (around 80%) due to 
a large number of relatively common genes of small effect (Matheson et al., 2011, McGuffin 
et al., 2003). Both have been proposed to be consistent with a neurodevelopmental model 
(Rapoport et al., 2012, Weinberger, 1987) which posits that SCZ and related disorders are 
influenced by both genetic and environmental factors impacting on the brain, at different 
developmental stages (Rapoport et al., 2012). Significant widespread cortical thinning is 
consistently found when comparing SCZ and BD patients to healthy controls (HC) (Knöchel et 
al., 2016, Nesvåg et al., 2012, Rimol et al., 2010, Goldman et al., 2009, Kuperberg et al., 
2003). It is unclear however whether these differences are related to genetic and/or 
environmental risk factors previously associated with SCZ.  Elucidating these components 
would help to further understand the underlying aetiologies of these disorders. 
 
Decreases in grey matter volumes have been found before disease onset (McIntosh et al., 
2011) and thinner cortices have been noted in SCZ patients when compared to HC in all lobes 
(Rimol et al., 2010, Goldman et al., 2009, Kuperberg et al., 2003). However, the most 
consistent findings have suggested that cortical thinning is most prominent in frontal and 
temporal regions (Sprooten et al., 2013, van Haren et al., 2011, Rimol et al., 2010, Goldman 
et al., 2009, Kuperberg et al., 2003), where it continues to decline after disease onset (Cobia 
et al., 2012). Despite reports of disease specific cortical alterations associated with BD, for 
example, in orbitofrontal regions (Knöchel et al., 2016), many studies have also highlighted 
cortical thinning findings which overlap with the aforementioned SCZ deficits (Hanford et al., 
2016, Knöchel et al., 2016, Rimol et al., 2010). Hence, frontal and temporal lobes are regions 






Both SCZ and BD have been associated with several environmental risk factors (Marangoni 
et al., 2016, Lawrie et al., 2011, van Os et al., 2010). Cannabis use, childhood adversity and 
obstetric complications (OC) have the strongest epidemiological evidence for an association 
with an increased risk of SCZ and BD, (Marangoni et al., 2016, Radhakrishnan et al., 2014, 
Stepniak et al., 2014, Matheson et al., 2013, Rapoport et al., 2012, van Os et al., 2010, 
Krabbendam & van Os, 2005). Urbanicity and migration are also strongly linked to SCZ 
(Stepniak et al., 2014, Rapoport et al., 2012, van Os et al., 2010, Krabbendam & van Os, 
2005); however, as environmental risk factors for BD the evidence is less conclusive (Demjaha 
et al., 2012). Nevertheless, both migration and urbanicity have been linked to an increased 
incidence of BD (Cantor-Graae & Pedersen, 2013, Pedersen & Mortensen, 2006).  
 
Although the evidence is limited, some of these factors have also been linked to deficits in 
cortical volume and thickness. Cannabis use has been associated with reduced global and 
frontal lobe volumes (Welch et al., 2011a), cortical thinning in general (Habets et al., 2011), 
and, more specifically, in dorso-lateral prefrontal cortex (DLPFC) and anterior cingulate cortex 
(Rais et al., 2010). Childhood adversity/trauma has been associated with cortical thinning 
globally (Habets et al., 2011) and in the limbic system (Souza-Queiroz et al., 2016), as well as 
decreased subcortical structure volumes (Barker et al., 2016b, Hoy et al., 2012). So far, OC 
have not been significantly related to cortical thinning (Haukvik et al., 2009; Smith et al., 2015) 
but birth complications have been previously linked to reduced hippocampal and cortical 
volume (Cannon et al., 2002a; van Erp et al., 2002) and may, alone or in accumulation with 
other risk factors, be linked to deficits in cortical thickness (CT). Migration and urbanicity are 
yet to be investigated in relation to CT but urbanicity has been linked with decreased grey 
matter volume in DLPFC within a healthy sample (Haddad et al., 2015). 
 
Our knowledge of how these environmental risk factors impact upon CT in SCZ and BD is 
therefore inconclusive. Given a lack of knowledge about how these factors confer risk, it is 





likely to occur and impact development at different stages of life (Dean & Murray, 2005; 
Stepniak et al., 2014) and several of these factors can be experienced by any individual. Prima 
facie, it seems likely that a higher number of insults may result in greater biological effects. 
One aim of the current study is therefore to determine the impact of environmental risk factors, 
in accumulation, on CT. 
 
Genome Wide Association Studies (GWAS) have advanced our understanding of the genetic 
underpinnings of SCZ and BD. Recently, the Schizophrenia Working Group of the Psychiatric 
Genomics Consortium (SWG-PGC, 2014) GWAS identified 108 genetic loci associated with 
SCZ, as well as several other markers that failed to reach genome-wide significance, 
suggesting a polygenic foundation to SCZ, with many genetic variants of individually small 
effect contributing to the overall phenotypic variation (International Schizophrenia 
Consortium., 2009). Strong evidence also exists for a polygenic basis for BD, with a strong 
overlap in the genetic variants associated with SCZ and BD (CDG-PGC, 2013, SPGWASC, 
2011, Purcell et al., 2009). Using the summary data from the SWG-PGC GWAS (including 
alleles associated with the risk of SCZ as well as their effect sizes) as the training dataset, 
PGRS for SCZ (PGRS-SCZ) can be created in an independent sample. Risk variants in the 
independent sample which are common to the training dataset are identified, these are then 
weighted by the effect sizes reported in the SWG-PGC GWAS and summed across individual 
genotypes in the independent sample (Euesden et al., 2015, SWG-PGC, 2014, Purcell et al., 
2009). Higher positive scores indicate a greater polygenic risk for disorder. 
 
Several studies have investigated the effect of these PGRS-SCZ on clinical and cognitive 
phenotypes (Whalley et al., 2016, Stepniak et al., 2014, McIntosh et al., 2013).  Thus far, 
structural neuroimaging phenotypes have been assessed with regard to the first SWG-PGC 
GWAS data, which identified 7 associated loci (SPGWASC, 2011), with inconsistent results 







Despite the fact that risk variants have been identified for BD separately (PGWASC-BDWG, 
2011), there is still a substantial amount of shared variation between these psychiatric 
disorders (CDG-PGC, 2013, SPGWASC, 2011). Furthermore, PGRS-SCZ have been 
previously used for analysis within a combined BD and SCZ patient group (Ruderfer et al., 
2014). Therefore, as the intention of the current study is to determine whether risks common 
to the development of both BD and SCZ are linked to CT, and the SCZ GWAS is more highly 
powered than the BD GWAS (SWG-PGC, 2014, PGWASC-BDWG, 2011), we have used the 
PGRS-SCZ. A second aim of the current study is to determine if a relationship exists between 
PGRS-SCZ, created using the most recent PGC SCZ data, and CT.  
 
Within the current study, global, frontal and temporal regions of CT were analysed to determine 
their relationship with PGRS-SCZ and environmental risk associated with SCZ. We 
hypothesised that both PGRS-SCZ and an accumulation of environmental risk factors would 
be inversely associated with cortical thinning in these regions, for both the patients and 
controls separately and when assessing differences between patients and controls. Due to the 
aforementioned overlap between structural findings, environmental, and genetic risk factors, 
and in order to increase power within the sample, SCZ and BD patient data were combined 
into one patient groups for analyses. 
 
2.5 Methods  
2.5.1 Participants Detailed participant information has been reported previously (Whalley 
et al., 2015). Briefly, participants were recruited as part of the Scottish Family Mental Health 
Study (SFMH), approved by the Multicentre Research Ethics Committee for Scotland 
(09/MRE00/81). Detailed clinical and MRI data were obtained for HC (n = 41) and patients 
with a DSM-IV diagnosis of SCZ (n = 38) or BD (n = 20) aged between 18 and 67 years. 
Clinical diagnoses were established using the structural interview for the DSM-IV (SCID; (First 
et al., 2002) conducted by one of two trained psychiatrists. For analyses purposes, SCZ and 
BD participants were combined into one patient group. Table 2.1 shows demographic 





BD groups separately, were also conducted and can be found, in full, in Appendix A (p14-
20). 
 
Table 2.1 Demographic and clinical characteristics for healthy controls (HC) and the 




 Mean (S.D) 
t/X2 P 
N 41 57   
Age 38.22 (14.39) 39.21 (11.80) 0.47 0.64 
Gender 
(Male/Female) 
23/18 37/20 0.45 0.50 
Illness Duration in 
years 
- 17.95 (11.81) 
Range: 0-45 
- - 
Age of Onset in 
years 





- 252.55 - - 
PANSS Total 31.54 (4.21) 54.38 (18.30) -9.02 6.14×-13*** 
PANSS Positive 7.17 (0.67) 12.45 (5.25) -7.44 5.57×-10*** 
PANSS Negative 7.29 (1.42) 13.38 (6.92) -6.40 2.48×-08*** 
PANSS General 17.07 (3.55) 28.55 (9.10) -8.59 8.22×-13*** 
SES   29.71  
1.68×-05*** Unemployed/Retired 1/5 26/8  
Manual/non-manual 8/28 7/15  
Young Mania Rating 
Scale 




0.87 (3.04) 9.98 (8.07) -7.50  
1.43×-10*** 
Paternal Age - 31.05 (6.68) - - 
NART IQ 111.2 (6.89) 110.5 (9,62) 0.44 0.66 
PGRS-SCZ -0.33 0.25 -2.62 0.01* 
ERS for 3 factors 1.29 (0.87) 1.68 (0.76) -2.31 0.02* 
ERS for 5 factors - 2.51 (1.09)   
***p corr ≤ .001, **p corr ≤ .01, *p corr ≤ .05,    .  p corr ≤ .10, HC = Healthy controls, S.D = Standard 
deviations, PANSS = Positive and negative syndrome scale, SES = Socioeconomic status, 
CPZ = Chlopromazine, ENIGMA = Enhanced neuroimaging genetics through meta-analysis 
(http://www.enigma.ini.usc.edu), NART IQ = National adult reading test intelligence quotient 
(measure of premorbid intelligence), PGRS-SCZ = Polygenic risk score for schizophrenia, 
ERS = Environmental risk score 
 
 
2.5.2 Imaging Procedures Magnetic Resonance imaging was performed at Edinburgh’s 
Clinical Research Imaging Centre (CRIC) (http://www.cric.ed.ac.uk/) on a Siemens Verio 3T 
MRI system (Siemens Medical Systems, Erlangen). Structural brain images were acquired 
using a T1-weighted magnetization prepared rapid acquisition gradient echo 





with an isotropic voxel resolution of 1mm parallel to AC-PC plane, field of view = 256mm × 
256mm. 
 
Brain scans were anonymised at the time of acquisition and a set protocol was adhered to for 
pre-processing of scans, regardless of clinical status. Structural images were processed using 
FreeSurfer (v5.3) (http://surfer.nmr.mgh.harvard.edu/fswiki/) to quantify thickness of cortical 
anatomical regions, volumetric segmentation, cortical surface reconstructions and cortical 
parcellation. See Appendix A2.1.1 (p1) for full procedure. The Desikan-Killiany atlas was used 
to define cortical anatomical regions (Desikan et al., 2006). A list of the regions of interest 
included in frontal and temporal lobes, using this atlas, can be found in Appendix A2.1.1 (p1). 
 
A trained rater (E.N) checked all scans for inaccuracies, blinded to group status. All scans 
were edited adhering to FreeSurfer procedures (http://freesurfer.net/fswiki/Edits) in order to 
increase the accuracy of the pial surface. Following this procedure, one scan was removed 
due to defective surface generation that could not be corrected by manual editing (HC=41, 
Patient=57). Average global and lobar CT values were extracted from each scan for analysis. 
 
2.5.3 Environmental Measures Environmental risk information was collected for all 98 
participants. The risk factor measures and subsequent calculation of an Environmental Risk 
Score (ERS) were based upon methods developed by Stepniak et al. (2014) and included 
three factors for controls; Childhood Adverse Events (CAE), Migration, and Cannabis Use, 
with a further two for the patient group; OC and Urbanicity. Environmental measures were 
defined as follows: CAE – measured using the Childhood Life Events Questionnaire (CLEQ, 
www.bdrn.org) which determined if participants had experienced one or more event out of a 
possible list of 13 adverse childhood events including death of a parent/friend, parental divorce 
and personal/parental hospitalisation. Abuse and bullying are not specifically enquired about 
however, a final question allows participants to disclose any other CAE not previously 
specified. Risk was recorded if the participant experienced one or more of the possible events 





another country; Cannabis Use – any recorded cannabis use before the time of scan;  OCs – 
any deviation from normal pregnancy or delivery (e.g. premature birth, jaundice); Urbanicity – 
calculated using the measure from Stepniak et al. (2014), to determine the cities that patients 
lived in from birth to 18 years old. Each city was placed into a category depending on its 
population (1: </= 10,000, 2: 10,001-50,000, 3: 50,001-100,000, 4: > 100,000) and was 
multiplied depending on the number of years spent living in that place. This was repeated for 
each city if the participant relocated and all scores were summed. The total score was then 
split into one of 2 groups - rural (score 18-45) and urban (score 46-72) upbringing, with 
placement in the urban group conferring risk. Environmental measures were scored as 1 or 0; 
with 1 representing that the risk was present for each participant. Frequencies of the individual 
factors for the combined patient groups and controls are displayed in Appendix A2.1.3 (p2-
3). Participants with unavailable information (NA) on factors were rated, conservatively, as 0, 
however, analyses with NA removed were also conducted with results reported in Appendix 
A2.2.3 (p6-9). The continuous ERS was determined by totalling the number of environmental 
measures experienced by each participant.  
 
2.5.4 Genotyping and Derivation of PGRS-SCZ Information on the genotyping process 
are presented in Appendix A2.1.2 (p2).  
Polygenic profile scores were generated using imputed genotype data. Imputation was 
performed in accordance with the ENIGMA 1000 genomes protocol (ENIGMA2 Genetics 
Support Team, 2013) Single nucleotide polymorphisms (SNPs) with an imputation R-squared 
quality score of > 0.3 were retained for further analysis resulting in 6,145,246 SNPs. All 
subsequent analyses were performed in PLINK (Purcell et al., 2007). Further QC criteria were 
applied to imputed data. Individuals with missingness > 2% were excluded, as were SNPs with 
a genotype call rate of < 98%, Hardy-Weinberg equilibrium p-value < 1 x 10-6, a minor allele 
frequency of < 5%, or those that were strand ambiguous. Clump-based linkage disequilibrium 
pruning (r2 0.2, 300kb window) was performed to create a SNP-set in approximate linkage 
equilibrium. Marker weights (logarithm of the Odds Ratio) and p-value association statistics 





autosomal SNPs) (Schizophrenia Working Group of the Psychiatric Genomics Consortium, 
2014). Five scores were generated for each individual, using SNPs selected according to the 
significance of their association with the phenotype in the discovery GWAS at nominal P-value 
thresholds of ≤ 0.01, 0.05, 0.1, 05, 1, as previously described (International Schizophrenia 
Consortium, 2009). These data were not available for 11 of the patients and 8 of the controls 
and they were therefore excluded (Patients = 46, HC = 33).  
 
Multi-dimensional scaling (MDS) was conducted to identify outliers within the population 
stratification using previously described protocols (ENIGMA2 Genetics Support Team, 2013). 
In plotting the MDS components, three outliers were identified and removed (Appendix A, Fig 
A2.1, p3). Four MDS components were included in subsequent PGRS-SCZ analysis models 
within this study, consistent with previous publications (Whalley et al., 2015, McIntosh et al., 
2013). Where sibling pairs were present in the sample, one half was removed to avoid 
relatedness issues, making the final sample with genotyped information HC = 32, Patients = 
43.  
 
2.5.5 Statistical Analysis Statistical analyses were conducted in R (v3.2.2). The effects of 
left and right global, frontal and temporal CT were investigated in line with our hypotheses. 
SCZ and BD patient data were combined into one patient group due to overlap between 
genetic risk, environmental risk and structural MRI findings. However, a secondary analysis 
examining the patients separately was performed. Some of these results are reported below, 
with full results reported in Appendix A (p14 - 20).  
 
Firstly, we assessed whether an accumulative ERS and, post-hoc, individual environmental 
risks were related to CT. Secondly, we tested for associations between CT and PGRS-SCZ 
and finally, we calculated whether any environmental effects remained after controlling for 
potential genetic effects. As the aim of the study was to determine whether there was an effect 





for patients than controls, analyses were conducted separately for each of these groups. 
However, we also tested for potential differential effects when comparing patients and controls 
using the three environmental factors common to both groups, as well as the PGRS-SCZ. 
ANCOVAs were run for each anatomical structure with the structure of interest entered as the 
outcome variable and ERS/PGRS-SCZ as the predictor variable. Results for all lobar structure 
analyses for ERS and PGRS-SCZ analyses were corrected for multiple comparisons using a 
False Discovery Rate (FDR) correction, with a rate of p=0.05 (Genovese et al., 2002). The 
same procedure was also followed for analysis of the SCZ and BD groups separately. Post-
hoc analyses were run to test for the effects of individual environmental risk factors on CT. 
Due to these factors all being correlated with the ERS (Appendix A2.2.1, p4), post-hoc 
analyses were FDR corrected across lobes and all individual environmental risk factors. 
 
For the ERS analyses, using the combined patient group (as well as the SCZ and BD groups 
separately) and controls separately, covariates included age (mean centred) and gender, with 
group (SCZ/BD) added as a fixed effect within patient models to control for potential group 
differences. ERS was the predictor of interest within the main environmental analysis. For 
additional post-hoc analyses the individual risk factor was the predictor variable. Age (mean 
centred), gender, and group for the patient analyses, were also included as fixed effects in the 
PGRS-SCZ analyses as well as four MDS components and the standardised PGRS-SCZ at 
threshold P ≤ 0.1. This threshold was utilised as it was shown to explain the most phenotypic 
variance in the discovery cohort (Schizophrenia Working Group of the Psychiatric Genomics 
Consortium, 2014). Results at the 4 other thresholds (P ≤ 0.01, 0.05, 0.5 and 1) are presented 
in Appendix A2.2.4 (p10-13). Total average thickness was added as a covariate for all frontal 
and temporal lobar analyses. The same models with the inclusion of an ERS or individual 
environmental risk factor/PGRS-SCZ by group interaction factor was also run to investigate 
potential group differences between the combined patient group and controls as well as 






A further analysis model, including the above ERS covariates, the PGRS-SCZ variables 
included as fixed effects and ERS as the predictor variable, was tested to determine the effect 
of ERS whilst controlling for PGRS-SCZ. 
 
Power was also calculated for the environmental risk analyses. As there is no previous effect 
size in the literature that links an accumulative ERS to CT, we estimated this based on a review 
by Lawrie et al. (2011), which includes the OR of many of the risk factors within the current 
study. Based on this review, we took an overall summary OR of 2 which is conservative as the 
OR for immigration for example is 5 (Lawrie et al., 2011). We converted this OR to an effect 
size using methods described in Chinn et al. (2000). Using this effect size in conjunction with 
sample size information for the current sample, we calculated power for the current study using 
the ‘pwr’ package in R. The results suggest that we have 88-96% power to detect relationships 
at p = 0.05 within the current sample. 
 
Chlorpromazine equivalents (CPZE) of patient’s antipsychotic use were calculated using 
previous methods (Woods, 2003). Spearman’s rank correlations revealed no significant 
relationship between CPZE and the current brain parameters.  
 
2.6 Results 
2.6.1 Group Differences No significant differences were found for age, gender or 
premorbid IQ (NART; National Adult Reading Test) between the combined patient group and 
controls, but significant differences were found for Socioeconomic status, Young Mania Rating 
Scale, Hamilton Depression Rating Scale and symptom severity (Table 2.1). 
 
There was a significant difference in CT between patients and controls globally (left and right 
hemispheres), and in right temporal lobes (Table 2.2); patients had significantly thinner global 






Table 2.2 Mean group differences in cortical thickness for healthy controls (HC) and 
patients with associated standard deviations (S.D) and p values 
 HC (n = 41) 
 
Patients (n = 57) 
 
  
 Mean (S.D) Mean (S.D) F P 
Left 2.52 (0.10) 2.44 (0.11) 11.63 1.00×-03*** 
Right 2.51 (0.09) 2.43 (0.10) 14.78 2.00×-04*** 
Frontal Left 2.56 (0.11) 2.49 (0.13) 0.83 0.36 
Frontal Right 2.49 (0.11) 2.44 (0.13) 3.64 0.06. 
Temporal Left 2.86 (0.12) 2.74 (0.17) 1.61 0.21 
Temporal Right 2.91 (0.12) 2.77 (0.15) 5.60 0.02* 
                   ***p corr ≤ .001, **p corr ≤ .01, *p corr ≤ .05, . p corr ≤ .10, S.D = Standard deviation 
A significant difference in PGRS-SCZ was also evident between groups (Table 2.1); patients 
had a higher mean score than controls at the P ≤ 0.1 threshold (t69.17 = -2.62, p = 0.01). 
Appendix A2.2.4 (p10-13) presents differences at other thresholds.  
 
There was also a significant group difference in ERS (Table 2.1); patients experienced a 
higher mean number of environmental risks compared to controls (t78.75 = -2.3, p = 0.02). 
 
Analyses were also conducted to determine potential group differences between SCZ and BD 
with some results reported below and in Appendix A (p14-20). No significant differences were 
found between these groups, with the exception of PANSS Positive Symptoms. 
  
2.6.2 Patient Analysis 
2.6.2.1 ERS Analysis A significant main effect was found for ERS (F1,51= 7.23, p = 0.01) 
which survived FDR correction (pcorr= 0.04); an increase in ERS was associated with a thinner 
right temporal cortex (Table 2.3).  
 
Table 2.3 Adjusted Mean Thickness in Right Temporal Lobe dependent on the number 
of environmental risk factors experienced by the patients (n = 57) 
 0 Risks 1 Risk 2 Risks 3 Risks 4 Risks 5 Risks 
Adjusted Mean 
Thickness (mm) 
2.85 2.82 2.79 2.76 2.73 2.70 
S.E 0.03 0.02 0.01 0.01 0.02 0.03 





2.6.2.1.1 Secondary Patient Analysis – ERS in SCZ and BD Groups 
Separately For the SCZ patients, there was a significant effect of ERS where an 
increase in environmental risk scores was related to lower cortical thickness in the 
right temporal lobe (F1,32=6.57, p=0.02). This effect was not significant within the BD 
patients but the same pattern was present (see Tables 2.4 and 2.5 and Appendix 
A2.2.4 (p10-14). 
 
Table 2.4 Adjusted Mean Thickness in Right Temporal Lobe dependent on the 
number of environmental risk factors experienced by Schizophrenia patients (n 
= 37) 
 0 Risks 1 Risk 2 Risks 3 Risks 4 Risks 5 Risks 
Adjusted Mean 
Thickness (mm) 
2.85 2.82 2.79 2.75 2.72 2.68 
S.E 0.037 0.026 0.017 0.017 0.025 0.036 
S.E = Standard error 
 
Table 2.5 Adjusted Mean Thickness in Right Temporal Lobe dependent on the 
number of environmental risk factors experienced by the Bipolar Disorder 
patients (n = 20) 
 0 Risks 1 Risk 2 Risks 3 Risks 4 Risks 5 Risks 
Adjusted Mean 
Thickness (mm) 
- 2.82 2.81 2.79 2.77 - 
S.E - 0.026 0.013 0.014 0.027 - 
S.E = Standard error 
 
2.6.2.2 Post-hoc Analysis of Individual Environmental Risk Factors Post-hoc 
analyses of individual environmental risk factors revealed no significant main effects which 
survived FDR correction, for the combined patient group (Appendix A2.2.3.1, p5-6). No 
effects of group (SCZ, BD) were found for the ERS or individual environmental risk analyses.  
 
 
2.6.2.3 PGRS-SCZ Analysis A significant main effect of PGRS-SCZ on Global CT was 
found in left (F1,33 = 4.33, p = 0.05) and right (F1,33=4.54, p = 0.04) hemispheres, due to a 





was found in these regions. No significant effects were found for any other structures 
(Appendix A2.2.4.1, p10). 
 
 
Fig. 2.1 Scatter plots showing global a) left and b) right cortical thickness, in mm2, and polygenic 
risk scores for schizophrenia in the combined patient group (SCZ = 37, BD = 20) 
 
2.6.2.3.1 Secondary Patient Analysis – PGRS-SCZ in SCZ and BD Groups 
Separately For both SCZ and BD patients, the pattern of results suggests that as 
polygenic risk scores increase, global and left temporal lobe cortical thickness values 
decrease (See Fig A2.3 and A2.4, Appendix A2.2.4 (p10-13). This was not a 
significant effect within the BD patients and only reached trend level for SCZ patients 
in the left (F1,15=3.51, p=0.08) and right (F1,15=3.63, p=0.08) hemisphere. 
 
2.6.2.4 ERS controlling for PGRS-SCZ Analysis When adjusting for possible effects of 
PGRS-SCZ, the main effects of ERS on CT in right temporal lobe, for the combined patient 
group, remained significant (F1,31 = 5.74, p = 0.02).  
 
2.6.2.4.1 Secondary Patient Analysis – ERS controlling for PGRS-SCZ in 





temporal CT in the SCZ patients remained significant when controlling for potential 
effects of PGRS-SCZ (F1,13=6.46, p=0.03) (see Appendix A, p10-13). 
 
 
2.6.3 HC Analyses 
2.6.3.1 ERS Analysis A main effect of ERS was apparent in controls within left and right 
temporal lobes but did not survive FDR correction. The pattern of this effect suggested that a 
higher ERS was associated with thicker temporal cortices. 
 
2.6.3.2 Post-hoc Analysis of Individual Environmental Risk Factors Post-hoc 
analyses of individual factors suggested a main effect of CAE on left and right temporal lobes 
which did not survive FDR correction but displayed the pattern that those who had experienced 
CAE had greater CT within these regions, compared to those who had not. No other factor 
had a significant effect (Appendix A2.2.3.2, p7). 
            
2.6.3.3 PGRS-SCZ Analysis PGRS-SCZ did not have an effect on any of the structural 
parameters in controls. (Appendix 2.2.4.2, p11) 
 
2.6.4 Interaction Analysis 
2.6.4.1 Group × ERS Analysis There was a significant ERS by group interaction in right 
temporal lobes (F1,91 = 6.23, p = 0.01); a higher risk score was associated with a thicker right 
temporal cortex within controls, but a thinner cortex within the combined patient group. 
However, after FDR correction, this result only revealed a trend towards significance (pcorr = 
0.06). There were no other associations for any other structures and there were no significant 
main effects for ERS (Appendix A2.2.3.3, p8). 
 
2.6.4.2 Post-hoc Analysis of Individual Environmental Risk Factors Post-hoc 





correction (F1,91 = 6.27, p = 0.01, pcorr = 0.04). This was due to thicker cortices for those controls 
who had experienced CAE compared to those who had not; whereas, in the combined patient 
group, the opposite pattern was apparent. No other individual risk factors were significant 
(Appendix A2.2.3.3, p8). 
 
2.6.4.3 Group × PGRS-SCZ Analysis There was a significant main effect of PGRS-SCZ 
in left (F1,64 = 8.41, p = 0.01) and right (F1,64 = 10.22, p < 0.01) hemispheres; an increase in 
PGRS-SCZ was associated with a thinner cortex within these regions, regardless of group 
(HC versus combined patient group) (Fig. 2.2a and b). There were no other significant main 
effects (Appendix A2.2.4.3, p.12-13). 
 
 
Fig. 2.2 Scatter plots showing that global a) left and b) right cortical thickness, in mm2, is 
negatively associated with increased polygenic risk scores for schizophrenia, regardless of 
group (HC = 32, Patient = 43) 
 
There was also a significant group by PGRS-SCZ interaction in left temporal lobe which 
withstood FDR correction (F1,63 = 6.88, p = 0.01, pcorr = 0.04). This was due to an increase in 
PGRS-SCZ being associated with a thinner cortex within patients (combined patient group) 
(Fig. 2.3a) but having no relationship in controls (Fig. 2.3b). No other interactions reached 






Fig. 2.3 Scatter plots showing left temporal lobe cortical thickness, is a) negatively associated 
with polygenic risk scores in the combined patient group (n = 43) and b) has no relationship with 
polygenic risk scores for schizophrenia in the HC group (n = 32) 
 
 
2.6.4.4 Group × ERS controlling for PGRS-SCZ Analysis When controlling 
for potential effects of PGRS-SCZ on ERS, the significant ERS by group interaction 
remained for right temporal lobe (F1,62 = 4.51, p = 0.04). The CAE group interaction, 
also remained significant (F1,62 = 7.22, p = 0.01). 
 
2.6.4.4.1 Secondary Patient Analysis - Group Interactions for SCZ 
and BD Groups Separately There were no significant interactions 
between ERS or PGRS-SCZ and group (SCZ versus BD patients) (see 
Appendix A2.2.4, p10-13).  
 
2.7 Discussion 
We examined whether an ERS, as well as PGRS-SCZ were associated with CT within a 
patient group (SCZ/BD) and HC. We report that an ERS for SCZ negatively affected right 
temporal CT within patients. Importantly, these effects were robust to controlling for PGRS-





within controls but did not survive FDR correction. Interaction analyses revealed a significant 
group by ERS interaction in right temporal lobe, in that, a thinner cortex was associated with 
increased ERS within patients whereas the opposite pattern was apparent within controls; 
albeit this interaction was a trend after FDR correction. There was also a significant group by 
PGRS-SCZ interaction in left temporal lobe, with higher PGRS-SCZ being related to a thinner 
cortex within patients whereas no relationship was apparent for controls. 
 
Cortical thinning in temporal lobe is commonly found in patients with SCZ and BD (Hanford et 
al., 2016, van Haren et al., 2011, Rimol et al., 2010, Goldman et al., 2009, Kuperberg et al., 
2003). As far as we are aware, our results provide the first evidence that an accumulation of 
environmental risk factors contribute to cortical thinning within this area. The opposite pattern 
(a higher ERS was associated with thicker temporal cortices) was seen in the separate 
analyses of control individuals, and in the interaction between the two groups, but these results 
did not survive FDR correction, possibly due to comparatively low power for these analyses.  
 
Analysis of SCZ and BD groups separately also showed a higher ERS was associated with 
lower temporal CT however, this effect was not significant for the BD group. Notably, there 
were no individuals who had experienced zero or five environmental risk factors in the BD 
group thus, lack of an effect could reflect differences in susceptibilities to or likelihoods of 
experiencing such factors. For example, urbanicity has been less conclusively associated with 
an increased risk of BD compared to SCZ (Demjaha et al., 2012) but, BD risk factors have 
been less researched than that of SCZ (Rowland & Marwaha, 2018). Thus, the authors 
suggest that these differences are more likely due to reductions in power as a result of splitting 
the sample (Combined patient group = 57; SCZ = 37, BD = 20). Additionally, there were no 
significant group (SCZ versus BD patients) by ERS interactions, further suggesting that the 
overall pattern of effects was similar for both SCZ and BD patient groups.  
 
We found a group (combined patient versus HC) by ERS interaction within right temporal lobe. 





whereas patients who experienced the same insult had thinner temporal cortices. Although 
CAE have been formerly linked to thinner cortices in patients (Habets et al., 2011), they have 
not been previously associated with a thicker cortex in controls. Habets et al. (2011) found a 
thicker cortex to be associated with increased levels of developmental trauma in siblings of 
SCZ patients, but not in controls. We, however, did not previously find this effect in those at 
familial high-risk (Barker et al., 2016a).  Our current replication of Habets et al. (2011) does 
support the possibility that experiencing CAE could thicken the cortex and may be related to 
resilience to developing a psychotic disorder. Within healthy populations, studies have shown 
that increased participation in practices which may promote mental wellbeing, such as 
meditation (Kang et al., 2013, Lazar et al., 2005) and physical exercise (Reiter et al., 2015), is 
associated with having a thicker temporal cortex, amongst other areas.  
 
An important point to acknowledge is that we received less full histories for ERS derivation in 
controls than patients; however, the present study has also directly compared the 
environmental risk factors common to both patients and controls. We report a group by ERS 
interaction in right temporal CT, whereby higher ERS was associated with a thinner cortex 
within patients but a thicker cortex in controls. We also report a group by CAE interaction in 
right temporal lobe. These results suggest a differential effect of environmental risk in patients 
and controls but must be interpreted with caution and require replication in much larger 
cohorts.  
 
We also report significant negative relationships between PGRS-SCZ and global CT within 
both the patient only analysis, and the full sample, irrespective of group. To our knowledge, 
this has not been previously reported – although we and others have reported thinner cortices 
in those at familial high-risk of SCZ (Sprooten et al., 2013, Byun et al., 2012, Goghari et al., 
2007). Previously, increased PGRS-SCZ have been linked to a reduction in white matter 
volume (Terwisscha van Scheltinga et al., 2013) and decreased gyrification in general 





to CT. Based on our findings we hypothesise that genetic risk for SCZ could disrupt global CT 
during development and thereby increase the risk of developing SCZ.  
 
Analysis of the SCZ and BD patient groups separately demonstrated the same pattern of a 
higher PGRS-SCZ being related to lower global CT however, this was not significant in the BD 
group and only reached trend level significance for the SCZ group. As, the sample size is 
reduced when investigating the effects of each group individually, we interpret this lack of 
significance as due to a lack of power and not a group difference however, future studies may 
benefit from addressing this more directly. 
 
A significant group by PGRS-SCZ interaction was reported; a thinner cortex in left temporal 
lobe was associated with higher PGRS-SCZ in the combined patient group but had no 
association with PGRS-SCZ in controls. This suggests potential localised differential effects 
between patients and controls.  
 
Analysis of the SCZ and BD patient groups separately showed no significant interactions 
between PGRS-SCZ and group, again, suggesting that the overall pattern of results was 
similar for both SCZ and BD patients.  
 
In the current study, we used PGRS for SCZ rather than BD for several reasons. Firstly, we 
were interested in determining the commonalities between these disorders and how they may 
impact upon CT. Secondly, PGRS-SCZ have been used previously within BD populations 
(Ruderfer et al., 2014). Thirdly, the original GWAS for SCZ was better powered than that for 
BD (SWG-PGC, 2014, PGWASC-BDWG, 2011). However, it would be of interest for future 
studies to determine the effects of the PGRS for BD in a larger sample. 
  
Given the potential interactive effects of genetic and environmental risk factors for SCZ on 
neuroanatomy, we conducted further analyses to determine whether the effects of 





environmental effects remained significant after so doing. We cannot rule out a gene-
environment interaction of PGRS-SCZ and ERS on CT, but our results do suggest that the 
effects of genetic and environmental risks for SCZ are not the same.  
 
A further limitation within this study is that we were not able to conduct corroborative interviews 
with parents, for example, therefore, it is likely that there is some missing information for 
individual environmental risk factors. We therefore decided that missing information (NAs) 
should be recorded as a 0 when calculating the ERS. This was considered the best approach, 
in order to include as much information as possible without potentially overstating the effect of 
environmental factors on brain structure. Additional analyses were also conducted with all NAs 
removed and are reported in Appendix A2.2.3 (p5-9). The results of these analyses showed 
a similar pattern to those reported here but did not survive FDR correction. However, by 
removing the NAs a substantial amount of data was lost suggesting that the lack of significance 
may reflect low power rather than the lack of an effect. This outcome provides further support 
for the current approach, but analyses within a larger cohort is necessary to determine if the 
effects can be replicated. 
 
Together, our results suggest that experiencing environmental risks for SCZ contributes to 
localised cortical thinning in patients with SCZ and BD. Higher genetic loading is associated 
with global cortical thinning but does not account for the effects of environmental risk. We thus 
provide further evidence for a neurodevelopmental model for SCZ which posits that both 
environmental and genetic factors contribute to the development of the disorders. Further, our 
results suggest that it might be possible to develop intervention strategies to address 
environmental risks for SCZ and measure their effect on CT. 
 
2.8 Chapter Conclusion 
Chapter Two suggests that environmental and genetic risk factors for schizophrenia can 
impact upon cortical thickness; with polygenic risk impacting the global structure and 





accumulation of environmental risk factors were found to be related to lower cortical thickness 
in the temporal region. Thus, experiencing more than one environmental risk factor may be 
more detrimental to neurodevelopment, particularly if experienced early in the developmental 
process. However, to fully understand this relationship and how we can use this information 
to implement preventative measures, it is still of import that we investigate the specific effects 
of these individual factors on cortical structure. The next chapter will begin to address this 
issue using the factor birth weight as a proxy for obstetric complications. 
 
In this chapter we also presented the first results of an association between higher PGRS-
SCZ and lower global cortical thickness. However, given the lack of reproducibility of 
associations with total brain volume and PGRS-SCZ (Terwisscha van Scheltinga et al., 2013, 
Papiol et al., 2014, van der Auwera et al., 2015), this result requires replication (see Chapter 
Four). Moreover, due to the movement towards ‘Big Data’ (previously defined as > 1,000 
scans; Smith and Nichols, 2018) in the imaging field, this sample size of 43 patients and 32 
controls, may now be considered as inadequate to fully answer the question of the relationship 
between cortical thickness with schizophrenia-associated risk factors (Smith and Nichols, 
2018), particularly in relation to genetics (He et al., 2017). The remainder of the thesis is 
therefore focused on further investigating the link between genetic and environmental risk 

















































Exploring the causal relationship of birth weight on adult cortical brain 
structure in UK Biobank 
 
3.1 Background 
In Chapter Two it was suggested that environmental factors were related to cortical thickness 
but differently to PGRS-SCZ and at a more localised level. However, Chapter Two utilised 
data from the SFMH study which, despite being larger than most neuroimaging samples 
(Smith and Nichols, 2018) and containing some rich environmental risk factors and symptom 
severity phenotype data, is impeded by its sample size in relation to ‘Big Data’ standards 
(Smith and Nichols, 2018). The remaining chapters of the thesis therefore implement data 
from UKB. 
 
UKB (http://www.ukbiobank.ac.uk/) is a large-scale population-based study that, on its 
completion aims to have 500,000 MRI brain scans at its disposal. The current release of data, 
which is the data that will be utilised for the majority of the current thesis, consists of 3,875 
MRI scans which have measures of global, lobar and parcellated regions of the cortex. 
Furthermore, genetic data for 488,377 individuals is available in this sample. 
 
Very recently, a further ~10,000 MRI scans were released however, as quality checks of this 
data had not been completed before submission of this manuscript, only the global measures 
of cortical volume, thickness and surface area from the first data release (excluding global 
cortical outliers) were used in the proceeding chapters. With regards to the SFMH sample, 
phenotypic information was recorded for five environmental factors thus, an accumulation 
effect could be tested. We searched the UKB database for variables that may match those 
used in the second chapter. Unfortunately, there was no cannabis information and the 
variables for adverse life events, urbanicity and migration were either not appropriate, not 





conducted. No all-encompassing variable existed for obstetric complications however, birth 
weight, which has been previously used to infer intrauterine growth restriction (IUGR; 
Raznahan et al., 2012) was used as a meaningful proxy for this variable. We therefore only 
tested for an association between cortical structure and birth weight in the current chapter. As 
noted earlier, it is also important that we fully understand individual factors in relation to cortical 
structure, particularly if they are potentially modifiable  (Johnson et al., 2017, Stilo and Murray, 
2010). Obstetric complications are relatively common in the British population (occurring in 
around 6.9% of the population) (Johnson et al., 2017) and potentially modifiable through 
prenatal health initiatives (Clifford et al., 2013) thus, further investigation of its link to 
schizophrenia could prove fruitful and is thus studied in the upcoming chapter. As UKB is a 
population-based sample it will allow us to test if there is an effect of birth weight on brain 
structure in normal weight variations and therefore be more generalisable to non-clinical 
samples. In this chapter we also aim to determine if there are any causal links between these 
two phenotypes using the statistical analysis - Mendelian Randomisation. Additionally, we 
discuss what this potentially causal link could mean for brain development in general and in 
relation to the cortical deficits associated with schizophrenia.  
 
This chapter is presented as the manuscript which has been submitted to the International 
Journal of Epidemiology in which, I am the first author. I can also confirm that I was responsible 
for the design of the experiment, analysing the data and writing the paper for this submission. 
 
3.2 Paper: Exploring the causal relationship of birth weight on adult cortical brain 
structure in UK Biobank through Mendelian Randomisation 
 
3.3 Abstract 
Background: Differences in the brain’s cortical organisation are linked to common psychiatric 
disorders and differences in cognitive ability. Low birth weight (BW, < 2.5kg) is associated with 
alterations in cortical brain structure, lower cognitive ability and psychiatric problems; 





function in later life. However, the relationship between BW within the normal range and adult 
brain structure in the general population is little understood, including whether a causal 
relationship exists. We therefore sought to test if there is a causal relationship between BW 
and brain cortical morphology in an adult population-based sample using Mendelian 
Randomisation (MR). 
Methods: The current sample included 1,680 individuals from the first release of brain imaging 
data from UK Biobank (UKB). Linear mixed effects models were first used to test for 
associations between BW and global and localised regions of brain cortical volume, surface 
area and thickness. Secondly, to test for causal relationships between BW and cortical metric 
phenotypes we used a two-sample MR framework, applying the inverse-variance weighted 
method.  
Results: In the full population-based sample, higher BW was significantly associated with 
greater global cortical volume (β = .104, p = 2.86×-07) and surface area (β = .100, p = 3.58×10-
07) but not thickness (β = -.054, p = .097).  The strength of these effects were widespread  
across the cortical mantle, including frontal, temporal and insular regions (β range = .037, .069, 
pcorr range = .037, .010) as well as testing within the normal BW range (global cortical volume: 
β = .097, p = 5.64×10-06; global surface area: β = .088, p = 2.60×10-06). We performed a GWAS 
of BW in UKB (n = 201,586) to identify BW-associated SNPs as proxies for BW. MR indicated 
significant causal links between lower BW and lower cortical volume of the insular lobe (β 
= .346, pcorr = .009), as well as surface area globally (β = .281, p = .009), in the insular lobe (β 
= .371, pcorr = .005) and middle temporal (β = .287, p = .045), medial orbitofrontal (β =.417, 
pcorr = .006) and IFG (β =.512, pcorr = .009) parcels.  
Conclusions: Our findings extend previous studies providing evidence of a potential causal 
effect of BW, as indexed by genetic variants, on several measures of cortical volume and 
surface area. The current MR results may therefore also partially explain the links between 
increased risk of psychiatric and cognitive impairment in individuals with lower BW, even within 








Cortical configuration is fully established during foetal life, and is followed by increases in 
thickness and surface area over the first two postnatal years (Lyall et al., 2015). Studies, using 
a range of imaging techniques, have identified cortical deficits both specific to and shared 
among common psychiatric disorders and their development (Birur et al., 2017, Norman et al., 
2016, Savitz et al., 2013) as well as a decline in cognitive abilities (Cox et al., 2017). Early 
complications of pregnancy (such as preterm birth or intrauterine growth restriction; IUGR), 
which result in low BW, are closely associated with abnormal cortical structure (Kapellou et 
al., 2006, S. Miller et al., 2016). However, the effect of normal population variation in BW on 
adult cortical morphology is less well known. Since abnormalities of adult cortical morphology 
are implicated in various psychiatric disorders (Lyall et al., 2015) and cognitive decrements 
(Richetto and Riva, 2014, Markham et al., 2010, Richards et al., 2002, Richards et al., 2001), 
indication of a link between BW and adult cortical structure, in the population-based samples, 
could provide further evidence that prenatal growth is implicated in their aetiology. 
Furthermore, quantifying the role of early-life determinants of cortical structure could signpost 
prenatal modifiable risk factors to minimise detrimental effects on the cortex. 
 
Preterm birth and IUGR are the leading causes of low and very low birth weight (LBW <2.5kg; 
VLBW <1.5kg) which are associated with impairments in cortical structure development that 
are apparent during the neonatal period (S. Miller et al., 2016, Kapellou et al., 2006). For 
individuals with LBW, VLBW or born small for gestational age, who underwent MRI between 
ages 6 and 19 years (n range = 55-157), lower BW was associated with lower global (De Bie 
et al., 2011, Martinussen et al., 2005) and regional surface area; predominantly in frontal and 
parietal gyri (Skranes et al., 2013). Lower global and regional volume has also been found in 
those with LBW compared to those born at term and appropriate for gestational age (De Bie 
et al., 2011, Taylor et al., 2011, Boardman et al., 2007, Martinussen et al., 2005). Conversely, 
those with LBW, have demonstrated regional thinning in some regions (e.g. parietal, temporal 
and occipital lobes) but thickening in others (e.g. frontal, cingulate and occipital lobes) (Bjuland 





compared to BW in the normal range have also found reduced cognitive ability, as defined by 
language and intelligence measures, in childhood (age range = 6 months-13 years old; n range 
= 64-53,000) and adulthood (Age = 18 years old; n = 161) (Goisis et al., 2017, Chaudhari et 
al., 2013, Torche and Echevarría, 2011, Ortiz-Mantilla et al., 2008, Tong et al., 2006); leading 
to an increased need for educational support (Johnson and Marlow, 2017, Johnson et al., 
2009). Furthermore, LBW has also been identified as a risk factor for developing a spectrum 
of adult psychiatric disorders, including schizophrenia, autism and attention-deficit 
hyperactivity disorder (Lærum et al., 2017, Rubio-Abadal et al., 2015, Forsyth et al., 2013, 
Indredavik et al., 2004, Cannon et al., 2002, Geddes and Lawrie, 1995); with poorer cognitive 
ability also noted in these psychiatric populations (Lærum et al., 2017, Forsyth et al., 2013). 
Thus, extremes of low BW may influence adult brain cortical structure and inform 
developmental origins of cognitive difficulties and psychiatric disorders. 
 
Although findings from LBW or VLBW populations have been informative, LBW affects around 
7% in the UK population and outcomes are confounded by preterm birth, IUGR, placental 
insufficiency, and maternal medical conditions (Johnson et al., 2017); therefore the 
relationship between BW and brain structure/function for the general population with BW in 
the normal range (2.5-4.5kg (Goisis et al., 2017, Haukvik et al., 2014)) is uncertain. A small 
number of studies of appropriately grown individuals born at full term have reported links 
between subtle variations in BW and differences in brain structure later in life (Haukvik et al., 
2014, Raznahan et al., 2012, Walhovd et al., 2012). Specifically, higher BW was associated 
with higher global cortical volume (Raznahan et al., 2012, Walhovd et al., 2012) and 
widespread higher surface area (Walhovd et al., 2012), including frontal, temporal and parietal 
lobes  (Haukvik et al., 2014, Raznahan et al., 2012). Raznahan et al. ( 2012) (n  = 450) also 
found a positive relationship between BW and global cortical thickness however, Haukvik et 
al. (2014) (n  = 359) did not find an association with this metric. Such inconsistencies indicate 
that further testing of the relationship between BW and cortical structure, amongst individuals 






Within normal BW samples, higher BW has also been related with higher cognitive ability in 
childhood (aged 7-15 years) (Shenkin et al., 2004, Richards et al., 2001) and adulthood (aged 
18 -79 years) (Grove et al., 2017), as well as higher cortical surface area, predominantly in the 
prefrontal cortex (Walhovd et al., 2016). Lower BW, within the normal range, has also been 
related to an increased risk for developing a range of psychiatric disorders (Abel et al., 2010) 
as well as lower surface area in individuals across the psychosis spectrum (Haukvik et al., 
2014). Thus, the associations between normal variations in BW and brain structure may also 
be present across the life course and be a potential contributor to the development of cognitive 
and psychiatric disorders. However, with the exception of surface area (Walhovd et al., 2016), 
these BW and cortical morphology associations have only been formally tested in samples up 
to ~30 years old (Haukvik et al., 2014, Raznahan et al., 2012). Furthermore, there has been 
no formal testing of whether this is a causal relationship.  
 
BW is influenced by both genetic and environmental factors (Gielen et al., 2008), with 
heritability estimates of between 26 and 30% from twin-based studies (Mook-Kanamori et al., 
2012). Furthermore, up to 60 single nucleotide polymorphisms (SNPs) have been associated 
with BW at the level of genome-wide significance (Horikoshi et al., 2016, Horikoshi et al., 
2013), explaining 2.0% (S.E ±1.1%) of the variance in BW and a genome-wide SNP-based 
heritability estimate of 15.1% (S.E ±0.9)  (Horikoshi et al., 2016). BW-associated SNPs can be 
used as genetic instruments to test for a causal influence of BW (the exposure) on cortical 
structure (the outcome) and act as unconfounded proxies for BW across the lifespan. The 
current study used two-sample, Mendelian randomisation (MR) to test whether the BW-cortical 
structure association indicates a causal relationship between BW and cortical morphology. 
Fig. 3.1 outlines the MR model and its assumptions - the Instrumental Variable (IV), consisting 
of SNPs robustly associated with the exposure (BW) is used to determine if the exposure 
causally affects the outcome (brain cortical structure). The current study identified 85 
independent BW-associated SNPs. These SNPs were identified by performing a GWAS of 
BW in a UK Biobank (UKB) sample (excluding individuals with imaging data) larger than that 





Ideally, genetic variants, which have a robust and well understood biological effect on the trait, 
would be used as instruments to determine causation (Davey Smith and Hemani, 2014). 
However, individual SNPs for complex traits tend to have small effect sizes, and often make 
for weak instrument variables (Hagenaars et al., 2017). Using multiple SNPs can increase the 
predictive power of the instrument however, this can also increase the likelihood of pleiotropic 
effects occurring and, in turn, violate the MR assumptions (Hagenaars et al., 2017, Davey 
Smith and Hemani, 2014). MR Egger methods were used for sensitivity analyses, including 
tests of heterogeneity and horizontal pleiotropy, to test for any violations of these assumptions 
(see Davey Smith and Hemani, 2014). 
 
 
Fig. 3.1 Model outlining the assessed pathway for Mendelian Randomisation and its assumptions. 
MR analysis is subject to three assumptions; 1) there is an association between the genetic variants of 
the exposure and the exposure itself; 2) the genetic variants are independent of any confounding factors 
that are related to the association between the exposure and the outcome; and 3) the genetic variants 
are independent of the outcome and therefore can only be associated with the outcome by operating 
through the exposure (this is also known as the exclusion restriction) (Bowden et al., 2016). Path 
numbers 1, 2 and 3 in the figure correspond to these assumptions. Adapted from Bowden et al. (Bowden 
et al., 2016).  
 
The current study therefore extends the current literature by testing 1,680 individuals over 45 
years old for associations between BW (in a population-based sample) and brain cortical 
volume, surface area and thickness (both globally and regionally). Notably, as we are treating 
BW as a continuous as opposed to a dichotomous variable, we are increasing its statistical 
power. Furthermore, testing of BW in the normal range, allows for results to be more 
generalisable to the whole population. Lastly, the application of MR to formally determine if 





associations between BW and cortical structure whereby higher BW would be linked with 
larger global cortical volume and global and regional surface area (particularly in frontal, 
temporal and parietal regions), and that these associations would be indicative of a causal 
relationship. No hypotheses of cortical thickness were made due to inconsistency of findings 
in the literature. 
 
3.5 Methods 
3.5.1 Participants Detailed participant information has been reported previously (Cox et al., 
2016) (http://www.ukbiobank.ac.uk/participants/), see Appendix B3.1.1 (p21-22). The current 
sample included white British, individuals with complete genetic, cortical and BW data, for three 
cortical parameters; cortical volume, surface area and thickness. Only individuals who reported 
to not be part of a multiple birth were included 
(http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=1777). Furthermore, global cortical outliers 
(±3 S.Ds), were removed for all three cortical parameters, resulting in a current sample of 1,680 
individuals (nmales/nfemales = 703/977; mean age at time of scan = 60.76 years, S.D = ±7.40 
years, range = 46-78 years) (Reus et al., 2017, Shen et al., 2017). We note here that the UKB 
sample is not considered to be representative of the general population, due to evidence of a 
‘healthy volunteer’ selection bias however, it can still be used to scientifically infer possible 
exposure ~ health outcome associations that may be generalised to wider populations (Fry et 
al., 2017). Ethical approval for UKB was received from the research ethics committee (REC 
reference 11/NW/0382) under application 4844. Informed consent was provided from all 
participants (see http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=200). 
 
3.5.2 Imaging Procedures UKB imaging details are described in full elsewhere (Alfaro-
Almagro et al., 2017, Cox et al., 2016, K. Miller et al., 2016), 
https://biobank.ctsu.ox.ac.uk/crystal/docs/brain_mri.pdf). In summary, images were acquired 
on a single 3T Siemens Skyra scanner. Structural brain images were acquired in the sagittal 
plane using a T1-weighted, three-dimensional, magnetization-prepared rapid gradient-echo 





on the imaging protocol (http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=2367) and imaging 
acquisition parameters (http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=1977) are 
documented online. Brain scans were anonymised at the time of acquisition and were 
processed locally on a server cluster at the Centre for Cognitive Ageing and Cognitive 
Epidemiology (CCACE, http://www.ccace.ed.ac.uk/), in Edinburgh using FreeSurfer (v5.3, 
http://surfer.nmr.mgh.harvard.edu/).  
 
3.5.3 MRI Analysis We processed the T1-W volumes from the first UKB imaging release 
locally to derive cortical measures of thickness (mm), surface area (mm2) and volume (mm3), 
for further details see Appendix B3.1.2 (p22-24). Briefly, parcellation of cortical structures was 
conducted in FreeSurfer v5.3 using the Desikan-Killiany neuroanatomical atlas (Desikan et al., 
2006). This generated 34 bilateral cortical parcels that can be attributed to eight lobar 
structures, each with volume, surface area and mean thickness measures (Desikan et al., 
2006). Eleven parcels were combined into four larger regions as previously described  (Cox 
et al., 2017, Klein and Tourville, 2012); resulting in 27 bilateral regions of interest (ROIs) which 
were assigned to one of nine lobar regions, see Appendix B3.1.2 (p22-24). The X, Y and Z 
co-ordinates of the centre of the brain mask within the scanner 
(http://biobank.ctsu.ox.ac.uk/showcase/field.cgi?id=25756, 
http://biobank.ctsu.ox.ac.uk/showcase/field.cgi?id=25757, 
http://biobank.ctsu.ox.ac.uk/showcase/field.cgi?id=25758)  were also fitted as covariates for 
the current analyses to account for varying head positions in the scanner; see Appendix 
B3.1.3 (p24-25) for further information on these variables.  
 
3.5.4 MRI Quality Control Procedures Quality checks were conducted on the success of 
processing on all scans. T1-weighted images were initially carried out by UKB (Brain Imaging 
Documentation V1.1, http://www.ukbiobank.ac.uk, Alfaro-Almagro et al., 2018) with further 
Quality Control (QC) procedures conducted locally. For local QC procedures see (Cox et al., 
2017) and http://enigma.ini.usc.edu/protocols/imaging-protocols/), images were visually 





identification issues) which removed 458 scans, see Appendix B Fig. B3.1 (p22). The 
remaining 3,875 scans were then assessed for minor errors (e.g. erroneous boundary 
placement, minor skull stripping issues and minor tissue omission) which resulted in removal 
of individual regions within scans (6,192 of the possible 295,052 regions were removed).  As 
global information was largely unaffected by the FreeSurfer reconstruction process, global and 
lobar values were extracted from the data with major errors removed but did not undergo QC 
exclusion for minor errors. However, exclusion of global cortical outliers (±3 S.D.s) provided a 
further internal imaging QC as in previous publications (Reus et al., 2017, Shen et al., 2017).  
 
3.5.5 Measure of Birth Weight Participants were asked to provide their own BW information. 
Recalled BW has been shown to have high agreement with recorded BW (r = .90) and 
considered a valid and suitable measure for epidemiological studies (Shenkin et al., 2017). 
BW data were collected at initial assessment and at the first repeat assessment 
(http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=20022). As information from both instances 
were comparable (r = .94), the BW variable included data from instance one as default, NA 
values from instance one were replaced by data from instance two. The BW range in the 
current sample was .91-5.78kg (mean = 3.39kg, S.D = ± .61kg). Participant numbers were 
calculated for normal (2.5-4.5kg (Haukvik et al., 2014, Goisis et al., 2017)) n = 1,471 (87.56%); 
LBW (1.5-2.5kg) n = 116 (6.90%); VLBW (<1.5kg) n = 8 (0.48%); and high BW (>4.5kg) n = 
85 (5.06%) ranges. As the aim of the current study was to analyse BW range in the general 
population, the initial analyses used the full range of BW information. However, further 
analyses were conducted to determine if the same patterns occurred in the normal BW range 
only.                                              
                                                                                                                         
3.5.6 Covariates Socioeconomic Deprivation was measured using the Townsend deprivation 
index (range = -6.26 – 9.16, mean = -2.04, S.D = ±2.63), calculated when the participant joined 
the UKB study. Individuals were assigned a score based on census output regarding their 
postcode (http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=189). Standing height was 





and was collected at initial assessment, first repeat assessment and at time of scan 
(http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=50), data from both instances were 
comparable (r = .99). As with BW, data from the first instance was used by default and missing 
values from instance one were replaced by data from instance two. 
 
3.5.7 Statistical Analysis - Phenotypic Associations All phenotypic analyses were 
conducted in R (v3.2.3) using a linear mixed effects (LME) model in package “nlme” (v3.1-127, 
Pinheiro et al., 2017), to determine whether cortical structures were associated with BW. LME 
models were first conducted in a repeated measures format with hemisphere fitted as a 
random factor. Analyses were also conducted to determine if there was a BW × hemisphere 
interaction which would require testing as an independent measure. This process was 
repeated for participants within the normal BW range (2.5 - 4.5kg) to test for associations that 
could not be skewed by extreme BW values. 
For regions that resulted in significant interactions (P < .05), analyses were conducted with an 
independent measure design using linear regression models without hemisphere as a 
covariate and reported as two separate structures in the results section.  
An LME model was tested across the full and normal BW range. This model included age, 
age2, sex and X, Y and Z co-ordinates of the brain mask within the scanner, height, Townsend 
deprivation index, and 15 principal components (see Appendix B3.1.3, p24-25), to account 
for population stratification (Bycroft et al., 2017), as fixed effects. 
Intracranial volume (ICV) was also included as a fixed effect for lobar and parcellation analyses 
to control for the size of specific regions relative to the whole brain. This measure of ICV was 
derived based on a UKB imaging derived phenotype (IDP), similar to that calculated by 
Statistical Parametric Mapping methods (https://www.fil.ion.ucl.ac.uk/spm/) whereby grey 
matter, white matter and ventricular cerebral spinal fluid are added together. Although this 
measure is different to traditional measures of ICV (e.g. FreeSurfer; 
https://surfer.nmr.mgh.harvard.edu/fswiki/eTIV), the authors do not expect this covariate to 
make any substantial changes to the results for two reasons. Firstly, this measure is highly 





(http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=25000) available in UKB (r = .898) and 
secondly, this measure has been validated in previous studies (e.g. Ritchie et al., 2018, Shen 
et al., 2017). 
Here we only report statistically significant associations (P < .05) between BW and cortical 
brain structure from these models however, results for all other regions can be found in 
Appendix B3.2.1.2 (p32-47). In line with previous studies, we also tested a Base model for 
both the whole and normal BW range which did not include additional covariates (see 
Covariates) (Haukvik et al., 2014, Raznahan et al., 2012). See Appendix B3.1.5 (p25-26) for 
further details. 
Standardised regression coefficients are reported throughout. Utilising the ‘p.adjust’ function 
in R (‘stats’ package v3.2.3), the false discovery rate (FDR) method, with a rate of P < .05 
(Genovese et al., 2002), was used to correct lobar and parcellation results for multiple 
comparisons. 
 
3.5.8 Genotyping and Imputation Processing Procedures for genotyping, imputation and 
quality control for UKB have been reported previously (Howard et al., 2018, Luciano et al., 
2018, Bycroft et al., 2017, Wain et al., 2015). Briefly, 488,377 blood samples were assayed 
using two different genotyping arrays; Applied Biosystems UK BiLEVE Axiom Array by 
Affymetrix (Wain et al., 2015) and Applied Biosystems UKB Axiom Array 
(http://www.ukbiobank.ac.uk/wp-content/uploads/2014/04/UK-Biobank-Axiom-Array-Content-
Summary-2014.pdf). Further information on these arrays can be found in Appendix B3.1.4 
(p25).  
Genetic QC was performed using the approach described by Howard et al. (2018). Firstly, 
participants were excluded based on shared genetic relatedness up to the third degree using 
kinship coefficients (>.044) identified using the KING toolset (Manichaikul et al., 2010), as 
previous (Howard et al., 2018, Bycroft et al., 2017). To maximise the sample, we subsequently 
added back in one member from each group of related individuals, using a genomic 
relationship matrix, and selected only those with a relatedness of less than .025 with any other 





ethnicity and a PC analysis (see Appendix B, p22 and 24) which revealed individuals with 
similar ancestral backgrounds. The final QC exclusion criteria included variant missing-ness 
per individual (>2%), gender mismatch, variant call rate (<98%), Hardy-Weinberg equilibrium 
(P < 10-6), minor allele frequency < .01, an imputation quality < .1, resulting in 331,374 
individuals and 7,730,951 variants. 
 
3.5.9 Instrumental Variable – Exposure We conducted a GWAS of BW using the UKB 
BGENIE pipeline (Bycroft et al., 2017), in order to identify genome wide significant, BW-
associated SNPs. This analysis was conducted using a subset of the UKB sample, 
independent from those with imaging data used in the, phenotypic, cortical brain structure ~ 
BW association analysis and excluded individuals who were part of a multiple birth (n = 
201,586, see Appendix B, Fig. B3.3, p48). Genome-wide SNP-based heritability for BW 
estimated in this sample was 10% (S.E ±0.5%). In order to identify independently-associated 
BW SNPs we utilised Functional Mapping and Annotation of genetic associations software 
(FUMA, http://fuma.ctglab.nl/, Watanabe et al., (2017)), resulting in the identification of 114 
genome wide significant SNPs (P < 5×10-8) with a MAF > 0.01 and HWE P < 1×10-6. Clump-
based linkage disequilibrium (LD) pruning was performed with a R2 of < 0.1 within a 250kb 
window. See Fig. 3.2, Table 3.1. These 114 SNPs explained 3% of the variance of BW in 








Fig. 3.2  Manhattan plot of independently associated birth weight SNPs identified using 
FUMA (Watanabe et al., 2017) 
 
 
Additional quality control of the data was conducted using the ‘clump_data’ and 
‘harmonise_data’ functions in the ‘TwoSampleMR’ (Hemani et al. 2018) package for R (v0.4.5) 
to ensure that the exposure and the outcome effects were on the same reference allele and 
no SNPs were in LD with each other. This resulted in the removal of an additional 27 SNPs 
with R2 > 0.001 as well as two SNPs which were palindromic with intermediate allele 







                        Table 3.1 85 Birth weight associated single nucleotide polymorphisms (SNPs) used in the current study 
 Genome-wide 
Significant SNPs 









1 rs13322435 LINC02029 3 G A 0.404 0.411 0.240 -0.047 0.003 1.69×-53 
2 rs1374205 - 2 C T 0.700 0.692 0.007 0.041 0.003 5.20×-33 
3 rs7306710 - 12 C T 0.519 0.528 0.210 -0.036 0.003 1.42×-32 
4 rs11708067 ADCY5 3 G A 0.243 0.239 0.712 0.039 0.003 3.04×-29 
5 rs222857 ELP5/CLDN7 17 T C 0.571 0.565 0.363 0.031 0.003 2.27×-24 
6 rs145965565 PTCH1 9 G T 0.095 0.091 0.206 0.047 0.005 3.84×-20 
7 rs34776209 IGF2BP3 7 T C 0.248 0.244 0.986 -0.031 0.003 1.35×-19 
8 rs3184504 SH2B3 12 C T 0.518 0.537 0.399 0.027 0.003 3.08×-19 
9 rs11187141 - 10 T A 0.376 0.378 0.706 0.027 0.003 8.87×-19 
10 rs9368222 CDKAL1 6 A C 0.262 0.261 0.641 -0.030 0.003 2.11×-18 
11 rs979532 LCORL 4 T C 0.739 0.741 0.574 -0.028 0.003 6.40×-17 
12 rs9909342 - 17 A G 0.383 0.391 0.793 0.026 0.003 7.13×-17 
13 rs28429551 GPSM1 9 A T 0.755 0.758 0.703 -0.028 0.003 2.59×-16 
14 rs9645500 HKDC1 10 G T 0.693 0.681 0.020 0.026 0.003 6.12×-16 
15 rs7744700 - 6 A T 0.292 0.289 0.578 -0.027 0.003 7.05×-16 
16 rs2047408 TET2 4 C G 0.669 0.670 0.402 -0.026 0.003 8.87×-16 
17 rs11698914 COMMD7 20 G C 0.771 0.764 0.481 -0.029 0.004 1.31×-15 
18 rs72851023 - 11 T C 0.076 0.074 0.657 0.044 0.006 6.22×-15 
19 rs12692386 ADAM17 2 G A 0.672 0.674 0.404 0.025 0.003 8.11×-15 
20 rs7772579 ESR1 6 C A 0.277 0.277 0.743 -0.026 0.003 1.31×-14 
21 rs7402983 IGF1R 15 C A 0.601 0.605 0.429 -0.024 0.003 1.82×-14 
22 rs2793003 RC3H2 9 C T 0.855 0.843 0.436 -0.032 0.004 2.19×-14 
23 rs12206634 SESN1 6 A G 0.121 0.121 0.992 0.035 0.005 5.31×-14 
24 rs2131354 HHIP 4 A G 0.528 0.518 0.354 0.022 0.003 7.06×-14 
25 rs798528 GNA12/AMZ1 7 C A 0.305 0.299 0.580 -0.024 0.003 7.31×-14 





27 rs515071 ANK1 8 G A 0.761 0.762 0.364 0.026 0.004 1.06×-13 
28 rs1801253 ADRB1 10 C G 0.737 0.732 0.289 0.025 0.003 1.68×-13 
29 rs12205495 TULP1 6 A T 0.218 0.212 0.384 0.026 0.004 3.64×-13 
30 rs10883846 - 10 T C 0.394 0.386 0.171 -0.022 0.003 5.09×-13 
31 rs2291261 ITPR2 12 A G 0.488 0.478 0.897 -0.022 0.003 6.18×-13 
32 rs11739073 - 5 A T 0.155 0.155 0.325 -0.029 0.004 9.38×-13 
33 rs12713004 KLHL29 2 G A 0.726 0.720 0.258 0.023 0.003 6.49×-12 
34 rs905938 ZBTB7B 1 C T 0.265 0.261 0.689 0.023 0.003 7.05×-12 
35 rs667515 - 11 C G 0.386 0.382 0.197 -0.021 0.003 7.93×-12 
36 rs4748981 - 10 C A 0.669 0.672 0.191 -0.022 0.003 1.13×-11 
37 rs768056 - 9 T C 0.177 0.178 0.276 0.027 0.004 1.33×-11 
38 rs1135856 PRR34 22 C T 0.292 0.284 0.816 -0.022 0.003 2.39×-11 
39 rs12656357 - 5 A T 0.217 0.214 0.160 -0.024 0.004 7.71×-11 
40 rs7336104 - 13 T C 0.178 0.176 0.382 -0.026 0.004 7.82×-11 
41 rs6467157 SND1 7 C T 0.295 0.289 0.734 -0.022 0.003 8.59×-11 
42 rs6513671 - 20 G A 0.383 0.382 0.777 0.020 0.003 1.00×-10 
43 rs12675643 - 8 A T 0.237 0.241 0.088 0.023 0.004 1.06×-10 
44 rs4681161 CPA3 3 C T 0.559 0.546 0.390 -0.019 0.003 1.70×-10 
45 rs2779165 UHRF1 19 C G 0.813 0.819 0.691 -0.024 0.004 4.48×-10 
46 rs3754140 PROX1 1 C T 0.262 0.260 0.986 0.021 0.003 5.23×-10 
47 rs817329 ZNF512B 20 G T 0.595 0.593 0.820 -0.019 0.003 5.30×-10 
48 rs2042874 LHFPL2 5 G A 0.432 0.426 0.010 0.019 0.003 5.34×-10 
49 rs62496915 MCPH1 8 G C 0.117 0.118 0.379 0.029 0.005 6.52×-10 
50 rs80089232 MLXIPL 7 C T 0.070 0.066 0.335 0.036 0.006 6.92×-10 
51 rs5762980 KREMEN1 22 G A 0.651 0.652 0.383 -0.019 0.003 1.00×-09 
52 rs255773 LILRB3 19 T C 0.465 0.460 0.028 -0.018 0.003 1.31×-09 
53 rs12889267 ARHGEF40 14 G A 0.167 0.164 0.325 -0.024 0.004 1.39×-09 
54 rs9827156 KLHL24 3 A G 0.261 0.273 0.225 -0.021 0.003 1.40×-09 
55 rs339969 RORA 15 A C 0.615 0.618 0.959 0.018 0.003 2.06×-09 
56 rs7941126 MAP3K11/KCNK7 11 G A 0.504 0.500 0.029 -0.018 0.003 2.13×-09 





58 rs13231861 CALCR 7 G A 0.451 0.442 0.250 0.018 0.003 2.55×-09 
59 rs57414412 - 11 A G 0.288 0.286 0.133 -0.020 0.003 2.72×-09 
60 rs13257363 SLC45A4 8 A G 0.411 0.404 0.139 -0.018 0.003 3.52×-09 
61 rs1476096 - 5 C A 0.581 0.590 0.073 0.018 0.003 4.05×-09 
62 rs74819596 DLK1 14 T C 0.108 0.104 0.453 -0.028 0.005 5.30×-09 
63 rs3217870 CCND2 12 T C 0.606 0.609 0.004 -0.018 0.003 5.51×-09 
64 rs2934844 PDE10A 6 T A 0.670 0.678 0.332 0.019 0.003 6.32×-09 
65 rs3806315 PTPN14 1 A G 0.594 0.577 0.347 0.018 0.003 8.20×-09 
66 rs55863716 - 11 A G 0.264 0.263 0.101 0.020 0.003 8.29×-09 
67 rs6873192 PIK3R1 5 G A 0.516 0.523 0.492 -0.017 0.003 9.27×-09 
68 rs116849452 ZNF888 19 G C 0.056 0.054 0.840 -0.038 0.007 1.00×-08 
69 rs4932373 FURIN 15 C A 0.325 0.319 0.745 -0.018 0.003 1.05×-08 
70 rs12656216 SKP2 5 A G 0.786 0.768 0.007 0.021 0.004 1.16×-08 
71 rs6971880 - 7 A T 0.064 0.072 0.744 -0.035 0.006 1.41×-08 
72 rs10741669 KCNQ1 11 A G 0.880 0.880 0.309 0.026 0.005 1.43×-08 
73 rs5030317 WT1 11 G C 0.267 0.286 0.024 -0.019 0.003 1.49×-08 
74 rs6930558 - 6 T G 0.745 0.750 0.270 0.020 0.003 1.58×-08 
75 rs7724489 - 5 T A 0.874 0.866 0.227 -0.025 0.005 1.63×-08 
76 rs7016987 ZFPM2 8 T C 0.194 0.206 0.254 0.021 0.004 1.65×-08 
77 rs9603672 - 13 A G 0.888 0.874 0.774 -0.027 0.005 1.73×-08 
78 rs4320142 STPG2 4 G T 0.248 0.248 0.641 0.019 0.003 2.34×-08 
79 rs2229742 NRIP1 21 C G 0.104 0.100 0.125 -0.027 0.005 2.56×-08 
80 rs975451 SLC35D1 1 C T 0.734 0.741 0.587 -0.019 0.003 2.86×-08 
81 rs118106744 - 12 T C 0.054 0.052 0.011 -0.036 0.007 3.34×-08 
82 rs41355649 CEBPA 19 A G 0.068 0.065 0.251 -0.033 0.006 3.40×-08 
83 rs2918307 - 19 G A 0.153 0.154 0.200 -0.023 0.004 3.85×-08 
84 rs1014448 - 12 T C 0.927 0.927 0.377 0.033 0.006 4.45×-08 
85 rs62157841 TMEM87B 2 A G 0.394 0.386 0.012 -0.017 0.003 4.61×-08 
                           Chr = chromosome, SNPs were annotated to genes using the Ensembl Variant Effect Predictor (McLaren et al., 2016), 
                        A positive effect size means that the effect allele for the SNP increases BW whereas a negative effect size means that the  






3.5.10 Instrumental Variable – Outcome The same UKB BGENIE pipeline (Bycroft et al., 
2017), as described above in relation to the IV-exposure, was utilised to conduct GWAS for 
cortical structures in a subset of the UKB sample with imaging data, independent from that of 
the sample used to perform the BW GWAS (n = 2,913). This sample is larger than that used 
for the phenotypic analysis as it was not restricted to individuals who also had BW data. The 
same summary statistics (major and minor alleles for each SNP, allele frequencies, beta 
coefficients, p-values and S.E) were extracted in order to form an IV-exposure for each of the 
cortical regions. 
 
3.5.11 Statistical Analysis - Two-Sample Mendelian Randomization Two-sample MR 
analysis was conducted as described in previous publications (Noyce et al., 2017, Bowden et 
al., 2016, Bowden et al., 2015) and as outlined below. This was applied on a region of interest 
(ROI) basis, where only cortical structures which were significantly phenotypically associated 
(P < .05) with BW (see Phenotypic Associations) were tested. We conducted a two-sample, 
Inverse-Variance Weighted (IVW) regression analysis using the MR Base R package 
‘TwoSampleMR’ (v0.4.5, https://mrcieu.github.io/TwoSmpleMR/). This analysis uses an 
Instrumental Variable (IV) which consisted of the 85 BW-associated SNPs, identified above. 
The IVW method performs a regression of two vectors (IV-exposure ~ IV-outcome) with the 
intercept constrained to zero; constraining the intercept to zero makes the assumption that all 
variants (SNPs) are valid IVs. Weighting the association by standard error allows correction 
for minor allele frequency (see Bowden et al. (2016)). MR analyses were also corrected for 
multiple comparison using FDR (R ‘stats’ package v3.2.3), with a rate of P = .05. ‘Single SNP’ 
and ‘leave-one-out’ sensitivity analyses were conducted to determine if a single variant was 
producing disproportionate effects, using the IVW method. To ensure that the third MR 
assumption was not violated (that the IVs are valid, showing no evidence of heterogeneity or 
horizontal pleiotropy) we used the ‘mr_heterogeneity’ and ‘mr_pleiotropy’ functions in the 
‘TwoSampleMR’ package. Heterogeneity was tested using IVW Cochran’s Q, with a P-value 
> 0.05 suggesting a lack of heterogeneity.  To test for pleiotropy, we used the MR-Egger 





similar to IVW regression. An intercept that is significantly different from zero in MR-Egger 
regression (P < .05) would suggest pleiotropic effects which will bias the IVW estimate (Noyce 
et al., 2017). 
 
3.6 Results 
3.6.1 Demographics In the current sample, BW was tested using the whole range within the 
population-based sample (n = 1,680) as well as individuals within the normal BW range (n = 
1,471). Fig. 3.3 shows the distributions of the two BW ranges.  
 
Fig. 3.3 Distribution of birth weight in kg Graph showing the distribution of the whole birth weight 
range in kg (dark grey and light grey areas combined, n = 1,680) where the light grey area represents 
BW in the normal range (n = 1,471) 
 
BW was significantly associated with sex (whole BW range: X2 = 89.376, p < 2.20×10-16; 
normal BW range: X2 = 76.368, p < 2.20×10-16); males had higher BW than females, and height 
(whole BW range: r = .267, p < 2.20×-16; normal BW range: r = .218, p < 2.20×10-16); taller 
individuals had higher BW, see Table 3.2. No significant associations were found between 
BW and age at scan (whole BW range: r = -.005, p = .775; normal BW range: r = -.008, p = 
.678) or Townsend deprivation score (whole BW range: r = .016, p = .340; normal BW range: 































***p corr ≤ .001, **p corr ≤ .01, *p corr ≤ .05,    .  p corr ≤ .10,  




Whole BW range 
 (n = 1,680) 
Normal BW range 
(n = 1,471) 
Range Mean S.D Statistics Range Mean S.D Statistics 
Sex 
- - - 
X2 = 89.376, p < 
2.20×10-16*** - - - 
X2 = 76.368, p < 
2.20×10-16*** 
Male  0.91 – 5.78 3.50 0.61 - 2.52 – 4.45 3.48 0.41 - 
Female 0.96 – 5.44 3.31 0.59 - 2.52 – 4.45 3.38 0.42 - 
Height 
143 - 194 169.14 9.32 
r = .267, p < 
2.20×10-16*** 143 - 194 169.18 9.18 
r = .218, p < 
2.20×10-16*** 
Age at time 
of scan 46 - 78 60.76 7.40 r = -.005, p = .775 
46.08 – 
77.83 60.62 7.41 r = -.008, p = .678
Townsend 
Deprivation 
Scale -6.26 – 9.16 -2.04 2.63 r = .016, p = .340 
-6.26 – 
9.16 -2.08 2.59 r = .025, p = .176 
73 
 
3.6.2 Associations Between Birth Weight and Cortical Structure Results for BW × 
hemisphere interactions on cortical structure can be found in Appendix B3.2.1.1 (p27-31). 
Results for regions with significant interactions are reported below as independent left and 
right structures. 
 
3.6.2.1 Cortical volume: There was a significant positive association between cortical volume 
and BW globally (β = .104, p = 2.86×10-07, R2 = .011) for three lobes (β range = .041, .052, 
pcorr = .009), and two out of the three individual parcels (β range = .070, .068, pcorr range = 
.028, .009); higher BW was related to larger cortical volumes in these regions. However, higher 
BW was associated with lower volume of the left lateral occipital parcel (β = -.059, pcorr = .028, 
R2 = 0.004). (See Table 3.3, Fig. 3.4). Results using a Base model to test these associations 
were largely similar, see Appendix B3.2.1.2 (p33-36). 
 
3.6.2.2 Cortical surface area: Higher BW was associated with higher global surface area (β 
= .100, p = 3.58×10-07, R2 = .010) along with the insular (β = .041, pcorr = .044) and parietal (β 
= .037, pcorr = .037) lobes, and several individual parcels (β range = .056 - .069, pcorr range = 
.035 - .010), including the middle temporal (β = .069, pcorr = .010) medial orbitofrontal (β = .056, 
pcorr = .032) and inferior frontal gyrus (IFG) (β = .059, pcorr = .035). See Table 3.3. 
 
3.6.2.3 Cortical thickness: No association was found between BW and global cortical 
thickness. However, negative associations were found between BW and the lateral occipital 














Table 3.3 Significant associations (Pcorr < .05) between birth weight and cortical 
structure using the whole birth weight range 
Brain Measure Effect 
Size 
S.D p value pcorr R2 
                   Cortical Volume 
Global 0.104 0.020 2.86 ×10-07*** - 0.011 
Lobes 
Insula 0.049 0.017 0.003 0.009** 0.002 
Parietal 0.041 0.013 0.002 0.009** 0.002 
Postcentral 0.052 0.017 0.002 0.009** 0.003 
Parcellations 
Left Lateral Occipital 
-0.059 0.020 0.003 0.028* 
 
0.004 
Middle Temporal 0.068 0.020 0.001 0.009** 0.005 
Supramarginal 0.070 0.020 0.001 0.009** 0.005 
               Cortical Surface Area 
Global 0.100 0.020 3.58 ×10-07*** -  0.010 
Lobes 
Insula 0.041 0.016 0.011 0.044* 0.002 
Parietal 0.037 0.013 0.005 0.037* 0.001 
Parcellations 
Medial Orbitofrontal 0.056 0.019 0.003 0.032* 0.003 
Middle Temporal 0.069 0.019 3.50×-04 0.010* 0.005 
Supramarginal 0.059 0.020 0.003 0.032* 0.004 
Inferior Frontal Gyrus 0.059 0.021 0.005 0.035* 0.003 
                Cortical Thickness 
Parcellations 
Lateral Occipital -0.097 0.026 1.70×10-04 0.005** 0.009 
***p corr ≤ .001, **p corr ≤ .01, *p corr ≤ .05, . p corr ≤ .10,  
Associations between birth weight and cortical volume, surface area and thickness n = 1,680). For clarity, 
only significant associations are reported here and left and right entries are displayed for regions with 









Fig. 3.4 Effect sizes and corrected p values for cortical parcellations Figures depicting a) 
effect sizes (standardised beta) and b) corrected p values for associations between the whole 
range of BW and cortical volume, surface area and thickness (n = 1,680), for each cortical 
parcellation 
 
3.6.3 Associations Between Birth Weight (Within the Normal Range) and Cortical 
Structure No hemisphere interactions were found with normal BW on brain cortical structure.  
3.6.3.1 Cortical volume: Higher BW was related to larger cortical volumes globally (β = .097, 
pcorr = 5.64×10-06, R2 = .009) but not in individual lobes and parcels. See Table 3.4.  
3.6.3.2 Cortical surface area: Higher BW was associated with larger global surface area (β 
= .088, p = 2.60×10-05, R2 = .008) but not individual lobes and parcels. 
3.6.3.3 Cortical thickness: No association was found between normal BW and global cortical 
thickness. However, a positive association between BW and the precentral lobe was found (β 
= .074, pcorr = .018) suggesting that higher BW was related to higher thickness in this area. 





Table 3.4 Significant associations (Pcorr < .05) between birth weight and cortical 
structure using the normal birth weight range 
Brain Measure Effect 
Size 
S.D p value pcorr R2 
           Cortical Volume 
Global 0.097 0.021 5.64×10-06*** - 0.009 
              Cortical Surface Area 
Global 0.088 0.021 2.60×10-05*** - 0.008 
            Cortical Thickness 
Lobes 
Precentral 0.074 0.024 0.002 0.018* 0.005 
***p corr ≤ .001, **p corr ≤ .01, *p corr ≤ .05, . p corr ≤ .10,  
Significant associations between normal ranges of birth weight and cortical volume, surface area and 
thickness (n = 1,471) 
 
3.6.4 Mendelian Randomisation Applying an ROI approach, the aforementioned brain 
structures which were significantly associated with BW in the whole BW range, were also 
analysed using an MR model to determine any causal effects of BW on cortical structures, see 
Table 3.5. The Two-sample, IVW regression analysis revealed evidence of a significant causal 
effect of BW on insular lobe cortical volume (β = .346, pcorr = .009). There was also a significant 
causal effect of BW on global (β = .281, pcorr = .009) as well as the insular lobe (β = .371, pcorr 
= .005), medial orbitofrontal (β = .417, pcorr = .006), middle temporal (β = .287, pcorr = .045) and 
IFG (β = .512, pcorr = .045) parcel cortical surface area. Another association between BW and 
parietal lobe cortical surface area was also found but was only nominally significant when 
correcting for multiple testing (β = .224, pcorr = .068). No evidence of heterogeneity was found 
for any region (Q, P > 0.05) nor was there any indication of horizontal pleiotropy (MR Egger 
Intercept, P > 0.05); see Table 3.5. Furthermore, ‘leave one out’ analyses suggested that IVW 
results were not driven by an individual SNP and that each of these genetic variants were 
symmetrically distributed around the IVW point estimate. Graphical representations of these 
sensitivity analyses can be found in Appendix B3.2.4.1 (p51-63). We therefore accepted the 
IVW results which suggest that BW, as indexed by genetic variants, has a causal relationship 
with cortical brain structure in these regions whereby higher BW is related to higher insular 
lobe cortical volume and surface area globally, in the insular lobe and the medial orbitofrontal 


























































































































































































































   
   
   
   


















































   
   
   



































































































































































































































































   


















































3.7 Discussion  
In the present study we found higher BW, using the whole range, to be significantly associated 
with larger brain cortical volume and surface area globally (β = .104, .100 respectively) and 
across several localised regions of the cortex; including frontal, temporal and parietal areas (β 
range = .032, .040). However, higher regional cortical thickness was related to lower BW in 
the occipital region (β = -.064, -.110), which corroborates some previous reports (De Bie et al., 
2011, Bjuland et al., 2013, Martinussen et al., 2005). Importantly, these associations were 
robust when covarying for age, sex, height and socioeconomic (Townsend) deprivation scores. 
When analysing only normal ranges of BW, fewer significant associations were found 
however, the same positive associations were apparent for cortical volume and surface area 
globally (β = .097, .088 respectively). MR analysis on significant cortical regions suggested a 
causal link between BW, indexed by genetic variants, and insular lobe cortical volume as well 
as surface area globally, in the insular lobe and in middle temporal, medial orbitofrontal and 
IFG parcels; whereby lower BW causes lower cortical volume or surface area in these regions.  
 
Our results, of higher BW being associated with larger cortical volume and surface area, 
support several previous findings (Haukvik et al., 2014, Skranes et al., 2013, Raznahan et al., 
2012, Walhovd et al., 2012, De Bie et al., 2011, Taylor et al., 2011, Martinussen et al., 2005, 
Allin et al., 2004). However, our sample size and analytic approach allowed us to identify 
several more specific, significant regions than has been previously possible, and to formally 
explore a causal hypothesis. Furthermore, this relationship was also present when restricting 
our analyses to the normal BW range, suggesting that these results were not driven by the 
12.44% of the data set with abnormal (< 2.5, > 4.5kg) BW. A large number of regions in the 
present study appear to be implicated in the effects of BW on cortical surface area in particular, 
suggesting that surface area is most susceptible to prenatal disruptions independent of 
biological size (indexed by height); predominantly in the frontal, temporal and parietal regions. 
This is consistent with neonatal findings of LBW/VLBW populations (Kapellou et al., 2006). 
Lower surface area in these areas has also been related to lower intelligence quotient (IQ) in 





Walhovd et al., 2016) and in psychiatric disorders (Rimol et al., 2012). These findings are 
further supported by recent evidence to suggest that increasing head size does not lead to a 
bigger brain across all regions, rather, there is a disproportionate areal up-scaling of fronto-
parietal networks which are linked with markers of heightened metabolic cost (Reardon et al., 
2018) thus, one reason that individuals who are born with lower BW have lower surface area 
in these regions may be due to an effort to reduce this cost. Together, these results provide 
further evidence of the neurodevelopmental origins of both cognitive impairments (Walhovd et 
al., 2016) and psychiatric disorders (Weinberger, 2017, Bora, 2015, Weinberger, 1987) as well 
as the specific role of surface area in this theory. 
 
The literature for associations of BW with cortical thickness has been less consistent. Some 
studies report lower BW to be associated with a thinner cortex in some regions but a thicker 
cortex in others (Bjuland et al., 2013, Raznahan et al., 2012, De Bie et al., 2011, Martinussen 
et al., 2005) or no effects (Haukvik et al., 2014). In the current study we found lower BW to be 
associated with higher lateral occipital cortical thickness, an association which has been 
previously reported (Martinussen et al., 2005, Sowell et al., 2008), but no evidence of a 
significantly thinner cortex in any region thus, partially supporting previous findings (Bjuland et 
al., 2013, De Bie et al., 2011, Martinussen et al., 2005).  
 
Cortical volume is the mathematical product of surface area and thickness (Wierenga et al., 
2014, Jalbrzikowski et al., 2013), thought to be under partially distinct genetic influence 
(Panizzon et al., 2009). As global effects in the current study were significant for cortical 
surface area but not thickness, volume effects in the present study appear to be driven by 
surface area. This pattern of relative importance of surface area but not thickness has been 
previously reported in relation to BW in adults (Hogstrom et al., 2013, Raznahan et al., 2012) 
as well as cognition in adults up to 73 years old (Cox et al., 2017); further highlighting the 






After conducting MR analysis on all significant cortical associations, a causal link was found 
between BW, as indexed by genetic variants, and surface area globally, in the insular lobe and 
the middle temporal, medial orbitofrontal and IFG parcels, as well as insular lobe cortical 
volume, which were not driven by pleiotropic effects. A nominally significant association was 
also found for parietal lobe surface area.  Furthermore, insular cortical volume as well as 
surface area of frontal and temporal regions have been formerly linked with the development 
or duration of psychiatric disorders, such as schizophrenia and bipolar disorder, using a range 
of modalities (Roberts et al., 2017, Takei et al., 2013, Rimol et al., 2012, Harms et al., 2010, 
Wylie and Tregellas, 2010, Ha et al., 2009, Adler et al., 2005). Specifically, Harms et al. ( 2010) 
found an association between cortical volume of the IFG and an increased familial risk of 
schizophrenia. In relation to cognition, Colom et al. (2013) found cortical volume and surface 
area of frontal areas to be related to fluid and crystallised intelligence  in young, healthy 
individuals. Thus, we have provided some evidence from MR indicating that higher BW may 
contribute to resilience in individuals with developmental origins of cognitive/psychiatric 
disorders mediated by frontal regions and, potentially, reduce cognitive impairments and the 
detrimental effects of psychiatric disorders. However, further testing is required to determine 
if these association between BW and cortical volume and surface area is found to be causal 
in a larger sample. 
 
Rapoport et al. (2005b) noted that the majority of events that can adversely affect the foetus 
will also hinder foetal growth. Thus, despite no current evidence of a causal influence of BW 
on the majority of brain regions, utilising measures to identify and prevent foetal growth 
restriction (such as customised growth charts, using GROW software (Gestation Related 
Optimal Growth (Clifford et al., 2013)) might ensure that all foetuses reach their genetic growth 
potential, assuming optimal in utero environment. These types of measures could potentially 
help prevent or reduce the detrimental effects of lower BW, in the general population, on 






3.7.1 Strengths and Limitations UKB has data relating to the maternal histories for the 
participants in the study but not for the individual’s own birth, thus there was no way to account 
for gestational age in the current study and it was therefore not possible to investigate specific 
effects of preterm birth and IUGR directly. Although gestational age may give us a more 
accurate picture of the foetal development in these individuals, differences in BW have been 
previously reported in studies testing participants who all had the same gestational age 
(Jablensky et al., 2005); lending credence to the current results. 
 
The age range in the current sample was older than previously tested (45-78 years) with a 
cross-sectional design. Although significant effects in this study, along with results from 
previous cohorts (Bjuland et al., 2013, Walhovd et al., 2012, De Bie et al., 2011, Taylor et al., 
2011, Martinussen et al., 2005), suggest the impact of BW on cortical morphology, particularly 
in relation to surface area (Walhovd et al., 2016), we cannot determine if these effects were 
present from early life for the current participants. Future studies of all three cortical metrics, 
with a longitudinal sample are required.  
 
As part of this study, we conducted the largest BW GWAS, to date and identified the largest 
number of BW-associated SNPs in order to create an IV to test for causal associations. 
Furthermore, using an MR approach to indicate causation of the associations between BW 
and brain cortical structure is novel in this area however, this method has its limitations. MR 
assumes robust associations between the genetic variant and the outcome but, despite 
statistical considerations, it is difficult to completely rule out pleiotropic effects (Hemani et al., 
2018) and it is thus possible that some of the variants here may not have a direct effect on 
brain structure. Replication of this genetic analysis in a much larger sample, with more 
statistical power, is desirable.  
 
This is the first study, to our knowledge, to assess whether individual differences in BW, as a 
continuum, across an older (over 30 years old), mainly healthy, population-based cohort are 





These considerations mean our results will have a greater relevance to the broader, non-
clinical members of the population as well as an increase in statistical power as a result of not 
dichotomising BW. It is also the largest BW study to analyse the brain at the global, lobar and 
parcellated level, using a single scanner, allowing for more reliable detection of small effects 
(K. Miller et al., 2016a). This increase in statistical power is helpful in this area; where subtle 
variations in BW could be linked to small effects on brain cortical structure and, in turn, lead to 
increased risk of psychiatric diagnoses and cognitive difficulties.   
 
3.7.2 Conclusion Establishing that BW variation is associated with cortical morphology in a 
large, middle-to-older aged, population-based sample, and when assessing normal BW 
ranges, gives further support to the hypothesis that subtle differences in BW may have life 
course effects on cortical structural development. Further, we have identified a tentative causal 
relationship between BW and the cortical structure of several distinct regions whereby, lower 
BW, indexed by genetic variants, is thought to cause lower insular cortical volume as well as 
global, insular, middle temporal, medial orbitofrontal and IFG surface area. Cortical structure 
has been previously associated with intelligence as well as an increased familial risk of 
schizophrenia, contributing to evidence for the neurodevelopmental origins of psychiatric 
disorders hypothesis. Moreover, BW has been linked with a number of prenatal insults and 
could potentially be a modifiable risk factor. The data therefore support the concept that 
optimal foetal growth (i.e. when a foetus reaches its individual growth potential) is important 
for brain structure in adulthood, highlighting the importance of devising better methods for 
detecting those at risk of sub-optimal growth in order to prevent such restrictions. These 
interventions could improve brain development and possibly lessen cognitive impairments as 
well as the cortical deficits associated with common psychiatric disorders. 
 
3.8 Chapter Conclusion 
Chapter Three thus provides evidence that lower birth weight was related to lower cortical 
volume and surface area over vast areas of the cortex, but higher cortical thickness in the 





also present when restricting the sample to only include individuals within the normal birth 
weight range, suggesting that the impact of birth weight on cortical structure can occur within 
subtle variations in weight within the wider population. We also provided evidence of a 
potential causal effect of birth weight, as indexed by genetic variants, on several measures of 
cortical volume and surface area. These results may therefore also partially explain the links 
between an increased risk of psychiatric disorders, such as schizophrenia, in individuals with 
lower birth weight however, schizophrenia associations were not specifically tested in this 
chapter. The next chapter therefore aims to use a PGRS-SCZ to further investigate the 




























































As noted in Chapter Two, a negative association was found between PGRS-SCZ and global 
cortical thickness. This relationship suggests that having a higher genetic loading for 
schizophrenia is related to lower cortical thickness across the entire brain. This effect was 
found across the whole sample and therefore, not limited to those who developed 
schizophrenia. Furthermore, the sample size was too small to rely firmly on these conclusions 
and measures of cortical volume and surface area were not assessed. The aim of Chapter 
Four was therefore to determine if this result can be replicated in a larger population-based 
sample – UKB, as well as to determine if any links exist between PGRS-SCZ and cortical 
volume and/or surface area. In addition, as birth weight (a proxy for obstetric complications) is 
a known risk factor for schizophrenia (Lærum et al., 2017, Rubio-Abadal et al., 2015, Forsyth 
et al., 2013, Clarke et al., 2006, Jablensky et al., 2005, Cannon et al., 2002b, Geddes and 
Lawrie, 1995) and was previously associated with cortical structure in Chapter Three, we also 
considered a potential relationship between this and both PGRS-SCZ and a birth weight × 
PGRS-SCZ interaction on cortical structure, in an attempt to address potential gene × 
environment interactions. 
 
This chapter is presented as the manuscript that is under review at Biological Psychiatry in 
which, I am the first author. I can also confirm that I was responsible for the design of the 
experiment, analysing the data and writing the paper for this submission. 
 
4.2 Paper: Impact of polygenic risk for Schizophrenia on cortical structure in 








Background: Schizophrenia is a highly heritable, neurodevelopmental disorder with many 
genetic variants of individually small effect contributing to phenotypic variation. Generally lower 
cortical thickness (CT), surface area (SA) and cortical volume (CV) have been demonstrated 
in schizophrenia . Furthermore, a range of obstetric complications (e.g. lower birth weight) are 
consistently associated with an increased risk for schizophrenia. We investigated whether a 
high polygenic risk score for schizophrenia (PGRS-SCZ) is associated with CT, SA and CV in 
a large population-based sample, and tested for interactions with birth weight. 
Methods: Structural 3T MRI scans, acquired on a single scanner, and genetic data were 
available for 2,864 UK Biobank (UKB) participants (nmale/nfemale = 1382/1482; mean age at time 
of scan = 62.35 years, ± S.D = 7.40). Linear mixed models were first used to test for 
associations between PGRS-SCZ and global and localised regions of CV, SA and CT. 
Secondly, linear regression was used to check for potential associations between PGRS-SCZ 
and birth weight, followed by linear mixed models to test for interaction effects of these 
variables on cortical structure. Results are reported using SNP inclusion threshold of P ≤ 0.1 
and false discovery rate correction of P < 0.05. 
Results: We found a significant negative effect of PGRS-SCZ on global CV (β = -.033, p = 
.039, pcorr = .195) and CT (β = -.043, p = .012, pcorr = .020), in that a higher PGRS-SCZ was 
associated with lower volume and thickness across the whole brain. We also report a 
significant negative association in insular lobe CT (β = -.050, pcorr = .025). No significant effects 
were found for SA. Furthermore, PGRS-SCZ was not associated with birth weight and no 
PGRS-SCZ × birth weight interactions were found for these cortical regions. 
Conclusions: These results suggest that individual differences in CT are partly influenced by 
genetics and are most likely not due to factors downstream of disease onset. This approach 
may help to elucidate the genetic pathophysiology of schizophrenia. Further investigation in 
case-control and high-risk samples could help identify any localised effects of PGRS-SCZ as 
symptoms develop. Future studies should also further investigate other potential 






4.4 Introduction  
Schizophrenia is a heterogeneous psychiatric disorder with twin heritability estimates (h2) of 
~80% (Matheson et al., 2011, Gejman et al., 2010, Purcell et al., 2009). Recent evidence 
suggests that the disorder is polygenic in nature, (Lee et al., 2012, Matheson et al., 2011, 
Gejman et al., 2010, Purcell et al., 2009) with genome-wide association studies (GWAS) 
identifying specific schizophrenia-inferring loci (SWG-PGC, 2014, CDG-PGC, 2013, Purcell et 
al., 2009). In line with a neurodevelopmental theory of schizophrenia, cortical deficits have 
been consistently associated with the disorder which are thought to predate disorder onset 
(Kinros et al., 2010, Rapoport et al., 2005a) and are caused by a combination of genetic and 
environmental factors (Rapoport et al., 2005b, Kinros et al., 2010). Limited research has fully 
explored the links between polygenic risk for schizophrenia and cortical structure with 
consideration of other schizophrenia risk factors. 
 
Differences in some aspects of brain structure have been consistently detected in groups of 
patients with schizophrenia compared to healthy controls (Kong et al., 2015). Recently, the 
field has moved towards studying cortical volume (CV), thickness (CT) and surface area (SA). 
These metrics are considered to have distinct developmental trajectories (Wierenga et al., 
2014) and a lot of evidence suggests that variation in these traits are heritable; h2  ranges from 
66-97% for CV (Peper et al., 2007) and averages around 80% for global CV (Kremen et al., 
2010, Wright et al., 2002), 81% for CT (Panizzon et al., 2009) and 89% for SA (Panizzon et 
al., 2009).  
 
CV has been most studied in schizophrenia, reporting lower CV in widespread areas of the 
brain in patients (Gupta et al., 2015, Kong et al., 2015, Rimol et al., 2012, Olabi et al., 2011, 
Ellison-Wright and Bullmore, 2010, Gutiérrez-Galve et al., 2010, Goldman et al., 2008, Honea 
et al., 2008, Goghari et al., 2007, Honea et al., 2005) and in the healthy relatives of individuals 
with schizophrenia as compared to controls (Brans et al., 2008, Boos et al., 2007, Goghari et 
al., 2007, Cannon et al., 2002b). However, as CV is the product of CT and SA (Wierenga et 





some associations between schizophrenia and brain structure (Kong et al., 2015, Panizzon et 
al., 2009). Lower CT has been associated with schizophrenia in several brain regions (Kong 
et al., 2015, Hartberg et al., 2011, van Haren et al., 2011, Rimol et al., 2010, Goldman et al., 
2009, Fornito et al., 2008, Kuperberg et al., 2003) and widespread patterns across the cortex 
(Kong et al., 2015, Sprooten et al., 2013, Crespo-Facorro et al., 2011, Rimol et al., 2010, Yang 
et al., 2010, Nesvåg et al., 2008, Goghari et al., 2007, Narr et al., 2005). Further, CT 
differences have been evidenced in frontal and temporal lobes of individuals at familial high-
risk of schizophrenia when compared to controls (Bois et al., 2015b, Sprooten et al., 2013, 
Byun et al., 2012, Ziermans et al., 2012, Jung et al., 2011, Goghari et al., 2007) and thus may 
be more easily identified in those at a higher genetic risk of the disorder. SA schizophrenia 
associations have received less empirical attention and existing studies report inconsistent 
findings (Gutiérrez-Galve et al., 2010). Whilst some studies suggest cortical SA is lower in 
schizophrenia patients compared to controls both globally (Palaniyappan et al., 2011) and in 
specific regions (Rimol et al., 2012, Hartberg et al., 2011, Palaniyappan et al., 2011, Gutiérrez-
Galve et al., 2010), whereas others have found SA to be higher (Bois et al., 2015a, Fornito et 
al., 2008) or no different (Hedman et al., 2016, Crespo-Facorro et al., 2011) in these groups.  
 
Recently, large GWASs have been used to identify genetic variants associated with 
schizophrenia (SWG-PGC, 2014, Lee et al., 2012, Purcell et al., 2009). From these findings, 
a polygenic risk score for schizophrenia (PGRS-SCZ) has been calculated (SWG-PGC, 2014, 
CDG-PGC, 2013, Ripke et al., 2013, Purcell et al., 2009); a higher score relating to a greater 
risk of developing the disorder. PGRS-SCZ allows for the assessment of genetic liability in the 
population – even among people who never develop the illness - and enables use of large-
scale samples such as UK Biobank (UKB; http://www.ukbiobank.ac.uk/).  
 
A small number of studies have tested PGRS-SCZ in relation to structural brain imaging 
phenotypes with inconsistent results. Reus et al. (2017) found no associations between 
regional subcortical volume or white matter microstructure and PGRS-SCZ using a subset of 





any cortical metrics. Some studies have reported higher PGRS-SCZ to be associated with a 
decrease in global grey and/or white matter volume (Caseras et al., 2015, Oertel-Knöchel et 
al., 2015, Terwisscha van Scheltinga et al., 2013) (nindividuals range = 89-274) with relatively 
small effect sizes and amount of variance explained (β = - .151, ΔR2 = .023 (change in R2 for 
regional white matter volume when PGRS-SCZ is added to hierarchical regression analyses), 
R2 = .042 (total brain volume); whilst others did not find an effect (van der Auwera et al., 2015, 
Papiol et al., 2014). Higher genetic loading for schizophrenia has also been previously 
associated with lower global CT in a case-control sample, regardless of group, as well as lower 
temporal CT in patients but not controls (Neilson et al., 2017a, Chapter Two). Lancaster et al. 
(2018) found no such association in a healthy control sample but did report nominal regional 
CT effects. Due to the limited sample sizes (n range = 75-99), replication of these findings is 
required.  
 
Another important consideration, as per neurodevelopmental theories of the disorder (Kinros 
et al., 2010, Rapoport et al., 2005a, Rapoport et al., 2005b), relates to potential effects of other 
risk factors for schizophrenia and their interactions between schizophrenia liability and cortical 
structure. Several obstetric complications (OCs), for example, have been consistently 
identified as risk factors for schizophrenia with some, such as birth weight, considered to be 
influenced by both genetic and environmental components (Gielen et al., 2008). Previous 
studies have also suggested that OCs are associated with greater cortical structure deficits in 
schizophrenia patients compared to controls (Cannon et al., 2002, van Erp et al 2002b). All 
three of the currently studied cortical metrics are considered to be highly susceptible to both 
genetic and environmental insults (Lyall et al., 2015). with subtle differences in birth weight, in 
particular, previously linked to lower CV, SA (Haukvik et al., 2014, Raznahan et al., 2012, 
Walhovd et al., 2012,) and CT (Raznahan et al., 2012) later in life. Mendelian Randomisation 
analysis of birth weight-associated single nucleotide polymorphisms (SNPs) also suggest that, 
for global and some localised regions of SA and CV, this effect may be causal (Chapter Three). 
Moreover, evidence suggests that a genetic liability for schizophrenia can lead to higher 





complications could themselves be associated with the schizophrenia-associated genes 
(Forsyth et al., 2013). Given this and the aforementioned associations between birth weight 
and schizophrenia, we also tested here whether the PGRS-SCZ was associated with birth 
weight and if any interactions were present between the two in relation to cortical structure. 
 
The current study therefore aims to examine the relationship between PGRS-SCZ and cortical 
structure in a population-based sample collected on a single scanner. Global and regional CV, 
CT and SA measures were analysed, with the specific hypothesis that PGRS-SCZ would be 
associated with lower global CT. Lower global, frontal and temporal CT in particular has been 
found in those at familial high-risk and global CT has been previously associated with a higher 
PGRS-SCZ. Furthermore, we predicted that these effects would interact with birth weight; 
individuals with a higher PGRS-SCZ and lower BW would have smaller CV, CT and SA. 
 
4.5 Methods  
4.5.1 Participants Detailed participant information has been reported previously (Cox et al., 
2016) (http://www.ukbiobank.ac.uk/participants/) and in Appendix C4.1.1 (p65). The current 
study included individuals with complete genetic and cortical data for three cortical parameters 
(CT, SA and CV). Birth weight information was also recorded for these individuals, along with 
whether they were part of a multiple birth. Participants were excluded based upon overlap in 
Psychiatric Genomics Consortium (PGC) training samples and schizophrenia status, see 
Derivation of Polygenic Risk Scores and Appendix C, Fig C4.1 (p66) for further information. 
Furthermore, global cortical outliers (±3 S.D.s), were removed for all three cortical parameters, 
resulting in a current sample of 2,864 individuals (nmales/nfemales = 1382/1482; mean age at time 
of scan = 62.35 years, S.D = ±7.40 years, range = 46-78 years). Ethical approval for UKB was 
received from the research ethics committee (REC reference 11/NW/0382) under application 







4.5.2 Imaging Procedures UKB imaging details in full are described elsewhere (Alfaro-
Almagro et al., 2017, K. Miller et al., 2016, Cox et al., 2016) 
(https://biobank.ctsu.ox.ac.uk/crystal/docs/brain_mri.pdf). In summary, images were acquired 
on a single Siemens Skyra scanner. Structural brain images were acquired in the sagittal plane 
using a T1-weighted, three-dimensional, magnetization-prepared rapid gradient-echo 
sequence at a resolution of 1x1x1mm with a field of view of 208x256x256. Further information 
on the imaging protocol (http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=2367) and imaging 
acquisition parameters (http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=1977) are 
documented online. Brain scans were anonymised at the time of acquisition and were 
processed locally on a server cluster at Centre for Cognitive Ageing and Cognitive 
Epidemiology (CCACE, http://www.ccace.ed.ac.uk/), in Edinburgh using FreeSurfer (v5.3, 
http://surfer.nmr.mgh.harvard.edu/).  
 
4.5.3 MRI Analysis We processed the T1-W volumes from the first UKB imaging release 
locally to derive cortical measures of thickness (mm), surface area (mm2) and volume (mm3), 
for further details see Appendix C4.1.2 (p66-68). Briefly, parcellation of cortical structures was 
conducted in FreeSurfer v5.3 using the Desikan-Killiany neuroanatomical atlas (Desikan et al., 
2006). This generated 34 bilateral cortical parcels that can be attributed to eight lobar 
structures, each with volume, surface area and mean thickness measures (Desikan et al., 
2006). Eleven parcels were combined into four larger regions as previously described  (Cox 
et al., 2017, Klein and Tourville, 2012); resulting in 27 bilateral regions of interest (ROIs) which 
were assigned to one of eight lobar regions, see Appendix C4.1.2 (p66-68). The X, Y and Z 
co-ordinates of the centre of the brain mask within the scanner 
(http://biobank.ctsu.ox.ac.uk/showcase/field.cgi?id=25756, 
http://biobank.ctsu.ox.ac.uk/showcase/field.cgi?id=25757, 
http://biobank.ctsu.ox.ac.uk/showcase/field.cgi?id=25758)  were also fitted as covariates for 
the current analyses to account for varying head positions in the scanner; see Appendix 






4.5.4 MRI Quality Control Procedures Quality checks were conducted on the success 
of processing on all scans. T1-weighted images were initially carried out by UKB (Brain 
Imaging Documentation V1.1, http://www.ukbiobank.ac.uk, Alfaro-Almagro et al., 2018) with 
further Quality Control (QC) procedures carried out locally. For local QC procedures (see Cox 
et al., 2017) and http://enigma.ini.usc.edu/protocols/imaging-protocols/), images were visually 
assessed for major errors (e.g. zero or partial output, substantial skull strip issues or tissue 
identification issues) which removed 458 scans, see Appendix C, Fig. C4.1 (p66). The 
remaining 3,875 scans were then assessed for minor errors (e.g. erroneous boundary 
placement, minor skull stripping issues and minor tissue omission) which resulted in removal 
of individual regions within scans (6,192 of the possible 295,052 regions were removed).  As 
global information was largely unaffected by the FreeSurfer reconstruction process, global and 
lobar values were extracted from the data with major errors removed but did not undergo QC 
exclusion for minor errors. However, exclusion of global cortical outliers (±3 S.D.s) provided a 
further internal imaging QC as in previous publications (Reus et al., 2017, Shen et al., 2017). 
 
4.5.5 Genotyping and Imputation Processing Procedures for genotyping, imputation 
and quality control for UKB have been reported previously (Howard et al., 2018, Luciano et 
al., 2018, Bycroft et al., 2017, Wain et al., 2015). Briefly, 488,377 blood samples were assayed 
using two different genotyping arrays; Applied Biosystems UK BiLEVE Axiom Array by 
Affymetrix (Wain et al., 2015) and Applied Biosystems UKB Axiom Array 
(http://www.ukbiobank.ac.uk/wp-content/uploads/2014/04/UK-Biobank-Axiom-Array-Content-
Summary-2014.pdf). Further information on these arrays can be found in Appendix C4.1.3 
(p68-69).  
Genetic QC was performed using the approach described by Howard et al. (2018). Firstly, 
participants were excluded based on shared genetic relatedness, up to the third degree, using 
kinship coefficients (>.044) identified using the KING toolset (Manichaikul et al., 2010) as 
previous (Howard et al., 2018, Bycroft et al., 2017). To maximise the sample, we subsequently 
added back in one member from each group of related individuals, using a genomic 





individual. Individuals were also excluded based upon a combination of both self-reported 
ethnicity and a principal component (PC) analysis (see Appendix C, p66 and 69) which 
revealed individuals with similar ancestral backgrounds. The final QC exclusion criteria 
included variant missing-ness per individual (>2%), gender mismatch, or a self-declared, non-
white British ancestry, variant call rate (<98%), Hardy-Weinberg equilibrium (P < 10-6), minor 
allele frequency < .01, an imputation quality < .1, resulting in 331,374 individuals and 
7,730,951 variants. 
 
4.5.6 Derivation of Polygenic Risk Score PGRS-SCZ were constructed using PLINK 
v1.9 (Purcell et al., 2007) to calculate the sum of all alleles that are associated with 
schizophrenia, across many genetic loci, and weighting these alleles by their effect sizes. 
These effect sizes have been previously estimated in the most recent PGC schizophrenia 
(PGC-SCZ, https://www.med.unc.edu/pgc/pgc-workgroups) GWAS (36, 989 cases vs 113,075 
controls; SWG-PGC, 2014). Individual identifiers were not available for PGC-SCZ within this 
sample thus, in an attempt to reduce the likelihood of any potential overlap between PGC-SCZ 
and the current sample, individuals form the PGC Major Depressive Disorder working group 
training sample (Wray et al., 2018) were excluded (n = 92). For the same reason, UKB 
individuals who reported a diagnosis of schizophrenia were also excluded (n = 812, see 
Appendix C, Fig. C4.1, p66) Schizophrenia status was determined from two separate 
variables within UKB: International Classification of Diseases (ICD-10) diagnosis 
(http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=41202; F20-F29 Schizophrenia, schizotypal 
and delusional disorders) and non-cancer illness 
(http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=20002). The former is a summary of the 
distinct diagnoses given from episodes in hospital; the latter was coded by a trained nurse, 
based on the description of a non-cancer illness given by the participant.    
To create a SNP-set in approximate linkage equilibrium, clump-based linkage disequilibrium 
(LD) pruning was performed with a r2 of < 0.25 within a 200kb window. For the remaining 
SNPs, marker weights (logarithm of the Odds Ratio) and p-value association statistics for 





autosomal SNPs) (SWG-PGC, 2014). Five scores were generated for each individual, using 
SNPs selected according to the significance of their association with the phenotype in the 
discovery GWAS at nominal P-value thresholds of 0.01, 0.05, 0.1, 05, 1, as previously 
described (Purcell et al., 2009). The SNP inclusion threshold was set at P ≤ 0.1 for the main 
results in this paper, as this threshold was shown to explain the most phenotypic variance in 
the discovery cohort (SWG-PGC, 2014). There were 86,124 SNPs, available in the current 
sample after QC, using the P ≤ 0.1 threshold. For results produced using the remaining SNP 
inclusion thresholds (P ≤ 0.01, 0.05, 0.5 and 1) see Appendix C4.2.2 (p72-83). PCs were also 
calculated to account for population stratification, further information of this process can be 
found in Appendix C4.1.5 (p69). The first 15 PCs were used in the current analysis. 
 
4.5.7 Measure of Birth Weight Participants were asked to provide their own birth weight 
information in UKB. Recalled birth weight has been shown to have high agreement with 
recorded birth weight and considered a valid and suitable measure for epidemiological studies 
(Shenkin et al., 2017). Birth weight data were collected at initial assessment and at the first 
repeat assessment (http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=20022). As information 
from both instances were comparable (r = .94), the birth weight variable included data from 
instance one as default, NA values from instance one were replaced by data from instance 
two. The birth weight range in the current sample was .91-5.78kg (mean = 3.40kg, S.D = 
±.61kg). Furthermore, only individuals who reported to not be part of a multiple birth were 
included (http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=1777).  
4.5.8 Covariates Socioeconomic Deprivation was measured using the Townsend 
deprivation index (range = -6.26 – 9.16, mean = -1.98, S.D = ±2.68), calculated when the 
participant joined the UKB study. Individuals were assigned a score based on census output 
regarding their postcode (http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=189). Standing 
height was measured using a Seca 202 device (range = 143 – 196cm, mean = 169.74cm, S.D 
= ±9.20cm)  and was collected at initial assessment, first repeat assessment and at time of 





comparable (r = .99). As with birth weight, data from the first instance was used by default and 
missing values from instance one were replaced by data from instance two. 
 
4.5.9 Statistical Analysis All analyses were conducted in R (v3.2.3). 
4.5.9.1 Associations Between PGRS-SCZ and Cortical Structure Linear mixed 
effects (LME) models (package “nlme”, v3.1-127, Pinheiro et al., 2017) were used to determine 
whether PGRS-SCZ (independent variable) were associated with cortical structures 
(dependent variable). LME models were first conducted in a repeated measures format with 
hemisphere fitted as a random factor. Analyses were also conducted to determine if there was 
a PGRS-SCZ × hemisphere interaction which would require testing as an independent 
measure. This model included age, age2, sex, genotype array, 15 PCs and X, Y and Z co-
ordinates of the brain mask within the scanner. ICV was also included as a fixed effect for 
lobar and parcellation analyses to control for the size of specific regions relative to the whole 
brain. This measure of ICV was derived based on a UKB IDP similar to that calculated by 
Statistical Parametric Mapping methods (https://www.fil.ion.ucl.ac.uk/spm/) whereby grey 
matter, white matter and ventricular cerebral spinal fluid are added together. Here we only 
report statistically significant associations (P < .05) between PGRS-SCZ and cortical brain 
structure from these models. Furthermore, the reported results were analysed using the SNP 
inclusion threshold of P ≤ 0.1 as this threshold explained the most phenotypic variation in the 
discovery cohort (SWG-PGC, 2014). Non-significant associations as well as results for all 
other thresholds as can be found in Appendix C4.2 (p72-83). Standard regression coefficients 
are reported throughout. Utilising the ‘p.adjust’ function in R (‘stats’ package v3.2.3), the false 
discovery rate (FDR) method, with a rate of P < .05 (Genovese et al., 2002), was used to 
correct results for multiple comparisons. 
 
4.5.9.2 Associations Between PGRS-SCZ and Birth Weight Using the full sample of 
individuals with cortical, BW and genotype information, excluding global cortical outliers (n = 
1,659, nmales/nfemales = 696/963; mean age at time of scan = 60.79 years, S.D = ±7.41 years, 





used, to test for associations between PGRS-SCZ (independent variable) and birth weight 
(dependent variable). This model included all fixed effects outlined in Associations between 
PGRS-SCZ and cortical structure, with the addition of height and socioeconomic deprivation 
as in previous publications (Haukvik et al., 2014, Raznahan et al., 2012), as fixed effects. LME 
models, using these same fixed effects with the addition of a PGRS-SCZ × BW interaction, 
along with main effects terms, were also used to test for potential interactional effects on 
cortical structure.  
 
4.6 Results 
4.6.1 Demographics Statistical analyses were conducted to determine if any of the current 
demographic variables were associated with PGRS-SCZ at the P ≤ 0.1 threshold (see Table 
4.1). No significant associations were found (P > 0.05). 
 
Table 4.1 Descriptive statistics for demographic variables and their associations with 
PGRS-SCZ 
 Range Mean S.D Statistics 
Gender 
(nmales/nfemales=1382/1482) 
- - - X2 = 2707.8, p = .513 
Age 46, 78 62.35 7.40 r = -.003, p = .863 
Birth weight (kg) .91, 5.78 3.40 .61 r = -.044, p = .069  . 
Height (cm) 143, 196 169.73 9.12 r = -.033, p = .077 . 
Townsend Deprivation 
Scale 
-6.26, 9.16 -1.98 2.68 r = .017, p = .363 
***p corr ≤ .001, **p corr ≤ .01, *p corr ≤ .05, . p corr ≤ .10, S.D = Standard deviations 
Mean, S.D. and range of all demographic variables within the current sample as well as test statistics for 
associations with PGRS-SCZ at the P ≤ 0.1 threshold (n = 2.864) 
 
4.6.2 Associations Between PGRS-SCZ and Cortical Structure Results for PGRS-
SCZ × hemisphere interactions on cortical structure can be found in the Appendix C4.2.1 
(p69-72). No significant hemisphere interactions were found in the current study, at the P ≤ 







A significant negative effect of PGRS-SCZ on global CV (β = -.033, p = .039, R2 = .001, see 
Fig. 4.1a) and CT (β = -.043, p = .012, R2 = .002, see Fig. 4.1b) was found, in that a higher 
PGRS-SCZ was associated with lower CV and CT across the whole brain. However, only the 
association with CT remained significant after multiple correction across all three cortical 
metrics(CT pcorr = .020, CV pcorr = .195). 
Fig. 4.1 Scatter plots showing a higher PGRS-SCZ is associated with a) lower global cortical 
volume (mm3) and b) lower global cortical thickness (mm) in the left and right hemisphere (n = 
2,864) 
 
PGRS-SCZ was also negatively associated with insular lobe CT (β = -.050, pcorr = .025, R2 
= .002, see Fig. 4.2).  No associations between PGRS-SCZ and SA were found at any 
















Fig. 4.2 Scatter plots showing a higher PGRS-SCZ is associated with lower insular lobe cortical 
thickness (mm) in the left and right hemisphere (n = 2,864) 
 
4.6.3 Associations Between PGRS-SCZ and Birth Weight There was no association 
between PGRS-SCZ, at any threshold, and birth weight. This was true for both the base and 
fully-adjusted model. (See Table 4.2) 
Table 4.2 Results for associations between PGRS-SCZ and birth weight at all P 




Fully Adjusted Model 
Effect 
Size 
S.D p value pcorr 
P ≤ 0.01 -0.016 0.024 0.513 0.513 
P ≤ 0.05 -0.037 0.024 0.122 0.305 
P ≤ 0.1 -0.041 0.024 0.090 0.305 
P ≤ 0.5 -0.021 0.024 0.380 0.513 
P ≤ 1 -0.019 0.024 0.423 0.513 
                       S.D = Standard deviation 
 
4.6.4 Effects of Interactions Between Birth Weight and PGRS-SCZ on Cortical Structure 
No significant interactions between birth weight and PGRS-SCZ impacting upon global CV or 









This is one of the first studies to analyse associations for CV, CT and SA measures within a 
single large, population-based sample, and the first to our knowledge to examine the 
association between these parameters and PGRS-SCZ. We report a link between an 
increased genetic liability for developing schizophrenia and lower global CV and CT, as well 
as insular lobe CT. In this and our previous studies (Neilson et al., 2017a (Chapter Two); 
Neilson et al., 2017b) we primarily test and report corrected results at P ≤ 0.1 level. We also 
include results corrected over all three cortical metrics to illustrate the effects of more stringent 
control for multiple comparisons and note that the association between PGRS-SCZ and global 
CV was not significant after this correction. Overall, these results suggest that lower CT, 
commonly reported in schizophrenia patients, may be driven by a genetic liability for 
schizophrenia and are most likely not due to factors downstream of disease onset (e.g. 
antipsychotic medication use; Lawrie et al., 2001) No significant associations were found for 
SA. 
 
Previous study of associations between PGRS-SCZ and brain volume have been inconsistent. 
Lee et al. (2016) found ICV to be significantly linked with enrichment of schizophrenia-
associated genetic variants but could not determine the direction of these effects. Another 
study, utilising a PGRS-SCZ created from the first PGC-SCZ GWAS (SPGWASC, 2011),  
found an association between decreased total brain volume and higher PGRS-SCZ 
(Terwisscha van Scheltinga et al., 2013) but attempts to replicate these results with the most 
recent PGC-SCZ GWAS findings (SWG-PGC, 2014) were unsuccessful (van der Auwera et 
al., 2015, Papiol et al., 2014). However, the sample sizes used within these studies are 
relatively small (n range = 122 - 763). This is especially pertinent when considering that, 
despite the current sample being much larger (n = 2,864) than these previous studies, our CV 
result did not survive FDR corrections for multiple comparisons over all five P-value thresholds. 
Thus, further testing in an even larger population-based samples is desirable. Calculations of 






The global CT association is consistent with previous familial high-risk studies for 
schizophrenia, which also found cortical thinning in widespread areas of the cortex both 
longitudinally (Hedman et al., 2016, Bois et al., 2015b, Ziermans et al., 2012) and cross-
sectionally (Sprooten et al., 2013, Byun et al., 2012, Jung et al., 2011, Goghari et al., 2007). 
A genetic enrichment study also found several CT parcels to be associated with schizophrenia 
risk variants (Lee et al., 2016). Furthermore, a case-control study found that a higher PGRS-
SCZ was associated with lower global CT in both the schizophrenia patient only analysis and 
in the whole sample (Neilson et al., 2017a, Chapter Two). Specific links between reduced 
insular cortex thickness and genetic risk for schizophrenia have been less commonly reported, 
although reductions in this region, among others, have been found in schizophrenia patients 
compared to controls and individuals at genetic high-risk of the disorder (Byun et al., 2012). 
Additionally, the insula is a region commonly reported to be involved in schizophrenia, for 
example in relation to auditory hallucinations (Wylie and Tregellas, 2010). 
 
The fact that no PGRS-SCZ associations were found for surface area is not entirely surprising. 
Evidence of SA abnormalities associated with schizophrenia has been inconsistent (Gutiérrez-
Galve et al., 2010) and familial high-risk studies have described it as a ‘weak intermediate 
phenotype’ for schizophrenia (Honea et al., 2008). However, evidence does suggest that this 
phenotype is highly heritable (Panizzon et al., 2009) and is associated with some deficits in 
the healthy relatives of schizophrenia patients (Goghari et al., 2007). A general limitation of 
PGRS, at present, is that the amount of phenotypic variation that they explain is far smaller 
than the heritability of the phenotype (Reus et al., 2017, Plomin, 2013); thus, it may be that 
the predictive power of PGRS-SCZ in combination with the current sample size are not large 
enough to detect SA effects.  
 
No association was found between PGRS-SCZ and birth weight, nor were there interaction 
effects between these two factors within global CV or CT.  As previous studies have found 
lower birth weight to be associated with lower CV (Haukvik et al., 2014, Raznahan et al., 2012, 





Raznahan et al., 2012), an increased risk of schizophrenia (Lærum et al., 2017, Cannon et al., 
2002a, Geddes and Lawrie, 1995) and several independent SNPs (Horikoshi et al., 2016, 
Horikoshi et al., 2013); we expected to find a link between these factors. However, the current 
findings do not support a significant shared effect of genetic variants for schizophrenia and 
birth weight CT. Further investigation is needed to determine this.  
 
4.7.1 Strengths and Limitations The main limitation of the current study and PGR-SCZ 
studies in general is that, at present, the variance explained by PGRS is relatively small (~2-
3%; Purcell et al., 2009) and that larger sample sizes significantly increase the power of PGRS 
(Dudbridge, 2013). Despite this study being the largest imaging PGRS study to date, with 
2,864 individuals (van der Auwera et al., 2015, Papiol et al., 2014, Terwisscha van Scheltinga 
et al., 2013, Reus et al., 2017), it is still relatively small compared to other PGRS studies (e.g. 
Liuhanen et al., 2017, Reginsson et al., 2017, Taylor et al., 2016). Furthermore, a post-hoc 
analysis (see Appendix D, p97-99) suggests that the current study was underpowered (5-
41%) for some analyses, highlighting the need for even larger imaging samples. Current 
calculations suggest a sample of at least ~21,500 to reliably detect some effect of current 
PGRS-SCZ on cortical structure. Given UKB’s goal of acquiring 100,000 scans by 2022 
(https://imaging.ukbiobank.ac.uk/), we should be able to improve our sample size in the near 
future. This sample size, coupled with larger discovery GWAS, will allow for detection of 
smaller effects (Reus et al., 2017, Dima and Breen, 2015, Thompson et al., 2014) and may 
eventually allow PGRS to be used in the development of personalised medicine (Dima and 
Breen, 2015) however, further research would be necessary.  
A further limitation, related to the derivation of the PGRS-SCZ, is that we were unable to 
remove any individuals utilised in the discovery dataset for the PGC schizophrenia working 
group that may also be included in the current UKB sample, as this information is not currently 
available. However, due to the methodological efforts made to overcome this issue (e.g. 
exclusion of schizophrenia cases and IDs from PGC MDD group) we believe this limitation to 






Although multi-centre collaborations have made larger samples more achievable, different 
acquisition protocols could lead to variability in image contrast and, in turn, disagreement over 
brain segmentation between sites; necessitating the development of reliable acquisition 
protocols to attempt to reduce such issues (Schnack et al., 2010). A strength of the current 
study is that all brain images were collected on a single scanner using the same protocol and 
analysis pipeline thus, by-passing multi-scanner variability problems and the need to assess 
reliability. Furthermore, as UKB is a population-based sample and all schizophrenia cases 
were excluded, we are also able to test for associations whilst avoiding confounds such as 
secondary effects of illness or antipsychotic medication use (Lawrie et al., 2001). 
 
Previous studies have reported both that individuals at familial high-risk, who developed 
schizophrenia, have significantly higher PGRS-SCZ than those at high-risk who remained well 
and that these PGRS are positively associated with gyral folding (Neilson et al., 2017b). It is 
possible that there are different genetic associations for different brain measures than derived 
for in the current study. Given the current sample consisted of older individuals (46-78 years, 
mean = 62.3), as compared to most schizophrenia studies (Liu et al., 2016, Caseras et al., 
2015, van der Auwera et al., 2015, Papiol et al., 2014, Terwisscha van Scheltinga et al., 2013), 
which commonly include age ranges of 18-55 years that more closely map to age of disorder 
onset, we cannot rule out effects of ageing on the current results. Further investigation in 
prospective case-control samples is required. 
 
Although the inclusion of birth weight, a proxy for OCs and risk factor for schizophrenia (Lærum 
et al., 2017, Lyall et al., 2015, Cannon et al., 2002a, Geddes and Lawrie, 1995) with both 
genetic and environmental components (Gielen et al., 2008), is a strength of the current paper, 
we cannot entirely rule out environmental effects on the results we report. For example, both 
cannabis use and developmental trauma have been linked with reductions in CT (Habets et 
al., 2011) and an accumulation of environmental risk factors (including migration, cannabis 
use, urbanicity, OCs and adverse events) has been associated with lower temporal CT 





the link between PGRS-SCZ and cortical maturation (French et al., 2015). Thus, other 
environmental risk factors should be explored in further studies of potential gene-environment 
interactions on structural brain measures in schizophrenia.  
 
4.7.2 Conclusion In summary, the current finding that lower global and insular lobe CT, is 
associated with an increased genetic loading for schizophrenia. This provides further evidence 
that individual differences in CT are, at least partly, influenced by a genetic component. 
Importantly, these findings also suggest that the schizophrenia and CT associations, reported 
here and in previous literature, are most likely not confounded by factors downstream of 
disorder onset (e.g. use of antipsychotic medication). Furthermore, it suggests that using a 
PGRS approach may help to elucidate the genetic pathophysiology of the disorder as GWAS 
and genomic imaging studies get larger they could identify how more specific genetic, 
expression and pathway effects impact upon global and/or particular brain structures, 
connections and networks. Further consideration of environmental risk factors for 
schizophrenia will also be crucial to understanding the nature of the relationship between 
schizophrenia and disrupted cortical structure.  
 
4.8 Chapter Conclusion 
In the current chapter, we replicated the finding of a relationship between PGRS-SCZ and 
global cortical thickness reported in Chapter Two. A higher PGRS-SCZ was linked with lower 
cortical thickness, but in a population-based sample of 2,864 individuals. Additionally, we 
found insular cortical thickness to present the same relationship. Furthermore, we did not find 
PGRS-SCZ to be associated with birth weight nor, did we find any PGRS-SCZ × birth weight 
interactions on cortical structure. Together these results provide further evidence of differential 
impacts of genetic and environmental risk factors for schizophrenia on cortical structure.  
 
Despite this study being the largest imaging PGRS sample, that we are aware of, it is still 
relatively small for a PGRS study (e.g. Liuhanen et al., 2017, Reginsson et al., 2017, Taylor et 





PGRS to be used in the development of personalised medicine (Dima and Breen, 2015). 
Furthermore, as in Chapter Two, other environmental risk factors should be explored in future 
































This thesis presented, three empirical studies which investigated the potential impact of 
polygenic loading and environmental risk factors for schizophrenia on cortical structure. Each 
chapter utilised a different methodological approach in order to answer a number of important 
questions; (1) is a PolyGenic Risk Score for Schizophrenia (PGRS-SCZ) and/or experiencing 
an accumulation of environmental risk factors for schizophrenia, associated with cortical 
thickness (CT) (Chapter Two); (2) is birth weight associated with not only CT but also cortical  
volume (CV) and surface area (SA) (Chapter Three); (3) are PGRS-SCZ associated with all 
three cortical metrics and, if so, are these effects associated with an interaction with birth 
weight (Chapter Four). Ultimately, the use of a range of methodological techniques within this 
thesis have enabled us to determine if any associations exist between brain structure and 
genetic and/or environmental risk factors for schizophrenia, and if these risk factors are 
differentially related. 
  
Chapter Two (‘The relationship between environmental and polygenic risk for schizophrenia 
and cortical thickness in SFMH’) investigated the impact of up to five individual environmental 
risk factors for schizophrenia on CT by means of analysis of covariance (ANCOVA) tests. 
Using PGRS-SCZ, the genetic association between schizophrenia and CT was also examined. 
Furthermore, the effects of environmental risk factors were controlled for PGRS-SCZ to 
determine if genetic and environmental impacts on schizophrenia are independent. As this 
was a case-control study, we were also able to test for differences between the two 
populations. Evidence was found to suggest that genetic and environmental risk factors did 
differentially impact CT across both patient and control groups. Such findings provide further 
evidence for a neurodevelopmental basis in schizophrenia. However, further investigation of 






Chapter Three (‘Exploring the causal relationship of birth weight on adult cortical brain 
structure in UK Biobank’) examined the phenotype birth weight, as a proxy for obstetric 
complications (OC), to determine if this risk factor (with both genetic and environmental 
components) was related to three cortical measures; CV, CT and SA. Mixed linear models 
were employed to test for effects in both the whole birth weight in addition to a sub-set of 
individuals falling within the normal birth weight range. A different technique was used to 
assess the genetic component to this phenotype. Additionally, a Genome Wide Association 
Study (GWAS) was conducted in order to identify genetic variants associated with birth weight 
and a Mendelian Randomisation (MR) analysis was tested to determine if birth weight 
associated genetic variants were causally related to cortical structure. Findings indicate that 
subtle differences in birth weight may have long term effects on cortical structural 
development. This chapter also found evidence of a causal relationship between birth weight 
and brain structure in which lower birth weight (as indexed by genetic variants) is thought to 
cause lower CV and SA. This chapter highlights the neurodevelopmental impact that low birth 
weight could have in non-clinical populations and, as such, denotes a potential target for 
interventions that may help to prevent birth weight restrictions.  However, further investigation 
into the specific impact of birth weight on cortical structure in the development of schizophrenia 
is required.  
 
Chapter Four (‘Impact of polygenic risk for Schizophrenia on cortical structure in UK Biobank’) 
aimed to replicate the findings from Chapter Two. Specifically, the association between PGRS-
SCZ and cortical structure was examined in a larger, population-based sample. A replication 
of global CT was found, suggesting that genetic risk variants for schizophrenia are associated 
with CT. A trend towards a correlation between birth weight and PGRS-SCZ was also evident 
in this chapter however, as the correlation coefficient was so small (- .044) and the p value 
was only marginal (.069) despite the large sample size (n = 2,864), this result is not considered 
strong enough to infer shared genetic architecture between schizophrenia and birth weight. 





weight on cortical structure and found no significant effects. Together these findings intimate 
that a higher genetic loading for schizophrenia is not related to birth weight and thus, again, 
do not support a shared effect of genetic variants for schizophrenia and birth weight on CT. 
Furthermore, in terms of interpreting the previous MR findings on the associations between 
birth weight and brain structure, it should be noted that potential genetic overlap between 
schizophrenia and birth weight does not violate the assumptions of MR and thus, these results 
should be considered separately. Chapter Four provided further evidence that genetic and 
environmental risk factors for schizophrenia may impact cortical structure differentially 
however, further investigation in to the relationship these factors have in relation to the 
development of schizophrenia is required. 
 
Together, the findings presented within this thesis raise several interesting points.  
Firstly, results suggest that polygenic and environmental risk factors for schizophrenia impact 
cortical structure, with stronger effects in individuals with the disorder compared to healthy 
controls. However, only a small amount of variance in these cortical abnormalities is explained 
by these effects, particularly in relation to PGRS-SCZ. Such results indicate that PGRSs may 
not have enough predictive accuracy for clinical utility but may be more useful when 
considered in conjunction with other risk factors (e.g. environmental factors or copy number 
variants) (Lewis and Vassos, 2017, Lawrie et al., 2011). However, despite the current effort to 
test for cortical associations with several environmental risk factors, many more factors remain 
in need of consideration (e.g. other OCs, additional childhood adversities) (Matheson et al., 
2013, Schlosser et al., 2012, Matheson et al., 2011, Stilo and Murray, 2010, Dean and Murray, 
2005, Mäki et al., 2005, Cannon et al., 2002b, Geddes and Lawrie, 1995). Nevertheless, this 
body of work provides evidence of an association between both genetic and environmental 
risk factors and alterations in cortical structure, highlighting potential mechanisms for their 
impact (e.g. synaptic pruning, myelination, neural stem cell proliferation) (Geoffroy et al., 2013, 
Lee et al., 2012). Furthermore, these results stress the importance of increasing public 
awareness of the link between these risk factors and schizophrenia development; particularly 






Secondly, Chapter Two evidenced a positive association between number of risk factors and 
cortical structure differences. However, chapters Three and Four suggest that, although birth 
weight variations are linked with cortical structure, differences in these variations are not 
associated and do not interact with the genetic liability for schizophrenia. Furthermore, 
previous studies have noted that whilst high incidences of these environmental risks are 
reported amongst individuals with schizophrenia, not all individuals who experience the same 
number and type of these factors go on to develop the disorder (Crush et al., 2018). As such, 
elucidation of resilience mechanisms or protective factors are required to better understand 
schizophrenia development (Radua et al., 2018, Bozikas and Parlapani, 2016, Schlosser et 
al., 2012). 
 
Thirdly, these results may highlight how both small and large samples can be utilised in ways 
which are complimentary of each other. Monteith et al. (2015) asserted that data of all sizes 
are required in healthcare and that small samples still have an important role in research 
advancements. In the current thesis, a small sample (n < 50 per cohort), which provided deep, 
case-control phenotype data (Chapter Two), highlighted a potential pattern of associations 
between cortical structure and schizophrenia risk. Meanwhile, the large population-based data 
sets (n = ~2,000; tested in Chapters Three and Four) provided evidence of a replication of 
these effects which may be more generalisable. This approach allows for researchers to both 
make use of modest neuroimaging samples, which are generally more resource efficient and 
simpler to analyse (Monteith et al., 2015); as well as replicate important findings in much larger 
samples that are better equipped to detect smaller effects (Smith and Nichols, 2018).  
 
5.2 Limitations 
Limitations relating to each specific chapter have already been detailed therefore, outlined 






5.2.1 Power Firstly, all studies contained within this thesis are limited by insufficient power 
resultant from small sample sizes. As a result, these studies may not be able to reliably detect 
environmental and genetic effects on cortical structure and thus, lack generalisability. Whilst 
the sample sizes used were considered to be, at least, moderate and normal (< 50) (Smith 
and Nichols, 2018), recent developments in neuroimaging technology and recruitment 
strategies have allowed the investigation of larger samples (Smith and Nichols, 2018, van 
Horn and Toga, 2014), especially with the advent of ‘Big Data’ (> 1,000 scans) (Smith and 
Nichols, 2018). Utilising ‘Big Data’ increases the probability of researchers detecting genetic 
variants that may be ‘clinically actionable’ (He et al., 2017)  as well as small imaging effects 
(Smith and Nichols, 2018) that may not be measurable in smaller samples. Moreover, for 
GWAS and PGRS analyses, larger sample sizes are necessary to achieve the greatest 
accuracy (Dudbridge, 2013). The issue of power may underlie why some cortical structure 
associations were found in Chapter Four but not Chapter Two. However, in increasing sample 
sizes, the probability of detecting false positives also increases (Smith and Nichols, 2018). To 
overcome such caveats, it is important to use power analyses to calculate the minimum 
sample size required to detect effects with adequate power. Post-hoc power analyses 
pertaining to Chapters Two and Four are given in Appendix D (p97-99). 
 
5.2.2 Environmental Risk Factors Although efforts were made within this thesis to tease 
apart the differential effects of genetic and environmental risk factors for schizophrenia on 
cortical structure, our ability to do so was limited by the availability of phenotypic data. For 
example, the Scottish Family Mental Health (SFMH) data set used in Chapter Two contained 
data on five environmental risk factors for schizophrenia however, only three of these were 
available for control participants. This caveat, alongside small sample size, limited our ability 
to statistically analyse potential gene × environment (G × E) interactions. Furthermore, whilst 
the UKB dataset has a wide range of phenotypic data, it was not designed to investigate 
schizophrenia risk factors. As such, this thesis was constrained by limited data on adverse life 
events, urbanicity and migration, and complete lack of data relating to cannabis. Furthermore, 





Going forward, UKB aims to execute data linkage with National Health Services records which 
may supply mental health diagnosis information and thus, overcome some of the data 
limitations in the current body of work. Further work is therefore required to collect or identify 
more variables that can be linked to schizophrenia as well as different strategies to statistically 
analyse them (e.g. structural equation modelling). 
 
5.2.3 Schizophrenia Onset/Development Associations between cortical structure and 
genetic and environmental risk factors for schizophrenia were evidenced in both a population-
based and case-control sample. However, as schizophrenia is thought to typically develop in 
late adolescence or early adulthood (Gogtay et al., 2011) and the age range for the samples 
used in the current thesis was 18-67 years (SFMH) and 46-78 years (UKB), the relationship 
of these associations with schizophrenia development could not be investigated. 
 
As birth weight and PGRS-SCZ are developmentally stable constructs, it is assumed that their 
associations with cortical structure would be evident earlier in life however, longitudinal 
assessments are required to confirm this as well as rule out potential brain ageing effects. 
Furthermore, testing for schizophrenia status (e.g. case-control/familial high-risk, duration of 
illness or severity of symptoms) would help elucidate whether these risk-associated cortical 
deficits are a result of the disorder or predate onset. Efforts were made to assess case-control 
differences in Chapter Two but were limited by sample size thus, use of large, prospective 
samples may be more beneficial. 
 
5.3 Future Directions 
In recent decades, an abundance of research has sought to investigate the aetiology, 
progression and prognosis of schizophrenia. Given the prevalence of the disorder (~ 1%) and 
its detrimental impact  (Gogtay et al., 2011), it is of the upmost importance that we find more 
efficacious ways to diagnose the disorder earlier, and to develop better treatments and 
interventions (Häfner and Maurer, 2006, McGlashan, 1998, McGlashan and Johannessen, 





these aims. It is likely that with the continued use of ‘Big Data’ samples (e.g. UKB) and 
mega/meta-analytic approaches more opportunities will become available to fully explore the 
relationship between risk factors for schizophrenia and the detrimental impacts these can 
have, particularly on the brain. Some potential directions for this research are highlighted 
below. 
 
1) First and foremost, future research should aim to replicate the results in the current 
thesis. We noted in the limitations section that larger sample sizes are required in 
order to increase the statistical power of our analyses (Smith and Nichols, 2018), 
particularly in relation to genetics based statistical methods such as PGRS (He et al., 
2017, Palla and Dudbridge, 2015, Dudbridge, 2013). Furthermore, calculating 
required sample sizes would allow for more confidence in the accuracy and 
generalisability of the results for clinical application. 
 
2) Another way in which schizophrenia-associated genetic variants can be used in order 
to determine intervention and prevention methods is through genetic pathway analysis 
(NPA-PGC, 2015). Rather than include variants across the whole genome to infer 
genetic risk (as in PGRS-SCZ), this method identifies a sub-set of genetic variants 
that are linked to distinct biological pathways and determines if they are implicated in 
the genetic aetiology of a disorder (NPA-PGC, 2015). Specifically, pathways linked 
with synapse and post-synapse related processes have been strongly associated with 
schizophrenia aetiology (NPA-PGC, 2015). Expanding on this information, it is 
possible to create a PGRS based on these pre-identified pathways and use this to test 
for associations with phenotypes of interest (e.g. Barbu et al., 2018). Thus, testing for 
an association between a PGRS for the identified pathways and CV, CT or SA would 
allow researchers to determine if these metrics are implicated in the manifestation of 
genetic risk for schizophrenia. Consequently, this would provide us with a mechanistic 






3) More in-depth investigation of environmental risk factors and how they impact upon 
and interact with brain structure. As noted in Chapter One, many studies have found 
several environmental factors to be linked with an increased risk of developing 
schizophrenia (Murray et al., 2017, Lawrie et al., 2011, Matheson et al., 2011, Stilo 
and Murray, 2010, van Os et al., 2010, Dean and Murray, 2005, Mäki et al., 2005) and 
the current thesis has evidenced birth weight, as well as an accumulative experience 
of childhood adversity, OC, urbanicity, cannabis use and migration, to be linked with 
cortical structure. However, future research would benefit from developing an 
environmental risk score approach. To illustrate, a recent study created a 
‘polyenviromic’ risk score using an approach similar to that used to devise PGRSs 
(Padmanabhan et al., 2017). Padmanabhan and colleagues (2017) found this score 
to be significantly correlated with transition to psychosis in high-risk subject; an 
approach that could be applied to cortical structure. However, this approach fails to 
consider genetic risk factors for schizophrenia. Furthermore, both this and the current 
environmental risk score approach fails to consider ‘dose’ effects of particular factors 
(e.g. cannabis) (Battistella et al., 2014) or the potential interactions they may have 
with each other (Padmanabhan et al., 2017, Neilson et al., 2017a (Chapter Two)); 
factors that should be addressed by future studies.  
 
4) Future research would benefit from investigating modifiable environmental factors 
which could be used for mental health interventions. Many of the recognised 
modifiable risk factors relate to better prenatal care and in utero environment 
(Keskinen et al., 2016, Tiemeier et al., 2016, Hamlyn et al., 2013) with one study 
identifying better mental health of the mother, during this period, as a protective factor 
for schizophrenia (Keskinen et al., 2016). Thus, further research into OCs in particular, 
could be a fruitful endeavour.  
 
5) It is also important to explore potential protective factors for schizophrenia (Keskinen 





their relationship with schizophrenia-associated cortical alterations. Protective factors 
could be environmental (Keskinen et al., 2016) or genetic (e.g. the mutant allele of 
FOS rs1063169 SNP) (Boyajyan et al., 2015) and both are worthy of investigation. 
Although previous studies have found an association between structural and 
functional brain imaging with resilience for Bipolar Disorder (Frangou, 2011), no such 
research has yet been conducted in schizophrenia. Whilst studies investigating 
resilience to schizophrenia are important, a lack of working definition for the construct 
presently inhibits such research (Luthar et al., 2000). 
 
6) A further suggestion would be to employ longitudinal, prospective samples to 
investigate the link between environmental factors and cortical structure. Such 
research would enable the detection of factors that contribute to cortical structure 
deficits temporally related to schizophrenia onset, whilst ruling out potential ageing 
effects on the brain. This method would allow for more accurate detection of early risk 
factors and the development of early intervention strategies which would align with the 
aims of the ‘Current Mental Health Strategy 2017-2027’ for the Scottish Government 
(https://www.gov.scot/Publications/2017/03/1750/0) as well as add to the evidence 
base for the development of future policies.  
 
7) Lastly, evidence suggests that the environmental risk factors for schizophrenia may 
also increase risk for other neurodevelopmental disorders. To illustrate, effects of 
variations in birth weight (and other OCs) on cortical structure have been found in a 
range of psychiatric and neurodevelopmental disorders  (Buoli et al., 2016, Haukvik 
et al., 2014, Abel et al., 2010). In addition, intercranial volume has been associated 
with genetic risk variants for attention deficit hyperactivity and autism spectrum 
disorders (Lee et al., 2016).  Hence, assessing associations between cortical structure 







5.4 General Conclusions 
In summation, this thesis outlined a collection of novel studies which attempted to disentangle 
the link between environmental and genetic risk factors for schizophrenia and cortical 
structure. Linear and mixed-method modelling, GWAS, and MR analyses were all employed 
to achieve this goal. Importantly, each chapter evidenced that both environmental and genetic 
risk factors associated with one or more cortical metrics. Furthermore, although the studies 
presented within this thesis suggest these factors impact upon the brain independently the 
role of G × E interactions could not be fully established. A limitation of this body of work pertains 
to the inability to determine at what point in the neurodevelopmental process these factors 
impact the brain or the direct relationship they have with schizophrenia development. 
However, finding evidence of links between schizophrenia risk factors and cortical structure 
provides us with an important building block upon which to determine the answers to these 
questions. Moreover, it has been recently suggested that the only way to improve clinical 
outcomes is to use early detection approaches, which consider complex models (incorporating 
all of the potential schizophrenia risk variables), integrated with clinical frameworks which 
highlight preventative interventions and are implemented by national health services (Fusar-
Poli et al., 2017). Applying the techniques outlined in the current thesis, to larger, longitudinal, 
prospective samples, as well as developing a more thorough investigation into individual 
environmental risk factors for schizophrenia will be an important starting point in this 
endeavour. Future research thus has the potential to identify meaningful, modifiable 
environmental risk factors for interventions to be targeted towards and, potentially, slow or 
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